Structural and Functional characterization of the Arabidopsis thaliana Voltage Dependent Anion Channel 1 and the Kinesin-like mKlp2 proteins by Boulbrima, Alexandre
U n iv er s i ty o f  H u d d e r s f i e l d  R e p o s i t ory
Boulb ri m a,  Alexan d r e
S t r u c t u r al  a n d  F u nc tion al ch a r a c t e riza tion  of t h e  Arabidopsis  t h alian a  Volta g e  
Dep e n d e n t  Anion  Ch a n n el  1  a n d  t h e  Kinesin-like  mKlp2  p ro t eins
Ori g i n a l  Cita t i o n
Boulb ri m a,  Alexan d r e  (201 9) S t r uc t u r al  a n d  F u n c tion al  ch a r a c t e riza tion  of t h e  
Arabidopsis  t h alia n a  Volta g e  De p e n d e n t  Anion Ch a n n el  1  a n d  t h e  Kinesin-like  
mKlp2  p ro t eins.  Docto r al t h e sis,  U nive r si ty of H u d d e r sfield.  
This  ve r sion  is available  a t  h t t p:// ep rin t s .h u d. ac.uk/id/ ep rin t/351 2 9/
The  U nive r si ty Re posi to ry is a  digi t al  collec tion  of t h e  r e s e a r c h  ou t p u t  of t h e
U nive r si ty, available  on  Op e n  Access .  Copyrig h t  a n d  Mo r al  Righ t s  for  t h e  
it e m s
on  t hi s  si t e  a r e  r e t ain e d  by t h e  individu al a u t ho r  a n d/o r  o t h e r  copyrigh t  
ow n e r s .
U s e r s  m ay  a cc e s s  full it e m s  fr e e  of c h a r g e;  copie s  of full t ex t  it e m s  g e n e r ally
c a n  b e  r e p ro d uc e d,  dis pl aye d  o r  p e rfo r m e d  a n d  given  to  t hi rd  p a r ti e s  in a ny
for m a t  o r  m e diu m  for  p e r son al  r e s e a r c h  o r  s t u dy, e d u c a tion al  o r  no t-for-p rofi t
p u r pos es  wi tho u t  p rio r  p e r mission  o r  c h a r g e ,  p rovide d:
• The  a u t ho r s,  ti tl e  a n d  full bibliog r a p hic  d e t ails  is c r e di t e d  in a ny copy;
• A hyp e rlink  a n d/o r  URL is includ e d  for  t h e  o riginal m e t a d a t a  p a g e;  a n d
• The  con t e n t  is no t  c h a n g e d  in a ny w ay.
For  m o r e  info r m a tion,  including  ou r  policy a n d  s u b mission  p roc e d u r e ,  ple a s e
con t ac t  t h e  Re posi to ry Tea m  a t :  E. m ailbox@h u d.ac.uk.






Structural and Functional characterization of the Arabidopsis thaliana 












A thesis submitted to the University of Huddersfield 
In partial fulfilment of the requirements for 









Copyright declaration  
1. The author of this thesis (including any appendices and/or schedules to this thesis) owns any copyright 
in it (the “Copyright”) and he has given The University of Huddersfield the right to use such Copyright 
for any administrative, promotional, educational and/or teaching purposes.  
2. Copies of this thesis, either in full or in extracts, may be made only in accordance with the regulations 
of the University Library. Details of these regulations may be obtained from the Librarian. This page 
must form part of any such copies made.  
3. The ownership of any patents, designs, trademarks and any and all other intellectual property rights 
except for the Copyright (the “Intellectual Property Rights”) and any reproductions of copyright works, 
for example graphs and tables (“Reproductions”), which may be described in this thesis, may not be 
owned by the author and may be owned by third parties. Such Intellectual Property Rights and 
Reproductions cannot and must not be made available for use without the prior written permission of 





The Voltage Dependent Anion Channel (VDAC) is a well characterized 
mitochondrial porin, known to participate in multiple cellular processes, ensuring the 
transport of ions, ATP, ADP and proteins of the respiratory chain between 
intermembrane space (IMS) and the cytosol. Hence, their abundance and strategic 
localization in the Outer Mitochondrial Membrane (OMM) cast them as a gatekeeper 
for the transit of ions and metabolites between the mitochondria and the cytosol. 
These channels were shown to exhibit a strong response to a variation of current, 
with frequent opening and closure of the channel, and the conservation in their three-
dimensional structure attest to their essential role. The study of plant VDACs could 
offer interesting insights into the cellular and sub-cellular functions of the channel, 
as the importance of VDACs in plant development, fertility and physiology, was only 
recently been uncovered. Filling this knowledge gap on plant VDAC could greatly 
enrich our understanding of VDAC physiology in all eukaryotes. 
Here, we report the successful purification of native and mutant Arabidopsis thaliana 
VDAC1 proteins. We highlight micelle-embedded AtVDAC structures by Small 
Angle X-Ray Scattering in 0.1 % (v/v) LDAO and show that in vitro refolded 
AtVDAC1 is mostly composed of beta sheets with a small helicity in circular 
dichroism experiments, in harmony with previous observations on eukaryotic 
VDACs. We demonstrate that the AtVDAC1 channel can exhibit voltage mediated 
gating activity when incorporated into a lipid bilayer, with an open state S0 
conductance of 0.54 nS and at least two closed states, S1 and S2, with conductances 
of 0.43 nS and 0.31 nS, respectively, close to those reported for other VDACs in 
similar salt concentrations. We also attempt to understand its sensing ability and 
denote a current-mediated preference for S1 state at -20 mV. Finally, we introduce a 
new parameter for the electrophysiological characterisation of the channel, the 
“power of charge” and report similar transfer of charges at -20 mV and -40 mV 
despite the lower gating activity associated with the S2 state. 
In parallel, a potential AtVDAC1-binding partner, mKlp2C-Ter (a truncated version 
of a mitochondria-restricted kinesin-like protein from A. thaliana), was also 
heterologously expressed, purified and characterised. We report its behaviour in 
solution using SAXS, and preliminary functional characterization by Isothermal-
Titration Calorimetry (ITC), highlighting an ability to bind zinc ions. These first 
steps constitute the groundwork for future binding studies focusing on AtVDAC1 
interaction with cytosolic partners, and the molecular and electro-physiological 
consequences of these interactions. 
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1. Chapter 1: Introduction 
 
Originally discovered in the late 19th century and called bioblast by Richard Altmann (Ernster and Schatz 
1981), the mitochondrion is one of the main organelles in eukaryotic cells. Early observations lead to 
believe it was composed of protein and lipids. Sometimes called “grana”, it was soon named 
“mitochondrion” by Carl Benda in 1890. It became apparent early that the organelle was associated with 
respiration in cells.  
The process of respiration was demonstrated first in 1939 by using minced muscle cells (Belitser and 
Tsybakova 1939). Two years later, Alfred Lipmann elaborated the concept that energy was being 
associated with Adenosine phosphate molecules (ADP and ATP) (Lipmann 1941). Further investigation 
and theories were elaborated during the next decade, but the involvement of the mitochondrion in this 
cellular process was still unknown (Ernster and Schatz 1981).  
The introduction of newer methods of tissue fractionation by Albert Claude allowed mitochondria to be 
isolated (Claude and Fullam 1945). This helped greatly in the biochemical characterization of 
mitochondria alone. Consequently, many enzymes such as the cytochrome oxidase were proven to be 
restricted exclusively to  mitochondria (Ernster and Schatz 1981). In 1948, discoveries highlighted the 
mitochondrion as the site of oxidative phosphorylation in eukaryotes (Kennedy and Lehninger 1948). 
Over the past 50 years, great progress has been in the description, composition and characterization of 
mitochondria. In summary (Figure 1.1), the outer mitochondrial membrane surrounding the organelle 
was measured at 60 to 75 angstroms (Å) thick and has a protein-to-phospholipid ratio like that of the 
cell plasma membrane (1:1 weight). It comprises two bilayers, probably resulting from the 
endosymbiosis of a proteobacterium into another bacterium (Thrash, Boyd et al. 2011).  
As the “energy factories” of the cell, mitochondria are involved in the production of energy in the form 
of ATP, via the citric acid cycle (Krebs cycle) and the oxidative phosphorylation. In cell development, 
the mitochondrion is essential, providing the necessary energy for cellular growth (Teixeira, Sanchez et 
21 
 
al. 2015). Furthermore, mitochondria are involved in numerous pathways in the cell such as those of the 
fatty acid metabolism, as well as those of calcium storage, programmed cell death (apoptosis) and the 
defence against pathogens(Greenberg 1996). 
 
Figure 1.1 Schematic representation of a mitochondrion with its essential features. Composed of two bilayers, 
the outer mitochondrial membrane (OMM) and inner mitochondrial membrane (IMM), the mitochondrion serves 
as the energy factory of the cell. ATP (red dots) is produced via the oxidative phosphorylation of ADP and Pi 
(yellow dots) catalysed by the ATP synthase (yellow). The different elements necessary for this reaction are 
produced via the Krebs Cycle (red), and series of complexes in the IMM such as the Cytochrome C (black). The 
transport across the membrane is achieved through specific channels (VDAC, in blue) for small reagents, or 
translocases (green) in the case of bigger proteins, pro-proteins and complexes. Most of its mitochondrial DNA 
(mtDNA) has been transferred to the nucleus, except for few genes. 
 
Structurally, the mitochondrion contains large numbers of membrane proteins called porins, amongst 
which the most abundant and major trafficking protein is the voltage-dependent anion channel (VDAC) 
(Colombini, Blachly-Dyson et al. 1996). Additional proteins such a translocases (Figure 1.1) can also 
be found but in a much lower concentration. The VDAC is the primary transporter of nucleotides, ions 
and metabolites between the cytosol and the intermembrane space (Blachly-Dyson and Forte , 
Hoogenboom, Suda et al. 2007). Larger proteins generally enter the mitochondrion with the help of a 
22 
 
N-terminus signal sequence, often binding to specific protein complexes called translocases (the 
complex TIM/TOM being the most famous), which will facilitate their transport across the membrane 





The programmed cell death (PCD) or apoptosis is a process involving multiple cascades with 
fundamental cellular consequences such as DNA degradation (Bortner, Oldenburg et al. 1995), 
proteolysis (Solary, Eymin et al. 1998) and membrane permeabilization (Henry-Mowatt, Dive et al. 
2004). It can be initiated by two signalling pathways, extrinsically or intrinsically (Elmore 2007) (Figure 
1.2).  
On one hand, the extrinsic pathway is characterized by the binding of extracellular signals, such as the 
tumour necrosis factor (TNF), the tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) 
and the apoptosis antigen-1 ligand (FASL), to specific receptors (death receptors), like the tumour 
necrosis factor receptor 1 (TNFR1) and the apoptosis antigen-1 FAS (Iqbal, Ataur Rahman et al. 2015). 
The binding of the ligand to its receptor will induce the recruitment of an adaptor protein as well as the 
initiating procaspase 8 to the cytoplasmic domain of the death receptor. Upon formation of this complex 
named the death-inducing signalling complex (DISC), the procaspase 8 will be activated (by auto-
proteolysis), converting it into a mature caspase 8 (Kantari and Walczak 2011). The latter will then 
activate additional caspases (namely 3, 7 and 6) (Slee, Adrain et al. 2001), triggering apoptosis, which 
will result in a proteolysis and DNA degradation in the cell, ultimately leading to cell death. 
On the other hand, the intrinsic pathway can be triggered by intracellular stress signals, most notably by 
oxidative stress or DNA damage (Ott, Gogvadze et al. 2007). Then, the mitochondrial stress will lead 
to mitochondrial permeabilization and the subsequent release of inter-membrane apoptogenic proteins 
such as the Cytochrome C (CytC), the Second Mitochondria-derived Activator of Caspases/direct IAP 
binding protein with low pI complex (Smac/DIABLO) and the apoptosis inducing factor (AIF) (Li, 
Nijhawan et al. 1997, Verhagen, Ekert et al. 2000, Li, Srinivasula et al. 2002, Suen, Norris et al. 2008). 
As a result, the CytC will then interact with the apoptotic protease-activating factor 1 (Apaf-1) in the 
cytosol, to enhance oligomerization and formation of an apoptosome (Wang 2001). The apoptosome  is 
formed with pro-caspase 9, which will then activate caspases 3 and 7, inducing cell death (Kroemer, 




Figure 1.2 Schematic representation of the extrinsic and intrinsic pathway of the PCD. The extrinsic pathway is characterized by the binding of extracellular signals, such 
as the tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) to specific receptors (death receptors). The binding of the ligand to its receptor will induce the 
recruitment of the initiating procaspase 8 to the cytoplasmic domain of the death receptor, and its activation into mature caspase 8. The latter will convert then activate additional 
caspases (namely 3, 7 and 6), triggering apoptosis, which will result in a proteolysis and DNA degradation in the cell. On the opposite, the intrinsic pathway can be triggered 
by intracellular stress signals, most notably by oxidative stress or DNA damage, that will lead to the mitochondria permeabilization and the subsequent release of intermembrane 
apoptogenic proteins such as the Cytochrome c (CytC). As a result, the CytC will then interact with the apoptotic protease-activating factor 1 (Apaf-1) in the cytosol, to enhance 




The mitochondrion indirectly plays a key role in the regulation of the intrinsic pathway which is 
modulated at different levels (Wang 2001). For example, the release of CytC and caspases from the 
mitochondria can be enhanced by members of the B cell lymphoma 2 (Bcl-2) family of proteins (Cory 
and Adams 2002) and by the Inhibitor of Apoptosis (IAP) family of proteins (Altieri 2010) respectively. 
Furthermore it has been proposed that the release of CytC from mitochondria could be regulated via the 
phosphorylation of its Tyr48 in vivo (Yu, Lee et al. 2008). Indeed, a mutant of a phospho-mimetic CytC 
homolog (which lost its mimetism) failed to induce downstream caspase activation (Pecina, Borisenko 
et al. 2010).  
Additionally, the Apoptosis Inducing Factor (AIF) released from the mitochondria also acts as an 
effector of the programmed cell death (Susin, Lorenzo et al. 1999). Upon release and cleavage of AIF 
by calpains and cathepsins, AIF is then translocated to the nucleus, where it will the induce chromatin 
condensation (Yuste, Moubarak et al. 2005) and the fragmentation of the nuclear DNA (Susin, Lorenzo 
et al. 1999).  
Interestingly, the caspase 8-mediated cleavage of BH3 interacting-domain death agonist (Bid) into tBid 
(truncated Bid), and the subsequent translocation of its C-terminal fragment will cause (either directly 
or indirectly) the release of CytC, inducing apoptosome formation, caspase activation and cell death 
(Wei, Lindsten et al. 2000). Consequently, the extrinsic pathway can be linked to the intrinsic pathway 
through apoptotic signals initiated by death receptors.  
In summary, the cell death is an essential process for the development and growth of many organisms, 
involving multiple interactions and cascades, thus multiple protagonists. For example, PCD mainly 
allows the formation of a mechanical support for the plant to develop (Greenberg 1996, Vanyushin, 
Bakeeva et al. 2004). Without this support, the plant could not sustain its own weight and would not be 
able to reach light, thus its development would be greatly affected (Greenberg 1996, Vanyushin, 





Any damage or dysfunction of mitochondria can compromise their integrity. These alterations of the 
mitochondria play an important role in many human diseases, because of the strong participation of the 
organelle on the overall cell metabolism. 
As a result, mitochondrial disorders often induce neurological disorders (Griffiths and Levy 2017), 
myopathy, diabetes, multiple endocrinopathy, and a wide range of systemic disorders (Zeviani and Di 
Donato 2004). One of the causes for the loss of mitochondrial integrity can arise from mutations in the 
mtDNA, and is a known factor in several diseases such as the Leber's hereditary optic neuropathy, the 
MELAS syndrome and the Kearns-Sayre syndrome (Taylor and Turnbull 2005) (example in Figure 1.3). 
Since the mitochondrial DNA in the zygote is coming from the maternal ovum, a lot of deficiencies are 
maternally inherited. Typically, mitochondrial DNA integrity is compromised by some large mtDNA 
rearrangements in the case of Kearns-Sayre syndrome, or point mutations in the case of the MELAS and 
the Kearns-Sayre syndromes (Zeviani and Di Donato 2004, Taylor and Turnbull 2005).  
 
Figure 1.3 Typical symptom in Kearns-Sayre syndrome.  People with Kearns-Sayre 
syndrome have progressive external ophthalmoplegia, a weakness or paralysis of the eye muscles that impairs eye 
movement and causes drooping eyelids (ptosis).  
 
Similarly, defects in nuclear genes can also lead to the malfunction of mitochondrial proteins, and these 
are associated with several diseases such as Friedreich's ataxia (McCormack, Guttmann et al. 2000) or 
Wilson's disease (Chinnery and Schon 2003). Fortunately, these diseases are generally recessive as they 
can affect vital proteins such the enzymes of the oxidative phosphorylation, like the coenzyme Q10 
deficiency (Zeviani and Di Donato 2004). Overall, the list of diseases is remarkably broad and includes 
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devastating pathologies such as the Parkinson's disease, epilepsy, stroke, cardiovascular disease, 
schizophrenia, dementia, Alzheimer's disease and diabetes (Pieczenik and Neustadt 2007, Lim, Rhein 
et al. 2010).  
 
 
Considering the central role of the mitochondrion in the production of energy necessary for cell survival, 
development and growth, its involvement in cellular aging process has been hinted for decades. A 
number of changes can occur to mitochondria during the aging process (Harman 1972).  
The main hypothesis, commonly referred as the mitochondrial free radical theory of aging, involves 
possible leakage of the high-energy electrons in the respiratory chain to form reactive oxygen species 
(see section 1.7.6), resulting in significant oxidative stress in the mitochondria (Harman 1956, Harman 
1972). This will lead to a high mutation rates in the mitochondrial DNA (mtDNA), ultimately causing 
its degradation (Bugger and Abel 2010). As a result, mutated mtDNA can only be found in about 0.2% 
of very old cells (Boffoli, Scacco et al. 1994). In addition, large deletions in the mitochondrial genome 





Originally discovered in the mid-70s (Colombini and Mannella 2012), the VDAC drew attention from 
the start. Indeed, they are most abundant proteins in the outer mitochondrial membrane (OMM) 
(Burdman, De Mot R Fau - Vanderleyden et al.). 
The abundance and strategic location of VDACs in the OMM, casts them in the role of safe keeper of 
mitochondrial function, as their opening and closure define the route that mitochondria should follow: 
normal respiration or suppression of mitochondrial metabolism leading to apoptosis and cell death 
(Madesh and Hajnóczky 2001).  
 
 
VDACs are ubiquitous among eukaryotes and have been characterized in several eukaryotic species, 
across all kingdoms. Interestingly, the number of isoforms is variable, ranging from one to six, but 
remains consistent in certain clades such as mammals (Blachly-Dyson and Forte 2001). For example, 
Saccharomyces cerevisiae has two isoforms (POR1/YVDAC1 and POR2/YVDAC2) (Cherry, Hong et 
al. 2012), but most plant species have 4 to 5 (Sayers, Barrett et al. 2009). In S. cerevisiae, the two knowns 
isoforms (POR1 and POR2) have been characterized so far, with POR1 being the essential porin and 
POR2 function still to be explained. 
Conversely, mammalian VDACs comprise three different isoforms (VDAC1, VDAC2 and VDAC3). 
These isoforms already display structural difference in their mRNAs due to exons counts (9 exons for 
VDAC1 and VDAC3 as opposed to 10 exons for VDAC2). However, they all have their start codon in 
the second exon, the first one being part of the 5’ UTR of corresponding mRNA (Sayers, Barrett et al. 
2009). 
Overall VDACs are part of a highly conserved family, with above 90 % nucleotide sequence identity 
between mice and human variants for example (Sampson, Lovell et al. 1997, Blachly-Dyson and Forte 
2001). Consequently, VDACs often share highly conserved features, such as their core structure (section 
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1.8) with some minor differences. In terms of evolution, DNA sequences suggest the different isoforms 
arose by gene duplication and evolved later to suit their functions (Young, Bay et al. 2007). To this day, 
some of the main differences remain to be explained or attributed to a specific function, like the N-
terminal extension (around 10 to 12 amino acids) at the end of hVDAC2 protein, likely required for 
NADH permeability (Bauer, Gieschler et al. 2011). Interestingly, hVDAC2 well‐structured N‐terminus 
and its enrichment in thiols confer to this isoform additional regulatory functions, anti‐apoptotic features 
and contribution to gametogenesis (Maurya and Mahalakshmi 2013, Maurya and Mahalakshmi 2016). 
Nevertheless, it was proven that all VDACs share conserved ancestral features, and could mostly be 
inter-changeable, as highlighted by rescue experiments in yeast. In fact, POR2 was actually discovered 
by suppression of POR1 in S. cerevisiae (Blachly-Dyson, Song et al. 1997). It was further demonstrated 
that POR2 did not confer additional activity but rather a possible involvement in additional cellular 
process (Blachly-Dyson, Song et al. 1997). Overall, it seems that the number of isoforms correlates with 
the complexity of the cells and hence the complexity of the organism (Homblé, Krammer et al. 2012). 
 
 
So far, numerous experiments have demonstrated the presence of all isoforms is not always essential for 
cell survival. For example, mice lacking the VDAC2 gene (VDAC2−/−) would die in the embryonic stage, 
as opposed to those lacking VDAC1, and could not be rescued by over-expression of VDAC1 (Shoshan-
Barmatz, De Pinto et al. 2010, Shoshan-Barmatz and Mizrachi 2012, Reddy 2013). Furthermore, there 
are several examples showing a differential location of the various isoform within one organism (Tateda, 
Watanabe et al. 2011). 
In mice, VDAC1 is the most highly expressed and displays a homogenous and high expression pattern 
compared to the other two isoforms, namely VDAC2 and VDAC3 (Sampson, Lovell et al. 1997). This 
is a clear example of differential expression and it suggests a potential variation in the role and 
importance of the different isoforms. Associated with the different expression pattern is the variable 
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localization of these isoforms. Indeed, VDACs are not only be restricted to the OMM, but can be 
exported to different compartments (Sampson, Lovell et al. 1997).  
This hypothesis was later confirmed when hVDAC1, thought to be located exclusively in the OMM, 
was reported to be localized in other cell compartments via immunofluorescence, flow cytometry and 
EM immunogold labelling (De Pinto, Messina et al. 2010). Similarly, hVDAC3 was shown to be located 
in the centriole of certain cells (De Pinto, Guarino et al. 2010). Moreover, these alternate compartments 
would differ depending on the cell type i.e.the plasma membrane of various cells (De Pinto, Messina et 
al. 2010), the sarcoplasmic reticulum of skeletal muscles (Shoshan-Barmatz, Hadad et al. 1996), the 
endoplasmic reticulum (ER) of rat cerebellum (Shoshan-Barmatz, Zalk et al. 2004), were all identified 
as VDAC locations. Following this discovery, the plasma membrane localized VDAC was named 
plasmalemmal VDAC1 ((pl)-VDAC1). Besides, the targeting of the channel to the plasma membrane is 
thought to be induced by a N-terminal signal peptide on the (pl)-VDAC1 (Buettner, Papoutsoglou et al. 
2000). Even though this isoform has clearly been identified in other vicinities than the OMM, its function 
and relevance are still questioned (Akanda, Tofighi et al. 2008). Its proposed roles include the 
rectification of the depolarization-induced chloride channel complex (Reymann, Florke et al. 1995), 
being involved in brain tissue volume regulation (Dermietzel, Hwang et al. 1994), and contributing to 





Plant VDACs have been understudied for many years due to their limited impact in the pharmaceutical 
industry. However, they have been described to act in plant mediation of development, growth or 
defence against pathogens (Greenberg 1996). In consequence, they could potentially be used as tools 
for the modulation of the growth or the defence against pathogens, or an alternative to pesticides. 
When the protein sequences of the four Arabidopsis thaliana VDAC isoforms (AtVDACs) are compared 
to each other, the degree of homology between sequences is variable (from 62% to 83%, see Table 1.1). 
AtVDAC1 is a house-keeping protein and its deletion prevents plant growth; whereas the other three 
seem to display variable sub-cellular location and function (Tateda, Watanabe et al. 2011). An additional 
pseudo-gene called AtVDAC5 has been identified but lacked essential structural elements of the channel 
(a number of beta-strands are missing), hence its relevance remained to be explained.  
Table 1.1 AtVDACs phylogeny. Similarity percentages between the protein sequences of Arabidopsis thaliana 
VDAC isoforms AtVDAC1, AtVDAC2, AtVDAC3 and AtVDAC4. 
 
The N-Terminal sequences of the AtVDACs are remarkably well conserved (Figure 1.4) suggesting a 
conservation of their primary function or structure. It has been demonstrated that the N-Terminal part 
of the sequence could be either located within or outside of the pore (see section 1.6) and that the alpha 
helical tail is known to be essential for ion trafficking in other organisms (Mertins, Psakis et al. 2012). 
Therefore, the high sequence homology could arise from a conservation of either the interactions with 
cytosolic partners, or their ion gating properties.   
 AtVDAC1 AtVDAC2 AtDAC3 AtVDAC4 
AtVDAC1  69% 83% 63% 
AtVDAC2 69%  65% 64% 
AtVDAC3 83% 65%  62% 




Figure 1.4 N-Terminal tail sequence alignment of AtVDACs. Protein sequence alignment of the first 80 amino 
acids of the Arabidopsis thaliana VDAC isoforms 1 to 4. Amino acids shared by all AtVDACs are shown in red. 
Isoforms are sorted out by the degree of similarity they share. Hence AtVDAC1 and AtVDAC3 are highly similar 
in their N-terminal sequence, and share a common feature known as the mitochondrial porin signal (MPS) later in 
the sequence (not shown).    
 
In plants, e.g. A. thaliana, some of its isoforms are restricted strictly to the mitochondrion (AtVDAC1 
and AtVDAC3) whereas AtVDAC2 and 4 can also be exported in other compartments, showing a 
uniform cellular expression (Tateda, Watanabe et al. 2011). Moreover, AtVDAC3 is weakly expressed 
and only found in leaf tips of seedlings, shoot meristems, and anthers, whereas the other three isoforms 
are expressed more ubiquitously (Tateda, Watanabe et al. 2011). Although AtVDAC1 and AtVDAC3 
share a common mitochondrial porin signal (MPS) in their C-Terminal region, which allows their 
restriction to the mitochondrial compartment (Tateda, Watanabe et al. 2011), only AtVDAC1 is essential 
for plant growth. This suggest AtVDAC3 might play a different role in plant metabolism, whereas 
AtVDAC1, AtVDAC2 and AtVDAC4 are already known to also play important roles in the reproductive 
stage (Tateda, Watanabe et al. 2011). 
In summary, plant VDAC isoforms must be exported to the right compartment (by the inclusion of 
targeting signals) so that they can interact with their cytoplasmic partners. these protein-protein 
interactions may differ from one compartment to another. Therefore, the VDACs from A. thaliana 
(AtVDAC1, AtVDAC2, AtVDAC3 and AtVDAC4) could provide interesting insights into Voltage 
dependent Channels’ panel of functions in the cell and the molecular interactions that drive the binding 









In the past 35 years, numerous experiments have been conducted to probe the structure of VDACs. 
Noticeably, the predicted structure of VDACs (in all kingdoms) always consists of a core of 19- to 20-
beta strands and an N-terminal tail (Figure 1.5, yellow and blue respectively). This great degree of 
structural conservation is reflected in all kingdoms, as illustrated by the comparison of the predicted 
secondary structures of S. cerevisae, Homo sapiens and A. thaliana (Figure 1.5). 
 
Figure 1.5 Core structure of Voltage-dependant anion channels (VDACs). 2D representation of VDACs 
structure in different organisms: S. cerevisae, H. sapiens and A. thaliana. This structure are based on structural 
simulations from Jpred (Drozdetskiy, Cole et al. 2015) and Forte webserver (Tomii and Akiyama 2004). 
Intermembrane segments (beta-barrels) are shown in yellow, whereas the N-terminal tail is circled in blue. 
 
Different structural experiments have been conducted over the years. In 2008, the three-dimensional 
structure of VDAC isoform 1 was characterized at the atomic resolution by three different experimental 
methods (Bayrhuber, Meins et al. 2008, Hiller, Garces et al. 2008, Ujwal, Cascio et al. 2008). More 
precisely, the structure of the human VDAC1 (hVDAC1) was solved by nuclear magnetic resonance 
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spectroscopy (NMR) (Hiller, Garces et al. 2008), as well as a combined approach using nuclear magnetic 
resonance spectroscopy and X-ray crystallography (Bayrhuber, Meins et al. 2008). 
 
Figure 1.6 Three-dimensional structure of mouse mVDAC1. Crystal structure of the mouse VDAC1 3EMN at 
2.3 Å resolution. Residues N55, V130, S161 and V227, different from the human hVDAC1, are represented in red 
(displayed using Pymol (L DeLano 2002)). 
 
Recently, another mammalian VDAC, the mouse VDAC1 (mVDAC1), had its structure solved by X-
ray crystallography (Ujwal, Cascio et al. 2008). The mouse mVDAC1 is highly similar to hVDAC1, 
with the exception of four amino acids (T55N, M130V, A161S and I227V), all located within or in close 













Figure 1.7 Three-dimensional structures of VDACs. Known three-dimensional structures of VDAC proteins 
from multiple species  (displayed using Pymol (L DeLano 2002)). (A) Solution NMR structure of hVDAC1 in 
green. (B) Crystal structure of the mouse VDAC1 3EMN at 2.3 Å resolution, in blue. (C) Crystal structure of the 
zebrafish VDAC2 zfVDAC2 at 2.8 Å resolution, in orange. (D) Dimer structure of hVDAC1 5XDO (in C222 
space group) at 3.1 Å resolution in light green.  
 
The VDAC crystal structures are fairly identical and feature the expected 19-stranded beta-barrel and 
the N-terminal alpha-helix, positioned horizontally midway within the pore (Ujwal, Cascio et al. 2008). 
This odd number of strands is characteristic of VDAC proteins, unlike other known transmembrane 
beta-barrels (Omp channels for example). Hence the barrel closure is dependent on parallel hydrogen 
bonding between strands 1 and 19, which constitute a weak point in the barrel structure (Bayrhuber, 
Meins et al. 2008, Hiller, Abramson et al. 2010). Additionally, the N-terminal helix is necessary for the 
preservation of a cylindrical barrel structure in hVDAC1, as well as fundamental functions such as ion 




gating (Geula, Ben-Hail et al. 2012). Later studies further improved our understanding of the VDAC1 
structure and allowed the identification of structurally or functionally important amino acid residues 
(Shanmugavadivu, Apell et al. 2007, Aram, Geula et al. 2010, Deniaud, Liguori et al. 2010, Reina, 
Palermo et al. 2010). For example, replacing glycine residues in the N-terminal domain provides the 
flexibility needed for N-terminal translocation from the internal pore to the channel face, to allow 
interaction with anti-apoptotic partners such as Bcl-2 (Geula, Ben-Hail et al. 2012). On the opposite, 
two cysteines residues were investigated in rat VDAC1, but were shown to be required neither for 
apoptosis nor for VDAC1 oligomerization (Aram, Geula et al. 2010). 
In contrast to VDAC1, the three-dimensional structure of VDAC2 and 3 have not been yet fully 
determined in human or mouse. Recently, the structure of zebrafish VDAC2 was resolved at 2.8 Å 
resolution in solution, using double electron–electron resonance spectroscopy and cross-linking 
experiments. A surprising outcome of this study was the concrete evidence that VDAC2 could be found 
as a dimer (Schredelseker, Paz et al. 2014), although the nature of the experiment (crystallography) 
might enhance this phenomenon.  
The crystal or NMR structures of VDACs (Figure 1.7) confirmed the great identity and the associated 
high degree of conservation of the structural motifs. Beyond the conservation of their core structure, the 
local content displayed a similar degree of homology (Figure 1.8) . Beta-sheets form the main core of 
the channel, while multiple loops are responsible for linking the various transmembrane strands. Located 
in the lumen of the pore, the N-terminal domain forms a relatively short alpha helix, whose flexibility 
is highly enhanced in solution (compared to its structure in crystals), as shown by hVDAC1 solution 






Figure 1.8 Organisation of secondary structure elements in the solved VDAC structures. Known three-
dimensional structures of VDAC proteins from multiple species and displayed using Pymol (L DeLano 2002), and 
coloured depending on the secondary structure composition; beta-sheets ( yellow), loops ( green) and alpha helix 
( red). (A) Solution NMR structure of hVDAC1. (B) Crystal structure of the mouse VDAC1 3EMN at 2.3 Å 
resolution. (C) Crystal structure of the zebrafish VDAC2 zfVDAC2 at 2.8 Å resolution. (D) Crystallographic 
dimer structure of hVDAC1 5XDO (in C222 space group) at 3.1 Å resolution. 
 
The mouse mVDAC1 3EMN was used to illustrate the overall charge distribution within the protein 
(based on amino acid composition; Figure 1.9). In fact, a great concentration of charges (positive and 
negative) can be found within the pore of mVDAC1, on the inner layer of the beta-barrel as well as on 
the alpha helical N-terminal domain. As expected, the external side of the pore is exposed to the lipidic 
environment of the OMM and does display a much greater concentration of hydrophobic chains. Non-




surprisingly, the loops exhibit a relatively high concentration of charges, potentially helping directing 
ions through the pore or serving as binding platform for potential binding partners.  
 
Figure 1.9 Charge distribution of mVDAC1. Known three-dimensional structure of Mouse mVDAC1 (3EMN) 
displayed using Pymol (L DeLano 2002), and coloured depending electrostatic charge. Positive (in red), negative 
(in blue) and neutral (in white). (A) Side view and Top view (B) of the crystal structure of the mouse VDAC1 
3EMN at 2.3 Å resolution coloured as described above.  
 
Considering the residues after the N-terminal region are mostly involved in the formation of the core 
channel (with the exception of the loops), focus has been greatly directed toward the N-terminal 25 
residues of VDAC1, to understand the functional implications of this domain. So far studies suggested 
this domain can position itself in various manners, such as being exposed to the cytoplasm (De Pinto, 
Messina et al. 2003), crossing the membrane (Colombini 2004) or lying on the membrane surface 
(Reymann, Florke et al. 1995).  
The great flexibility of the N-terminal domain contrasts with the crystal structures obtained to this date. 
In fact, all three-dimensional structures of VDAC1 confirmed that the N-terminal region is mostly alpha 
helical and located inside the pore. It is thought to be only weakly bound to the channel wall, thus 
retaining a high flexibility even within the channel pore (Bayrhuber, Meins et al. 2008, Hiller, Garces 
et al. 2008, Ujwal, Cascio et al. 2008). This is achieved mainly through several hydrogen bonds between 




helical region of this domain is relatively short (around 10 to 15 amino acids) and is positioned within 
the barrel, approximately halfway through the channel pore (Bayrhuber, Meins et al. 2008).  
The position and organisation of the helix was similar in crystal structure of mouse VDAC1, with the 
helical region (amino acids 6 to 20) formed by two segments.  Residues 11-20 were difficult to observe 
by NMR, confirming the expected flexibility of this segment (Hiller, Garces et al. 2008). 
Another important feature of the N-terminal helix of VDAC1 is the presence of a great number of 
glycine residues (21GlyTyrGlyPheGly25) (Colombini and Mannella 2012, Shoshan-Barmatz and 
Mizrachi 2012), which is thought to provide the flexibility required for N-terminal domain translocation 
out of the internal pore of the channel (Geula, Ben-Hail et al. 2012). Furthermore, the portion that 
connects the N-terminal domain to the first beta-strand of the barrel is highly conserved among 
mammals (Summers and Court 2010). However, despite the “GlyTyrGlyPheGly” motif being conserved 
in mammalian VDAC1s (Ujwal, Cascio et al. 2008) (as well as in Caenorhabditis elegans), it is not 
present in yeast, indicating an evolutionary divergence (Summers and Court 2010). 
Further investigations suggested that the N-terminal region of VDAC1 exhibits a dynamic equilibrium, 
being either located within the pore or outside of the channel, on the cytoplasmic side of the OMM 
(Geula, Ben-Hail et al. 2012). For example, the use of anti-VDAC1 antibodies targeting the N-terminal 
region highlighted an interaction with membrane-bound VDAC1, indicating this portion can also be 
accessible, thus possibly located outside the pore (Gincel, Silberberg Sd Fau - Shoshan-Barmatz et al. , 
Junankar, Dulhunty et al. 1995, Abu-Hamad, Sivan et al. 2006).  
Moreover, the mobility and location of the N-terminal domain has been proven to be essential in multiple 
processes such as interacting with the anti-apoptotic and pro-survival factors, hexokinase Bcl2, (HK)-I 
and HK-II (Abu-Hamad, Arbel et al. 2009, Geula, Ben-Hail et al. 2012) or voltage gating (Popp, Court 
et al. 1996, Mannella 1997, Koppel, Kinnally et al. 1998) and. For example, N-terminal-truncated 
murine VDAC1 exhibited no voltage dependence but still displayed high conductance at different 
membrane potentials (Popp, Court et al. 1996, Koppel, Kinnally et al. 1998, Abu-Hamad, Arbel et al. 
2009). Supporting evidence was also offered from mutagenesis experiments, where mutations in the 
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alpha-helix of the Yeast VDAC led to a modulation the voltage-sensing mechanism of the channel 
(Thomas, Blachly-Dyson et al. 1993). 
In summary, Voltage-dependent anion channels generally comprise 19 beta-strands forming 
transmembrane domains and an alpha-helix at the beginning of the sequence, inserting itself into the 
lumen of the barrel protein (Figure 1.8). When predicting the structure of a VDAC using bioinformatics, 
the number of transmembrane domains can vary from 18 to 19 depending on the software flexibility 
(Figure 1.5). Typically, NMR experiments and/or X-ray crystallography experiments are conducted to 
finally uncover the structural features of a specific VDAC, thus leading to changes in the structural 
paradigm of these proteins. 
 
 
To this date, no crystal structure has yet been published for any plant VDACs. In the case of A.thaliana, 
the comparison of the predicted structures demonstrates the high degree of sequence and structural 
homology. It is defined mainly by the pore, consisting of 19 beta-strands, whereas most differences are 
concentrated on the loops (or the edges of the beta-strands), which are expected to form potential binding 
sites for interactions with cytosolic partners. An example is given in Figure 1.10, with predicted structure 
of AtVDAC1, generated by homology modelling using SWISS-Model workspace (Artimo, 
Jonnalagedda et al. 2012)) with 3EMN (mouse VDAC) as template. The amino acids differing in 
AtVDAC2 were highlighted (Figure 1.10, green) on the AtVDAC1 model, and proved to be mostly on 





Figure 1.10 Predicted 3D-model comparisons of AtVDAC1 and AtVDAC2. Structure of AtVDAC1 obtained 
using the Expasy server for structural modelling by homology (SWISS-Model workspace (Artimo, Jonnalagedda 
et al. 2012)) with 3EMN (mouse VDAC) as template, and shown using Pymol (L DeLano 2002). Common amino 
acids between AtVDAC1&2 are shown in red. Different amino acids are in green. 
 
In parallel, all four AtVDAC structures were obtained as above, by homology modelling using 
mVDAC1 3EMN as a template, and compared (Figure 1.11). No dramatic changes could be observed 
when superposing the structures. Minor conformational changes, mostly in the loops linking the 
transmembrane domains, can be distinguished, but again not to a dramatic extent. These minor 




Figure 1.11 Predicted 3D-models of AtVDAC1-4 by homology modelling. Structures of the four AtVDACs 
were obtained using the Expasy server for structural modelling by homology (SWISS-Model workspace (Artimo, 
Jonnalagedda et al. 2012)) with 3EMN (mouse VDAC) as template, and shown using Pymol (L DeLano 2002). 
AtVDAC1, AtVDAC2, AtVDAC3 and AtVDAC4 are shown in green, blue, red and yellow respectively. 
 






The main role of the Voltage dependent anion channel is the regulation of mitochondrial osmosis by 
ensuring the transport of ions across the membrane (Colombini 1989). The characterization of VDACs 
conductance has been in progress for over 30 years, with numerous examples. In humans, the three 
isoforms share structural and functional similarities despite different expression and location patterns 
(see section 1.5.2) (Engelhardt, Meins et al. 2007, De Pinto, Guarino et al. 2010, Yu, Raschle et al. 2012, 
Maurya and Mahalakshmi 2013). The Planar Lipid Bilayer assay (PLB), or Black Lipid membrane 
(BLM), is a powerful method used to probe the electrophysiological behaviour of VDAC channels. 
Such experiments were undertaken for hVDAC1 and hVDAC2 and demonstrated channel activity upon 
reconstitution into lipid bilayers (Xu, Decker et al. 1999). More recently, the third isoform (hVDAC3) 
was also characterized by BLM but exhibited only slightly voltage-dependent conductance (Checchetto, 
Reina et al. 2014). Additional assays were performed on other organisms, such as the mouse mVDAC1 
(Mertins, Psakis et al. 2012), to improve our understanding of the channel gating behaviour. 
Overall, VDAC channels are highly dependent on the voltage across the membrane, as the latter 
modulates the ion-selectivity of the channel (Hodge and Colombini 1997). This phenomenon is known 
as voltage dependence and is defined by a response of the channel to the application of a membrane 
potential. Typically, the channel will open and close upon application of a voltage, allowing the passage 
of ions in the directions of the current or in the opposite direction. This last parameter is dependent on 
the ability of the channel to either conduct cations, anions or both (Hodge and Colombini 1997).      
In the main open conductance state, VDAC1 selectivity shift towards anions as opposed to cations, 
whereas the close state can exhibit a preference for cations and a diminished selectivity for anions 
(Colombini, Blachly-Dyson et al. 1996). The closed VDAC1 is mostly permeable to small ions (e.g. 
Cl−, K+, Na+) but to large anions as well, such as glutamate (Gincel, Silberberg et al. 2000), ADP and 
ATP (Rostovtseva and Colombini 1997). Large cations, such as acetylcholine, dopamine (Gincel, 
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Silberberg et al. 2000) and Tris (Benz, Kottke et al. 1990) have also been shown to be transported in 
some cases.  
Overall, VDACs are known to exhibit a linear response to the application of a voltage (Figure 1.12., 
instantaneous VDAC), with an increase in absolute current recorded upon increase of the absolute 
voltage. Nevertheless, a decrease in the observed current can sometimes be observed at high voltages 
applied, ultimately corresponding to the closure of the channel under these conditions (Figure 1.12., 
Steady-state VDAC).  Structural elements as well as modification to the channel (phosphorylation for 
example) can also influence the channel’s response to the voltage.  
 
Figure 1.12 Typical current recording of VDAC. I/V (Ohm) plot for VDAC, under instantaneous (short pulse, 
empty dots) or whole cell current (steady-state, black dots). The decreasing trend at higher voltages is a result from 
a complete closure from the channel (Sabirov et al. 2001). 
 
The N-terminal region of VDAC1, considered a 25 residue-long sequence containing at least an alpha-
helical structure, seems to have an obvious role in the voltage gating of the channel. Over time, this 
hypothesis has been demonstrated in several studies (Peng, Blachly-Dyson et al. 1992, Thomas, Blachly-
Dyson et al. 1993, Popp, Court et al. 1996, Koppel, Kinnally et al. 1998, Abu-Hamad, Arbel et al. 2009, 
Geula, Ben-Hail et al. 2012).  
In S. cerevisiae, VDAC1 (scVDAC) mutants were also tested. It was shown that mutations in the alpha-
helix (Asp16 and Lys20, both highly conserved residues) and in beta-strands β1 to β5 (Lys46, Lys61, 
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Lys65 and Lys84) all affected the voltage-sensing mechanism of the channel (Thomas, Blachly-Dyson 
et al. 1993). A wide range of suggestions have already been proposed to explain the flexibility of the 
domain. Possibly, the N-terminal domain could be part (to some extend) of the channel wall but act as 
well as a voltage sensor. Finally, its ideal location within the centre of the pore can either allow or 
prevent the passage of ions and other metabolites through the VDAC channel (Colombini, Blachly-
Dyson et al. 1996, Koppel, Kinnally et al. 1998).  
For example, the voltage dependence of the channel was abolished in N-terminal-truncated mutant of 
the mouse VDAC1 (Δ(26)mVDAC1) at any voltages (De Pinto, Reina et al. 2008, Abu-Hamad, Arbel 






An example of a typical BLM recording is given in Figure 1.12 for the mVDAC1 (Mertins, Psakis et al. 
2012). Briefly, the protein is inserted into a lipid bilayer between two compartments filled with either 
symmetric or asymmetric solutions of salt. A voltage is then applied, creating membrane potential, 
resulting in gating activity for the channel. In this instance, two chambers (CP2A and a bilayer chamber 
BCH-22A from Warner Instruments) were both filled with 10 mM Tris/HCl (pH 7.4), 1 M KCl and 5 
mM CaCl2. Protein (7.5–15 µg, resuspended in DMPC) was added to one of the compartments beside 
the planar lipid layer and a membrane potential was created. Current was recorded using a Multi-patch 
700B patch-clamp amplifier connected to a Digidata 1440A A/D converter and traces were visualized 
through the pClamp 10.2 software (Axon Instruments). Data were collected at 5 kHz and sampled at 
200 Hz for analysis.  
 
 
Figure 1.13 Typical current recording of mVDAC1. A. Representative traces of the recorded current during a 
BLM assay on mVDAC1 (Mertins, Psakis, 2012). Different gating activities could be observed at +10 mV and 
+40 mV, and three states could be identified, namely the open state S0 (conductance = 3.94 nS, in blue), and two 
closed states S1 (conductance = 2.61 nS, in red) and S2 (conductance = 1.90 nS, in green). B. Corresponding I/V 
(Ohm) plot for mVDAC1. Colour for the different states (S0, S1 and S2) are as above. 
 
The native channel mVDAC1 exhibited an expected gating behaviour, corresponding to a linear 
response to the application of both positive and negative potentials (Figure 1.12B). Noticeably, the porin 




conductances, denoted S1 and S2. This type of behaviour is typical of VDAC, and perfectly illustrates 
the variety of responses the channel can exhibit when voltage is applied. For reference, the conductance 
calculated of the open state, called S0, was characterized at 3.94 nS, whereas the two closed states S1 
and S2 were reported to be 2.61 nS and 1.90 nS respectively (Mertins, Psakis et al. 2012). These values 
were in close proximity to the previously published VDAC conductance of various organisms (see 
chapter 7, Table 7.1), usually around 4 nS for the open state, and a two-fold lower conductance (around 






As mentioned previously, the voltage-dependent anion channel is responsible not only for the traffic of 
ions across the OMM, but also other metabolites. In fact, VDAC1 has been shown to mediate the influx 
of metabolites such as NADH, pyruvate, succinate and malate into mitochondria and the efflux of newly 
formed molecules stemming from mitochondrial processes such as hemes (Shoshan-Barmatz, De Pinto 
et al. 2010). In the open state, ATP and ADP molecules can transit through VDAC1, allowing the 
exchange of newly produced ATP against ADP from the cytosol (Rostovtseva and Colombini 1997). 
The latter will then be converted to ATP via the oxidative phosphorylation, whereas the former will be 
utilized as energy supply in multiple cell reactions (Bonora, Patergnani et al. 2012, Lu, Huang et al. 
2014). Furthermore, the role of VDAC1 in the cell homeostasis has been demonstrated by down-
regulation of VDAC1 expression, resulting in reduced metabolite exchange between the mitochondrion 
and the cytosol. This greatly inhibited cell growth, and confirmed the previous findings and hypothesis 
(Abu-Hamad, Sivan et al. 2006). An additional layer of regulation comes from the VDAC itself as it is 
capable of limiting the flux of metabolites from and to the mitochondria (Vander Heiden, Chandel et al. 
2000, Holmuhamedov and Lemasters 2009). 
In addition to channelling ATP and ADP, VDAC1 supposedly acts as a binding platform for kinases 
from the cytoplasm. By allowing a close proximity between the enzymes and their substrates, the VDAC 
enhances the use of the metabolites by the Hexokinase 1 (HK1) and the creatine kinase (CrK) to produce 
glucose-6-phosphate and creatine phosphate in brain and muscle, respectively (Dolder, Wendt et al. 
2001). This hypothesis involves the formation of a complex between VDAC1, the creatine kinase and a 
phospho-nucleotide carrier, the adenine nucleotide translocase (ANT) (Dolder, Wendt et al. 2001). In 
parallel, the interaction of VDAC1 with HK1 allows for a cross-talk between glycolysis and oxidative 
phosphorylation (Dolder, Wendt et al. 2001, Sun, Shukair et al. 2008). Recently, dimeric αβ-tubulin was 
shown to block VDAC1 conductance, regulating its permeability to ATP (Gurnev, Rostovtseva et al. 




Reactive oxygen species (ROS) such as hydrogen peroxide H202, superoxide anions 02- and hydroxyls 
are known to be produced during the respiratory chain reactions, taking place in the mitochondria. In 
human mitochondria, ROS represent up to 2 % of the consumed oxygen converted (Murphy 2009). 
When released to the cytosol, ROS are highly reactive molecules that will attack everything from lipid 
to protein and DNA (Ott, Gogvadze et al. 2007). Typically, around 99 percent of the ROS is contained 
and process by mitochondrial enzymes such as the Manganese superoxide dismutase (MnSOD) and 
Copper/zinc superoxide dismutase (Cu/ZnSOD) (Valko, Rhodes et al. 2006, Mailloux, McBride et al. 
2013), but the remaining percent still represent a threat to the cell survival, especially when enhanced 
by a sudden release of ROS from the mitochondria. 
However, the mechanism of transport of ROS from the mitochondria is yet to be unveiled, although a 
hypothesis involving VDAC1 has been formulated, where the latter would mediate the release of ROS 
from the Inter-membrane space (IMS) to the cytosol (Han, Antunes et al. 2002). Furthermore, the closure 
of VDAC1 seemed to cause oxidative stress in the mitochondria, thus reinforcing this theory (Tikunov, 
Johnson et al. 2010). 
ROS are a well-known contributor to cell proliferation and cell death (Buttke and Sandstrom 1994, Patel, 
Day et al. 1996, Fiskum 2000, Yuan and Yankner 2000). ROS have been linked to the release of CytC 
from the mitochondria (Petrosillo, Ruggiero et al. 2001, Petrosillo, Ruggiero et al. 2003). Interestingly, 
the apoptosis induced by superoxide anions 02- was greatly affected when using antibodies targeted at 
VDAC1 or channel inhibitors (Shoshan-Barmatz, Hadad et al. 1996, Madesh and Hajnóczky 2001, 
Simamura, Hirai et al. 2006).  
Finally, the interaction between kinases and VDAC1 was shown to have an effect on the release of ROS 
from the mitochondria (Sun, Shukair et al. 2008). More precisely, over-expressed hexokinase HK-I and 
HK-II bound to VDAC1 induced a decrease in ROS release in HEK cells (Ahmad, Ahmad et al. 2002, 
Bryson, Coy et al. 2002, da-Silva, Gómez-Puyou et al. 2004), as well as protection against cell death 
(Bryson, Coy et al. 2002) . Hence, the interaction between hexokinases and VDAC1 might act as a 





VDAC1 is a necessary component of a protein complex ensuring the cholesterol distribution and 
transport to  mitochondria (Rone, Fan et al. 2009). Therefore, it plays an important role in the altered 
level of cholesterol in Morris hepatoma cells (Campbell and Chan 2008). Indeed, the cholesterol import 
into the mitochondrion is mediated by a complex called the “transduceosome” (Rone, Midzak et al. 
2012). This multi-protein complex is composed by a combination of proteins from the cytosolic and 
from the Outer mitochondrial membrane, namely the steroidogenic acute regulatory protein (StAR), 
translocator protein (TSPO), and VDAC1 (Papadopoulos, Liu et al. 2007, Aghazadeh, Rone et al. 2012, 
Rone, Midzak et al. 2012). 
Moreover, high concentration of cholesterol has been shown to reduce the overall activity of membrane-
associated proteins. Indirectly, this attribute is responsible for the inhibition of a decent number of 
metabolic functions of VDAC1 (Campbell and Chan 2008). In addition, it was suggested that higher 
concentration of cholesterol found in the mitochondria of cancer cells affected the binding of hexokinase 
HK to VDAC1 (Baggetto, Clottes et al. 1992, Pastorino and Hoek 2008). Finally, it was suggested that 
the glycine rich region the N-terminal region of VDAC1 could contain the binding site for cholesterol 
(position 22 to 24) (Thinnes and Burckhardt 2012). 
 
 
It was recently shown that VDAC1 might act as a lipid sensor and associate with additional proteins to 
form a complex allowing the transport of fatty acids through the OMM in rat liver mitochondria (Lee, 
Kerner et al. 2011, Martel, Allouche et al. 2013). In this theory, VDAC could be described as an anchor 
between the outer surface of the OMM and the intermembrane space. Proteins such as the acyl-CoA 
synthetase (ACSL) and the carnitine palmitoyl-transferase 1a (CPT1a) are thought to be part of the 
complex and work closely to convert acyl-CoenzymeA into acylcarnitine (Lee, Kerner et al. 2011).  
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Finally, the biological synthesis of cholesterol, called cholesterogenesis, displayed elevated level in 
various cancer cells (Mares-Perlman and Shrago 1988). Noticeably, cancer cells usually display a two 
to ten-fold increase in mitochondrial cholesterol content, mainly in the OMM, in comparison to liver 
mitochondria (Pedersen 1978, Baggetto, Clottes et al. 1992, Yu, Gong et al. 2005).  
 
Calcium is a known cellular co-factor implicated in many cellular processes, such as the modulation of 
cytosolic calcium signals (Gunter, Buntinas et al. 2000), the secretion (Maechler, Kennedy et al. 1997, 
Lee, Miles et al. 2003), the control of oxidative phosphorylation (Cox and Matlib 1993, Maack, Cortassa 
et al. 2006), the indirect modulation of the glycolysis and the Krebs cycle (Nichols and Denton 1995, 
Martinovich, Golubeva et al. 2012) and the cell death (Giacomello, Drago et al. 2007).   
The transport of calcium into the mitochondria can also be linked to the apoptotic cell death. The high 
level of calcium will enhance the release of the CytC, leading to apoptosis. In cancer cells, calcium can 
also be associated with the high content of reactive oxygen species (ROS) (Martinovich, Golubeva et 
al. 2012). 
However, all known mitochondrial calcium transporters are located within the inner mitochondrial 
membrane (Gincel, Zaid et al. 2001). These transporters are only accessible through the participation of 
VDAC1 in the OMM (Gincel, Zaid et al. 2001, Rapizzi, Pinton et al. 2002, Tan and Colombini 2007). 
Besides, VDAC1 has been shown to exert an actual control of the permeability of OMM to calcium 
(Rapizzi, Pinton et al. 2002, Báthori, Csordás et al. 2006). Interestingly, both open and closed states of 
VDAC1 exhibited different permeability to calcium, with the closed showing a preference for the 
divalent cation (Gincel, Vardi et al. 2002, Tan and Colombini 2007). 
More recently, an additional mechanism involving protein/protein interactions between Bcl-xL and 
VDAC isoforms 1 and 3 was discovered. This interaction can modulate the transfer of calcium into the 
mitochondrion by increasing calcium transfer across the OMM, and is one of many pieces of evidence 
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for the involvement of VDAC1 in the cross-talk between mitochondria and the endoplasmic reticulum 




Early experiments such as the over-expression of VDAC1 were key in demonstrating the ability of the 
channel to induce apoptotic cell death (regardless of cell type) (Godbole, Varghese et al. 2003, Zaid, 
Abu-Hamad et al. 2005, Ghosh, Pandey et al. 2007, Lü, Dong et al. 2007, Abu-Hamad, Zaid et al. 2008). 
More precisely, it has been shown that VDAC1 over-expression in endothelial cells enhanced the 
activation of caspase 9 leading the overproduction of ROS, thus resulting in an increase of the 
endostatin-induced apoptosis (Yuan, Fu et al. 2008).   
Conversely, several functions of the VDAC confer this channel a central role as a gateway to the 
mitochondria, as well as from the mitochondria to the cytosol. Indeed, the release of apoptosis-inducing 
proteins from mitochondria to the cytosol seems to always involve the VDAC channel directly or 
indirectly (Tsujimoto and Shimizu 2002, De Pinto, Messina et al. 2003, Shoshan-Barmatz and Gincel 
2003, Shoshan-Barmatz, Israelson et al. 2006, Shoshan-Barmatz, De Pinto et al. 2010, Golan 2012, 
Shoshan-Barmatz and Ben-Hail 2012). 
Mainly, the involvement of VDAC1 in the multiple processes regulating the release from CytC or its 
maintenance in the mitochondria are a testament to the VDAC1 function as a regulator of apoptosis via 
the mediation of cytochrome C release. Not only was VDAC1 shown to be responsible for the transit 
and release of CytC from proteoliposomes in vitro (Shimizu, Narita et al. 1999, Madesh and Hajnóczky 
2001, Zalk, Israelson et al. 2005), but the use of specific anti-VDAC1 antibodies resulted in the 
inhibition of CytC release, the interaction between Bax (Bcl-2-associated X) and VDAC1 and ultimately 
cell death. (Madesh and Hajnóczky 2001, Shimizu, Matsuoka et al. 2001, Zheng, Shi et al. 2003). 
Similarly, in mutant yeast, VDAC1-deficient mitochondria also displayed a lack of CytC release 
(Shimizu, Narita et al. 1999, Shimizu, Shinohara et al. 2000), thus confirming the central role of VDAC 
in mitochondrial CytC osmosis. 
Ultimately, the restriction of CytC into the mitochondria has been further characterized to include 
additional mediators, such as the Hexokinases or Bcl proteins, and highlighted again the central role of 
VDAC1 in providing a platform for apoptosis inducers or repressors. For example, the interaction 
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between mVDAC1 and Hexokinase HK1 was prevented in mVDAC1 mutants E72Q, E65Q and E188Q 
overexpressing both recombinant proteins in HEK cells (Zaid, Abu-Hamad et al. 2005, Abu-Hamad, 
Zaid et al. 2008). This abolition of the interaction between the VDAC channel and HK1 led to a decrease 
of CytC release and cell death (Abu-Hamad, Zaid et al. 2008). In other cases, the overexpression of HK1 
would indeed protect against apoptosis (Zaid, Abu-Hamad et al. 2005, Abu-Hamad, Zaid et al. 2008). 
Similarly, recombinant Bcl-xL was shown to maintain VDAC in its open configuration, thus promoting 
its permeability to ADP and beta-NADH and preventing CytC release (Vander Heiden, Li et al. 2001). 
In addition, the interaction between Bcl-xL and mVDAC1 and mVDAC3 was also shown to promote 
matrix Calcium accumulation by increasing the transit of calcium across the outer mitochondrial 
membrane (Huang, Hu et al. 2013).  
 
 
Although the diameter of the VDAC1 pore in its open state is about 2.5 nm (Hiller, Garces et al. 2008, 
Colombini 2016), which is sufficient to allow the passage of small molecules such as ions, ATP or other 
nucleotides in or out of the mitochondria, proteins such as CytC are likely to require an additional 
transport mechanism (Colombini 2016).  
The oligomerization of VDAC1, leading to the formation of a large flexible pore (see Figure 1.13), has 
been proposed to explain the ability of CytC to transit between the cytoplasm and the OMM (Zalk, 
Israelson et al. 2005, Abu-Hamad, Arbel et al. 2009, Keinan, Tyomkin et al. 2010, Shoshan-Barmatz, 
De Pinto et al. 2010, Keinan, Pahima et al. 2013, Shoshan-Barmatz, Mizrachi et al. 2013). Interestingly, 
apoptosis induction in human cells lead to VDAC oligomerization (Keinan, Tyomkin et al. 2010). It was 
shown that VDAC1 can shift in from the monomeric toward the oligomeric form in response to various 
apoptosis inducers, regardless of the cell type or apoptosis inducer, including arsenic trioxide, 
staurosporine, etoposide, curcumin, cisplatin, selenite, H2O2, tumour-necrosis factor α, or simply UV 
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light. In that instance, oligomerization was enhanced up to 20-fold, confirming the preference for an 
oligomeric state during apoptosis (Colombini 2016).  
 
 
Figure 1.14 VDAC oligomerization as a gateway for CytC release from the mitochondria. The monomeric 
VDAC (left, in green) will oligomerize to form a supra-molecular assembly allowing the transit of cytochrome 
(CytC) from the IMS to the cytoplasm. 
  
So far, VDAC1 has been demonstrated to be able to exist as higher-order oligomers, such as dimers, 
trimers, tetramers, and hexamers (Shi, Chen et al. 2003, Zalk, Israelson et al. 2005, Gonçalves, 
Buzhynskyy et al. 2007, Hoogenboom, Suda et al. 2007, Malia and Wagner 2007, Keinan, Tyomkin et 
al. 2010, Shoshan-Barmatz, De Pinto et al. 2010). FRET experiments highlighted the dynamicity of the 
oligomerization process, defined by an equilibrium between monomeric and oligomeric forms (Zalk, 
Israelson et al. 2005), whereas atomic force microscopy (AFM) experiments on native VDAC1 and 
chemical cross-linking experiments using both purified and membrane-embedded VDAC1 confirmed  
the assembly of dimers, trimers, tetramers and higher VDAC1 oligomers (Zalk, Israelson et al. 2005, 
Gonçalves, Buzhynskyy et al. 2007, Hoogenboom, Suda et al. 2007). Finally, electron microscopy-based 
analysis of  crystallized OMM highlighted the propensity of VDAC1 channels to be organized into 
ordered arrays of hexamers with inter-channel contacts (Guo, Smith et al. 1995). Recently it was 
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suggested that the particular lipid composition of the OMM, significantly enhances VDAC1 
oligomerization (Betaneli, Petrov et al. 2012).  
In addition to the oligomerization of VDAC channels, an additional theory involving the oligomerization 
of Bax and Bak, and the subsequent formation of a selective large channel, sufficient for CytC release 
across the OMM, has been proposed (Antonsson, Montessuit et al. 2000, Eskes, Desagher et al. 2000, 
Antonsson, Montessuit et al. 2001, Reed 2006). Briefly, Bax is normally found as a monomer in the 
cytosol of cells and its oligomerization is prevented by another regulator named Bcl-2. Upon apoptosis 
induction and activation by tBid (Lovell, Billen et al. 2008), Bax will form large complexes (between 
96 kDa and 260 kDa) that will associate with the mitochondria, and insert into the mitochondrial 
membrane (Bleicken, Classen et al. 2010, Zhang, Zhu et al. 2010), allowing the transit of CytC from the 
mitochondria to the cytosol. Again, its association with VDAC1 to form hetero-oligomers allowing 
CytC release was also suggested (Banerjee and Ghosh 2004). Although multiple pathways and 
mechanisms of CytC release has been proposed, the possibility of them co-existing within a single model 
of cell death is reasonable, and their activation might depend on the cell type and the nature of the 






In normal cells, a number of pro-apoptotic factors such as CytC, Smac/DIABLO and AIF resides in the 
mitochondria, most notably in inter-membrane space (IMS) (Shoshan-Barmatz, Israelson et al. 2006, 
Shoshan-Barmatz, De Pinto et al. 2010, Shoshan-Barmatz and Mizrachi 2012). The mechanism allowing 
the release of these factors during mitochondria-mediated apoptosis still remains unclear, especially 
concerning their transition through the OMM.  
Different models have been proposed, either involving a disruption of OMM integrity by osmotic matrix 
swelling or an increase in OMM permeability due to the formation of a large supramolecular assembly 
allow for the release of proteins, such as CytC (see section 1.8.1).  
The osmotic matrix swelling involves closure of VDAC1 channel which will cause a defect in 
mitochondrial ATP/ADP exchange in the mitochondrial, which will in turn lead to the disruption of the 
OMM and the subsequent release of inter-membrane proteins into the cytosol (Vander Heiden, Chandel 
et al. 2000, Vander Heiden, Li et al. 2001). 
Nevertheless, the main hypothesis involves the formation of a large multi-protein complex called the 
Permeability Transition Pore or PTP. This supramolecular assembly has been demonstrated to 
participate in many cell death scenarios and to serve as a calcium release channel, regulating the 
matrixial level of calcium via its transient or persistent opening, the latter leading to an uncontrolled 
release of calcium (Rasola and Bernardi 2011). High concentration of calcium will in turn depolarizes 
the mitochondria by opening the PTP. The opening this “megapore” will allow the release of IMS 
proteins such as CytC (Crompton 1999, Baumgartner, Gerasimenko et al. 2009), inducing apoptosis and 




Figure 1.15 Simplified model for the Permeability Transition Pore (PTP). Schematic representation of the 
core complex called the PTP, which allows the free exchange of small and large metabolites, pro-apoptotic factors 
(CytC) or water between the cytoplasm, the intermembrane space (IMS) and the mitochondrial matrix. The 
different contributor to this supra-molecular complex are VDAC1 at the OMM, adenine nucleotide translocase 
(ANT) in the IMM, and cyclophilin D (CypD) in the mitochondrial matrix. 
 
The proposed PTP complex is likely composed of VDAC1 at the OMM, adenine nucleotide translocase 
(ANT) in the IMM, and cyclophilin D (CypD), which is present in the mitochondrial matrix (Shoshan-
Barmatz and Gincel 2003, Tsujimoto and Shimizu 2007). The PTP is thought to form a high-
conductance non-specific pore linking the inner and outer mitochondrial membranes (Figure 1.14). Its 
opening is likely to occur in response to over-production of ROS or calcium in the cytosol and will allow 
free transit of water and low-molecular weight metabolites into the mitochondrial matrix. This influx of 
substrates will ultimately provoke mitochondria swelling and the release of pro-apoptotic factors into 







Voltage dependent anion channels (VDACs) are the eukaryotic equivalent of bacterial outer-membrane 
porins (Zeth 2010). Located in the outer-mitochondrial membrane (OMM) (Shoshan-Barmatz and 
Gincel 2003), VDACs allow the exchange of different metabolites, such as ions, ATP, for ADP, Pi and 
other respiratory substrates (e.g. pyruvate, malate) into the mitochondrion (Vanyushin, Bakeeva et al. 
2004, Tan and Colombini 2007).  
Moreover, VDACs are capable of mediating the flux of Ca2+  (Tan and Colombini 2007) or superoxide 
anions (Han, Antunes et al. 2002), and influence the uptake of cholesterol  (Shoshan-Barmatz and Gincel 
2003), essential for multiple signalling cascades in young, normal, aged and diseased cells. This 
exchange is dependent on the ability of the channel to switch between open and closed states with the 
later state being impermeable to substrates like ADP and ATP (Shoshan-Barmatz and Gincel 2003, 
Colombini 2016). The open state of the channel confers predominately anion selectivity and the partially 
or fully closed forms of VDACs conduct cations (Madesh and Hajnóczky 2001). It is believed that 
transient potentials across the OMM (metabolically or inner mitochondrial membrane driven) are 
sufficient to support the channel’s gating in vivo  (Mertins, Psakis et al. 2012). 
The abundance and strategic location of VDACs in the OMM, casts them in the role of a safekeeper of 
mitochondrial function, as their opening and closure define the route that mitochondria should follow: 
normal respiration or suppression of mitochondrial metabolism leading to apoptosis and cell death 
(Madesh and Hajnóczky 2001).  
 
 
The strategic location of VDACs in the OMM implies that there might act as binding partners for 
cytosolic proteins. Mammalian hexokinases have long been described to interact with VDACs, resulting 
in a shift in the susceptibility of mitochondria to pro-apoptotic signals (John 2003, Pastorino and Hoek 
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2008). This can lead to suppression of apoptosis, a mechanism particularly interesting in the study of 
tumours (John 2003).  
In plants, studies using virus-induced gene silencing (VIGS) of a hexokinase-encoding Hxk1 caused 
necrotic lesions on leaves, abnormal leaf morphology, and retarded plant growth in Nicotiana 
benthamiana. It was further demonstrated that the Hexokinase 1 Hxk1 was associated with the 
mitochondria, and this association required the N-terminal membrane anchor (Kim, Lim et al. 2006). 
An interesting discovery concerned the interaction between VDACs and tubulin, the latter acting as an 
inhibitor of VDACs (Rostovtseva and Bezrukov 2012). These findings showed that not only does the 
mitochondria bind to the cytoskeleton (for movement across the cell), but there are other interactions 
involved in the process, leading to a different cascade of reactions. Indeed, VDAC interaction with 
tubulin at the mitochondria–cytosol interface enhances a mechanism of regulation of mitochondrial 
energetics, limiting the uptake of ATP and other metabolites (Rostovtseva and Bezrukov 2012).  
Another member of the cytoskeleton, the kinesins, has been described to interact with VDACs in plants. 
Indeed, the A. thaliana kinesin KP1 specifically interacts with AtVDAC3, regulating the respiration 
during seed germination at low temperatures (Yang, Chen et al. 2011). An example of this interaction 
is given in Figure 1.15 with the colocalization of AtVDAC3 and KP1 using YFP-tagged recombinant 
proteins expressed in A.thaliana. Both proteins colocalised in the mitochondria of the protoplasts, 
confirming the interaction between the channel and the kinesin. This feature casts as well both VDACs 




Figure 1.16 In vivo interaction between AtVDAC3 and Kp1. Taken from Yang et al. (2011)(Yang, Chen et al. 
2011) (A) Co-localisation of the KP1 and VDAC3 complex with mitochondria in Arabidopsis thaliana mesophyll 
protoplasts transformed with the constructs KP1-tail-YFPN and YFPC-VDAC3. The mitochondria were stained 
by MitoTracker. And the scale is given by grey bars (5 μm). (B) Co-localisation of VDAC3 with mitochondria. 
Arabidopsis mesophyll protoplasts transiently overexpressing GFP-VDAC3 were stained as above. 
  
Finally, some of the VDACs features, including specific interactions, are conserved amongst species. 
For example, recent studies showed that members of the apoptosis regulator Bcl (B-cell lymphoma) 
family, which are not present in plants, can interact with plant VDACs (Vander Heiden, Li et al. 2001, 
Godbole, Varghese et al. 2003). 
In summary, members of the hexokinase family, Bcl family and kinesin family all displayed a direct or 
indirect (via the mitochondria) interaction with the VDAC channel from A.thaliana. These families of 
protein can constitute a great foundation for the characterization of potential AtVDAC binding partners, 
and their molecular interactions with the channel. More specifically, the kinesin family of protein will 








Kinesins represent a superfamily of microtubule-based motor proteins that are essential in the cell. They 
perform various functions, the most common being the transport of organelles or different “cargos”, 
such as vesicles, super-complexes of proteins, and even chromosomes during the mitosis across the cell 
(Lawrence, Dawe et al. 2004, Hirokawa, Noda et al. 2009). They can contribute to the regulation of 
microtubules (important for mitosis) (Hirokawa, Noda et al. 2009), transcription factor (example of 
Kif7/Gli transcription factor (Cheung, Zhang et al. 2009)) or other proteins such as VDAC (Yang, Chen 
et al. 2011) but the mechanism of action is still unclear (Hirokawa, Noda et al. 2009). In plants, a 
Kinesin-like protein, called KIN-7D, MKRP2 or mKlp2 (accession number; Q8W5R5), contains an 
extended region in its N-Terminal motor domain that has been proven to act as an MTS (mitochondrial 
targeting signal) (Itoh, Fujiwara et al. 2001), thus implying the possibility of AtVDAC protein acting as 
a binding platform for this kinesin. 
 
Kinesins conventionally comprise a heavy chain dimer and two light chains. The heavy chains are 
responsible for the overall structure of the complex; a conventional kinesin can be described as an 
elongated protein, with the head comprising the motor domains that bind to microtubules and allowing 
the movement of the protein, and the tail domains (Hirokawa, Noda et al. 2009). The tail domains, in 
association with the light chains, are responsible for the cargo recognition and binding (Hirokawa, Noda 
et al. 2009). The region linking both main domains (head and tail) is called the stalk domain and allows 







Figure 1.17 Schematic representation of conventional Kinesins structure. The motor domains (blue) are 
contained within the head, whereas the cargo binding sites (red) reside in the tail domain. The stalk is shown as a 
coiled structure (black) formed by the two heavy chains. Light chains are not shown here but are part of the tail, 
enabling substrate specific recognition and binding.    
 
 
In kinesins, the motor domain is responsible for the movement along the microtubules, harbouring both 
the ATP- and microtubule-binding activities (Cross 2004). Several crystal structures have been obtained 
of the motor domain alone and revealed strong structural similarities to the catalytic domain of the actin-
based motor-myosin (Kull, Sablin et al. 1996). Briefly, the motor domain consists primarily of a single 
alpha/beta arrowhead-shaped domain, with a relatively wide nucleotide-binding cleft (Marx, 
Thormählen et al. 1998). It contains four motifs that are common to P-loop containing proteins with a 
Walker fold (Walker, Saraste et al. 1982) such as myosin and G-proteins. The Walker motif can be 
described as GxxxxGKT/S, which forms a phosphate binding loop (P-loop) between the third beta-
strand and the second alpha helix, allowing nucleotide binding via the phosphate chain (Walker, Saraste 
et al. 1982). An example is given in Figure 1.17, with the bound to ADP (Figure 1.17, blue). 





Figure 1. 18 Three-dimensional structure of the human ubiquitous kinesin motor domain. Crystal structure 
of the human ubiquitous kinesin motor domain 1BG2 at 1.8 Å resolution, shown from the front (A) or the side (B) 
of the molecule. A bound ADP molecule is shown in blue (displayed using Pymol (L DeLano 2002)). 
 
The molecular movement, called motility, has been described previously. In summary, kinesin takes 
eight nanometres steps, each time alternating between its two heads (Asbury, Fehr et al. 2003), to move 
along microtubule protofilaments (Svoboda, Schmidt et al. 1993). The presence of ADP or ATP in the 
active site will dictate the conformation adopted by the kinesin motor domain on the microtubules (Cross 
2004). Indeed, kinesin are strongly attached to the protofilaments in the presence of ATP or absence of 






Figure 1.19 Kinesin moving alongside a microtubule. Schematic representation of kinesins moving along a 
microtubule protofilament (in blue). The binding of ATP (in red and black circle) on the first motor domain will 
induce a rotation of the neck linker, displacing the second motor domains upfront. The release of ADP (red dot) 
from the latter will allow this motor domain to strongly bind the microtubule. Finally, the hydrolysis from ATP to 
ADP and the release of pyrophosphate (Pi, black dot) will enhance the detachment of the first motor domain from 
the protofilament, creating movement of the cargo (green) alongside the microtubule.  
The catalytic movement of kinesins alongside microtubules protofilaments is also associated the 
conformational changes of the neck linker, a 15 amino acid peptide at the C-terminal end of the motor 
domains (Rice, Lin et al. 1999). This peptide will adopts a well-defined structure as it docks onto the 
motor domain core, and will switch its orientation from the (-)end toward the microtubule (+)end 
(Asenjo, Krohn et al. 2003). 
 
 
Whereas the head domain is well defined as the microtubule binding and interacting region, the tail 
domain is intrinsically disordered (Seeger and Rice 2012). 
This tail domain is really variable due to the different type of cargos the kinesins have to transport 
(Hirokawa, Noda et al. 2009). For example, the Kinesin-1 has been demonstrated to be involved on the 
intracellular transport of proteins (Xia, Roberts et al. 2003), ribonuclear protein complexes (Kanai, 
Dohmae et al. 2004) and cellular compartment such as Golgi (Echard, Jollivet et al. 1998), Endoplasmic 
Reticulum vesicles (Stauber, Simpson et al. 2006), endosomes (Imamura, Huang et al. 2003) or the 
mitochondria (Nangaku, Sato-Yoshitake et al. 1994, Wozniak, Melzer et al. 2005).  
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The variety of cargo the kinesins can recognize is mainly achieved through the kinesin light chains 
(Hammond, Griffin et al. 2008). Specific motifs known as tetratricopeptide repeat domains (D'Andrea 
and Regan 2003), a versatile protein interaction platform, have been identified to explain this great range 
of adaptative interactions. 
Thus, alternative binding partners (aside from conventional cargos mentioned previously) can be 
identified. The example of KIFC3 (kinesin family member C3 from Mus musculus) highlight this 
feature; this kinesin can interact with the ubiquitin-specific protease USP47, a protease that removes 
ubiquitin chains from substrates and inhibits proteasome-mediated proteolysis (Sako-Kubota, Tanaka et 
al. 2014). The interaction of KIFC3 with USP47 will prevent the latter to remove ubiquitin chains from 
the E-cadherin and recruit it to the adherens junction of the cells. The depletion of either KIFC3 or 
USP47 will both result in cleavage of the E-cadherin, suggesting this interaction plays an important role  





Plant VDACs have been so far understudied in terms of structural and functional characterization. 
However, recent studies (Tateda, Watanabe et al. 2011) highlighted specific expression patterns of the 
four isoforms of Arabidopsis thaliana. Considering AtVDAC1 has been shown to be essential for cell 
development and growth, this isoform is the primary target for characterization studies focusing on its 
structure and its electrophysiological behaviour. Primary work has already begun with the successful 
cloning of AtVDAC1 gene into an expression vector by Msc Felix Brademann, for the heterologous 
production of AtVDAC1 protein in Escherichia coli cells.   
In addition to its essential function as an ion transporter, VDAC has been shown to interact with multiple 
partners such as Bcl protein, Hexokinases or kinesins. Thus, this study aims at providing the groundwork 
for future binding studies, focusing on the interaction of AtVDAC1 with chosen partners. 
On one hand, AtVDAC1 mutants have to be designed to further explore the hypothesis that the channel 
might act as a platform for the aforementioned partners. On the other hand, several hypothetical 
AtVDAC1 partner proteins must be produced to be used in interaction studies with the native channel 
protein and/or its mutants.  
Two specific partners have been identified, namely the Nicotiana Benthamiana Hexokinase 1 and the 
Kinesin-like mKlp2. The former has been shown to relocate to the mitochondria in A.thaliana, caused 
by the presence of an MTS. Due to the history of VDAC interaction with hexokinases, it is highly 
possible the Hexokinase 1 binding to the mitochondria is mediated through interaction with the VDAC 
channel. In a similar fashion, the A.thaliana Kinesin-like mKlp2 and mKlp1 has also been shown to 
relocate to the mitochondria via a possible MTS. Recently, the interaction between AtVDAC3 and the 
mKlp1 isoform was demonstrated, thus leaving the possibility for mKlp2 to use a similar platform to 




In summary, the study will consist in the following steps: 
1.Design of AtVDAC1 mutants and production of constructs by PCR-directed mutagenesis   
2.Cloning of the mKlp2 gene into a suitable expression vector 
3.Subsequent heterologous expression of the different proteins in E.coli BL21 (mKlp2C-Ter) or Omp9 
(AtVDACs) cells 
4.Purification of the protein by a combination of either Ion exchange chromatography or affinity 
chromatography and Size exclusion chromatography. 
5.Structural characterization of all proteins by Small Angle X-ray Scattering and/or Circular Dichroism 
6.Functional characterization of AtVDAC1 protein by Black lipid membrane (BLM) assay 




2. Chapter 2: Materials and Methods 
 
Buffers and media for this study were prepared according to the composition listed in Table 2.1. 
Table 2.1. Buffers and media. 
Buffer/media Composition 
Resuspension buffer (RE) 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 0.2 mM PMSF  
TN buffer 50 mM Tris-HCl (pH 8.0), 100 mM NaCl  
TEN-triton buffer 
50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10 mM EDTA, 
2 % (v/v) Triton X-100  
Denaturation buffer 
25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 100 mM NaCl, 1 
mM EDTA, 10 mM DTT, 6 M Guanidinium chloride  
Refolding buffer 1 
25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 100 mM NaCl, 1 
mM EDTA, 10 % (v/v) Glycerol, 2.29 % (v/v) LDAO  
Refolding buffer 2 
25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 10 mM NaCl, 1 
mM EDTA, 1 mM DTT, 10 % (v/v) Glycerol, 0.12 % 
(v/v) LDAO  
Elution buffer for ion 
exchange chromatography 
(VDACs) 
25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 1 M NaCl, 1 mM 
EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12 % (v/v) 
LDAO  
Elution buffer for size 
exclusion chromatography 
(VDACs) 
25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 100 mM NaCl, 1 
mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12 % 
(v/v) LDAO  
Elution buffer for affinity 
chromatography Ni-Nta 
(mKlp2C-Ter) 
25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) 
Glycerol, 500 mM Imidazole 
Elution buffer for size 
exclusion chromatography 
(mKlp2C-Ter) 
25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) 
Glycerol  
Dialysis Buffer 
25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 




Tryptone 10 g/L, Yeast extract 5 g/L, NaCl 10 g/L. Add 
1.5% Agar if solid (Plates) 
LB Auto-Induction Tryptone 20 g/L, Yeast extract 5 g/L, NaCl 5 g/L 
SOB media Tryptone 20 g/L, Yeast extract 50 g/L, NaCl 0.5 g/L 
Transformation buffer (TB) 
10 mM PIPES, 55 mM MnCl2, 15 mM CaCl2, 250 mM 
KCl 
TBE Buffer 900 mM Tris base, 900 mM Boric acid, 20 mM EDTA, 
12.5 mM NaOH  
SDS Sample Buffer 
(Laemmli) 
0.25 M Tris-HCl (pH 6.8), 0.5 M DTT, 10 % (w/v) SDS, 
50 % (v/v) Glycerol, 0.5 % (w/v) Bromophenol blue 
10x SDS Run Buffer 
(Laemmli) 
250 mM Tris, 2 M Glycine, 1% (w/v) SDS 
SDS-PAGE Coomassie 
Staining Solution 
50 % (v/v) Methanol, 10 % (v/v) Glacial Acetic Acid, 
0.25 % (w/v) Coomassie R-250  
SDS-PAGE Destaining 
Solution 
50 % (v/v) Methanol, 10 % (v/v) Glacial Acetic Acid  
Silver Nitrate Solution 0.1 % (w/v) AgNO3 in dH20 
Developing Solution 3 % (w/v) Na2CO3, 0.05 % (v/v) Formaldehyde  
Silver destaining Solution A 633 mM NaCl, 231 mM Cupric Sulphate  
Silver destaining Solution B 1.75 M Sodium Thiosulfate  
TBS buffer 10 mM Tris-HCl (pH 7.5), 150 mM NaCl  
TBS-Tween buffer 
10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.05 % (v/v) 
Tween  
TBS-Tween/Triton buffer 
10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.05 % (v/v) 
Tween, 0.2 % (v/v) Triton X-100  
Blocking buffer 
0.5 % (w/v) Western blot Blocking reagent from Novex® 
in TBS-tween 
Western Blot transfer buffer 1X blotting buffer from Novex® in 20 % (v/v) methanol  
Thin layer chromatography 
solvent 
63: 35: 5, v/v/v chloroform: methanol: ammonium 
hydroxide 
Black lipid membrane BLM 
buffer 




50 mM Tris-HCl (pH 7.5), 0.1 mM TCEP, 100 mM NaCl, 
3 % (v/v) glycerol 
 
 
The plasmid pET-20b(+) was used as an expression vector in this study, for the cloning of the AtVDACs 
and mKlp2C-Ter genes and the expression of the corresponding recombinant proteins. Its main 




Figure 2.1 pET-20b(+) Plasmid map and cloning region – Overview of the pET-20b(+) vector map and the 
nucleotide sequence of the cloning/expression region, with the associated restriction sites. (Taken from Novagen®)  
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Gene sequences of the Voltage Dependent Anion Channels (AtVDAC1, AtVDAC2 and AtVDAC4) and 
the Kinesin-like mKlp2C-Ter from Arabidopsis thaliana are provided in Table 2.3. The corresponding 
Gene IDs and locus numbers are provided as well. 
Table 2.2 DNA sequences of AtVDACs and mKlp2C-Ter genes. DNA sequences of the genes used in this study, 
provided in FASTA format, as well as their accession number on   
Gene  






















































































The AtVDACs genes were amplified by PCR from plasmid templates harbouring GFP-tagged 
AtVDACs (kindly provided by Prof. T.Kusano from Tohoku University, Japan). The primers used for 
this DNA amplification are reported in Table 2.3. 
Table 2.3 Primers used for the amplification of AtVDACs. Expected sizes of PCR products pre- and post-double 
digests with EcoRI and NdeI, are indicated. The nucleotides responsible for binding EcoRI and NdeI are 
highlighted with a black and red line, respectively.  

























Bacterial strains used in this study and their respective genotype are listed in Table 2.2. The cloning 
stages were performed using Escherichia coli DH5α cells, whereas the expression of the recombinant 
proteins AtVDACs and mKlp2C-Ter was performed in Omp9 and BL21 DE3 cells, respectively. 
Table 2.4 Escherichia coli strains and associated genotypes. E. coli strains used for the production and 
expression of proteins  and their respective genotype . DH5a cells were used to propagate and maintain plasmids, 
Omp9 and BL21 DE3 cells were used for the production and expression of AtVDAC proteins mKlp2C-ter protein, 
respectively.  
E.coli strains Genotype 
DH5α F-φ80lacZ∆M15 ∆(lacZYA-argF) U169 recA1 endA1 hsdR17 (rk-, mk+) phoA 
supE44 λ- thi- 1 gyrA96 relA1 
Omp9 F- ompT hsdSB (rB- mB -) gal dcm (DE3), ∆lamB ompF: :Tn5 ∆ompA ∆ompC 
∆ompN 
BL21 DE3 fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
 
 
Chemically competent cells were prepared based on a previous methodology (Inoue et al.,1990) (Inoue, 
Nojima et al. 1990), known to yield great amounts of competent cells.  
Frozen cells were streaked onto a LB plate and incubated overnight at 37oC. The next morning, 10-12 
large colonies were transferred to 250 mL SOB medium (Table 2.1) in a 2 L flask and incubated at         
18 oC (200 rpm) until an OD600 of 0.6 was reached. Then, the flask was immediately put on ice for at 
least 10 minutes, then moved to a sterile 500 mL Sorval bottle and centrifuged at 6,000g for 10 min (at 
4 oC). Supernatant was discarded, and cells were re-suspended in 80 mL ice-cold transformation buffer 
(TB, Table 2.1) and incubated on ice for 10 minutes. Then, the cells were centrifuged again at 6,000g 
for 10 min (at 4 oC).  Supernatant was discarded, and the final pellet was re-suspended in 20 mL of ice-
cold TB buffer and DMSO (SIGMA®) was added at 7 % (v/v). Following a 10 minute incubation, cells 
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were aliquoted into 1 mL eppendorfs and immediately frozen in liquid nitrogen for long term storage at 
-80 oC. 
 
Storage, expression plasmids and/or plasmids harbouring synthetic genes were routinely used to 
transform E. coli DH5α chemical competent cells. For IPTG inducible expressions, E. coli Omp9 
chemical competent cells were transformed with pET-20b(+)-based expression plasmids. Omp9 cells’ 
advantage is the absence of bacterial porins that could be co-produced, co-refolded and co-purified with 
AtVDACs (Mertins, Psakis et al. 2012). In the case of mKlp2C-Ter, E. coli BL21 (DE3) cells were used 
for overproduction. 
50 µL E. coli DH5α or 200 µL chemically competent (see section 2.3.2) E. coli Omp9 or BL21 (DE3) 
cells were thawed on ice. Following the addition of 1 to 5 µL of desired plasmid (50 ng), cells were 
incubated for 30 minutes on ice. Then, they were heat shocked at 42 °C for 45 seconds and placed back 
immediately on ice for 2 minutes. After adding 800 to 950 µL of LB-medium the solution was incubated 
for 1 hour at 37 °C with shaking at 180 rpm. Cells were subsequently centrifuged for 3 minutes at 3000 
rpm. 800 µL of the supernatant were discarded and cell pellet was resuspended in the remaining volume. 
Cells were then plated onto prepared LB-agar plates containing ampicillin (concentration = 200 µg/mL) 
and incubated overnight at 37 °C. 
 
 
40 mL of LB containing ampicillin (200 µg/ mL) were inoculated with cells harbouring the gene of 
interest and left overnight at 37 °C shaking at 180 rpm. The following day, 2% (v/v) of the overnight 
cultures were used to inoculate 5 flasks of 400 mL LB, supplemented with ampicillin (200 µg/ mL). 
When OD600nm was between 0.4 and 0.6, IPTG was added to a final concentration of 1 mM and cells 
were incubated for 4 hours at 37 °C with shaking (180 rpm). Cultures were then centrifuged 10 minutes 
at 6,500 rpm (7,800g) (Avanti J-26 XPI from Beckmann Coulter®). Supernatant was either collected 
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(in the case of mKlp2C-Ter), or discarded, and pellets (in the case of AtVDACs only) were resuspended 
in a total of 20 to 45 mL of resuspension buffer RE (50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 0.2 mM 
PMSF) and kept overnight at 4 °C.  
 
40 mL of LB containing ampicillin (200 µg/ mL) were inoculated with cells harbouring the gene of 
interest and left overnight at 37 °C shaking at 180 rpm. The following day, 2 % (v/v) of the overnight 
cultures were used to inoculate 5 flasks of 400 mL LB (Auto-Induction), supplemented with ampicillin 
(200 µg/ mL), 4 mL 60 % (v/v) Glycerol, 2 mL 10 % (w/v) Glucose and 10 mL 8% (w/v) Lactose. Cells 
were then incubated for 5 to 6 hours at 37°C with shaking (180 rpm), or overnight at 30°C. Cultures 
were then centrifuged 10 minutes at 6500 rpm (7800g) (Avanti J-26 XPI from Beckmann Coulter®). 
Supernatant was discarded, and pellets were resuspended in a total of 20 to 45 mL of resuspension buffer 







The different AtVDAC genes were amplified by PCR from plasmid templates harbouring GFP-tagged 
AtVDACs (kindly provided by Prof. T.Kusano from Tohoku University, Japan). The genes were 
amplified with primers designed to add EcoRI/NdeI restriction sites to facilitate sub-cloning into 
plasmid pET-20b(+).  Primers used are detailed in Table 2.3 (section 2.2) and the components are listed 
in Table 2.5 (below).  
Table 2.5 PCR components. Volumes and concentrations are indicated. 
Components Volumes Final concentration 
Polymerase buffer 5X 10 µL 1X 
dNTPs 1 µL 200 µM 
DNA template 1 µL <250 ng* 
Forward primer 2.5 µL 0.5 µM 
Reverse primer 2.5 µL 0.5 µM 
Polymerase (Phu®) 0.5 µL 1U/50 µL 
Deionized water Adjust to 50 µL 0.25 µL 
*Typically, 1/10, 1/100 and 1/1000 dilutions of the DNA sample are tested  
 
Components were mixed together according to the recipe in Table 2.5, and the mixture was left in a 





Figure 2.2 PCR parameters. Scheme representing the parameters used for the amplification of the AtVDAC 
genes by PCR. 
 
The correct amplification of the different fragments was analysed by Agarose gel electrophoresis (see 
2.4.6). Once amplified, each fragment was digested with EcoRI/NdeI (Table 2.3). 
 
 
Colony PCR were used to monitor the production of pET-20b(+)AtVDAC1 plasmid from colonies 
picked up from an LB(+amp) plate. This test would serve as a pre-screen for the expression of AtVDAC1 
gene from E.coli Omp9 cells.  
Typically, a single colony would be picked up from an LB plate (+ampicillin at 200 µg/mL) and 
resuspended in 10 µL of dH20. This would serve as the DNA template for the PCR reaction, as 1 µL 
would be used in the PCR mixture (see Table 2.5), and the remaining volume would be used as a primary 
inoculum for the cell cultures. 
 
Prior to insert and vector ligations, DNA fragments (PCR amplified AtVDAC genes (section 2.4.1) and 
pET-20b(+) were digested with EcoRI and NdeI (Table 2.6). Reactions were incubated at 37 °C 




Table 2.6 AtVDAC restriction digest components. Volumes and concentrations are indicated. 
Components Standard overnight digest Quick control digest 
Buffer 10X Cutsmart® 5 µL 1 µL 
DNA 20 to 40 µL 4 µL 
Restriction endonuclease 1 1.25 µL 0.25 µL 
Restriction endonuclease 2 1.25 µL 0.25 µL 
Deionized water Adjust to 50 µL Adjust to 10 µL 
 
Additionally, restriction endonuclease digests were used for the identification of colonies transformed 
with the desired plasmid construct are listed in table 2.5 (for more information on the mutants, see 
section 2.4.5). 
Table 2.7 Restriction endonucleases and their application. 
Enzyme Application Supplier 
XmnI E256Q mutant New England Biolabs ®   
Hpy99I E256L and K260S mutant ThermoFisher ® 
HpaI D258N mutant New England Biolabs ® 
BanII D180S mutant New England Biolabs ® 
HindII D177N mutant New England Biolabs ® 
EcorI Cloning of AtVDACs New England Biolabs ® 






Digested fragments (vector pET-20b(+) and insert AtVDAC genes) were analysed on 1.5% (w/v) agarose 
gel (in 900 mM Tris base, 900 mM Boric acid, 20 mM EDTA, 12.5 mM NaOH). They were then excised 
from the gel and purified using the QIAGEN gel purification Kit®, according to the manufacturer’s 
instructions. 
 
The ligation is the process of covalent linking between two DNA fragments, catalysed by the T4 DNA 
ligase, using cohesive binding. An example is given in Figure 2.2, where the palindromic regions of the 
enzyme EcoR1 can be seen close to each other. This specific pattern is typical of restriction 
endonucleases and can allow (when using two different enzymes) a directed insertion of an insert into 
its respective vector.  
 
Figure 2.3 Example of cohesive joining of fragments with sticky ends. Two fragments of double stranded DNA 
harbouring cohesive nucleotides. The palindromic site is typical of the restriction enzyme EcoRI.  
 
The reaction is performed with various Insert/vector molar ratios ranging from 1:1 to 9:1 depending on 
the reagent concentration, with a minimum of 50ng of vector pET-20b(+). In the case of AtVDACs (on 
average), for a 1:1 molar ratio, the N amount of insert needed (for 50 ng of vector) using a size ratio R 














Equation 2.1 Equation 2.1 Calculation of the amount of insert. The N amount of insert is calculated using the 












Depending on the molar ratio and the concentration of the different DNA preparations, volumes of insert 
and vector are mixed together with a T4 ligase buffer (to a 1X concentration), 1 Unit of T4 DNA ligase, 
and water to a total of (10-20 µL). The ligation mix is then incubated for 16 hrs at 16°C and then used 
to transform competent E. coli DH5α cells. 
 
 
Mutagenesis was carried out using the Q5® Site-Directed Mutagenesis Kit from New England Biolabs 
(NEB®), according to the manufacturer’s instructions. Briefly, pET-20b(+) harbouring the AtVDAC1 
gene was used as a PCR template. The AtVDAC1 gene was amplified with back to back primers (Figure 
2.4) containing single to triple point mutations in their sequences (Table 2.6). Successful mutations 
allowed the desired codon alteration and the incorporation of unique restriction endonuclease sites, 
facilitating screening of positive clones. After re-ligation, the newly amplified plasmid would contain 
the mutation of interest. 
 
Figure 2.4 PCR site directed mutagenesis basic principle. Schematic representation of the methodology used 
in the PCR driven mutagenesis. The native plasmid pET-20b(+)AtVDAC1 (left) is amplified by PCR using back 
to back primers (in blue). After ligation the newly amplified plasmid (right) contains the mutation of interest (red 
cross).  
 
In the case of T156C mutant primers, no appropriate unique restriction enzyme binding site could be 
engineered into the AtVDAC1 gene. Consequently, its identity was confirmed by automated DNA 
sequencing performed on a few colonies. For all other mutants, only the positive colonies identified by 
restriction digests would be sent for DNA sequencing (Eurofins®). Results of the DNA sequencing are 







Table 2.8 Mutagenic primers and enzymes used to control nucleotide replacements. Mutated nucleotides 




Agarose gels were prepared in TBE buffer (see section 2.1). Typically, 0.4g of agarose would be mixed 
into 40mL of TBE buffer and warmed in the microwave. Once completely dissolved the agarose solution 
was allowed to cool down briefly before adding SybRsafe reagent (Invitrogen ®) at 1/10000 ratio. Once 
mixed properly, the solution was poured into a gel casting device and left to set for 30 to 40 minutes. 
Once set, the gel was moved into an electrophoresis chamber filled with TBE buffer. Samples and a 1 
kb DNA size ladder from NEB ® would then be loaded into predefined wells and run at 200V for 30min.    
 
Mutation Forward primer Reverse primer Enzyme 
E256Q CAATCTGGACAAGTTGACACAAG TGAAGAATGACTTCGGTTTCCACTC XmnI 
E256L CAATCTCTGGACTCGTCGACACAAAG TGAAGAATGACTTGGGTTTCCACTC Hpy99I 
D258N CTGGAAGTTAACACAAAGTCAA AGATTGTGAAGAATGACTTGGGTT HpaI 
K260S AAGTCGACACATCGTCGATTGACAAGA TCCAGAGATTGTGAAGAATGACTTGGG Hpy99I 
T156C CTGGAAATTTCTGCAAGATCAATGC ACTTGGTGTCAAATGAAACATCAGTAC none 









Resuspended cell pellets (in 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 0.2 mM PMSF) were sonicated 
with a Vibra CellTM sonicator. The sonicator will mechanically disrupt cell membranes and release 
cellular components. The parameters were as follows: 5 seconds of pulse followed by 10 seconds pause 
to dissipate heat generated by the sonication process, for 10 minutes. The procedure was repeated twice.  
 
Sonicated samples were then washed with different buffers to reduce contaminant levels, prior to IB 
solubilisation and subsequently concentrate the desired protein in those fractions (Figure 2.5). Samples 
were first resuspended in TEN-triton buffer (50 mM Tris-HCl (pH 8), 100 mM NaCl, 10 mM EDTA, 
2% (v/v) Triton X-100) and centrifuged at 33500g for 20min. The process was repeated 4 times before 
3 washes with TN buffer (50 mM Tris-HCl (pH 8), 100 mM NaCl) followed. Finally, samples were 
resuspended in 10-20 mL 50 mM Tris-HCl (pH 8), 100 mM NaCl and aliquoted in Eppendorf cups. The 




Figure 2.5 Washing of inclusions bodies. Flow diagram illustrating the experimental procedures used for the 






The in vitro refolding step was carried out based on an approved method (Yamaguchi and Miyazaki 
2014). Inclusion bodies produced in the previous steps were mixed with denaturation buffer (25mM 
NaH2PO4/Na2HPO4 (pH 7.0), 100 mM NaCl, 1 mM EDTA, 10 mM DTT, 6 M Guanidinium chloride) 
to a final concentration of 10 mg/mL in a total volume of 5 mL (50 mg total). Samples were then heated 
for 10 minutes at 60 °C and subsequently centrifuged for 10 minutes at 14000 rpm. The supernatant was 
then added drop wise to 45 mL of refolding buffer 1 (RF1; 25mM NaH2PO4/Na2HPO4 (pH 7.0), 100 
mM NaCl, 1 mM EDTA, 10% (v/v) Glycerol, 2.29% (v/v) LDAO) and left stirring overnight at 4 °C. 
The following day the solution was centrifuged at 5,700 rpm (6,400g) for 10 minutes and the supernatant 
was added again drop wise to 450 mL of refolding buffer 2 (RF2; 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 
100 mM NaCl, 1 mM EDTA, 10 % (v/v) Glycerol, 0.12 % (v/v) LDAO) and left stirring overnight at 4 
°C. The next day the solution was filter-sterilized using Corning® bottle-top vacuum filters and 
subjected to Ion Exchange Chromatography (IEC). 
 
Since AtVDAC1 proteins can putatively exhibit different biochemistry and stability regarding the 
additives used, their refolding efficiency may vary. A refolding screen was carried out to test different 
types of salts and sugars known to contribute to the refolding of proteins (Alibolandi and Mirzahoseini 
2011). Solubilty was expressed by the percentage of successfully refolded AtVDAC relative to the 
unfolded protein (Figure 2.6) in the refolding buffer tested. Different samples are collected during the 
dilution process and analysed on SDS PAGE 10 % (v/v). The amount of AtVDAC protein is then 
estimated for each lane using ImageJ ® software and a ratio is calculated between the supernatant 
fractions and their corresponding resuspended pellets. Additional samples are collected beforehand to 
assess the initial amounts and monitor potential issues during the process. Thus, they can be used to 





Figure 2.6 Refolding screen (RF1). Flow diagram illustrating the experimental procedure used in a small-scale 
refolding by sequential dilution of the AtVDAC protein. Sample is first heated at 60 °C for 10 minutes, centrifuged 
and resuspended in refolding buffer 1 (RF1) with a 1 to 10 dilution. After stirring overnight at 4 °C, the process is 
repeated with the refolding buffer 2 (RF2). The refolded protein is now solubilized in the supernatant. Samples 






Filtered refolded protein was applied overnight at 4 °C to a strong cation exchanger (Fractogel® EMD 
SO₃⁻ (M) from Merck Millipore®, or HiTrap SP XL 1 mL and 5 mL from Life Sciences®), using a 
peristaltic pump. The following day the protein of interest was eluted with an increasing concentration 
of NaCl (from 1 mM to 1 M, see Table 2.1), using the AKTA Prime® device. The solid supports used, 
possess different structural and chemical properties. More precisely, the Fractogel® EMD SO₃⁻ (M) 
contains a matrix of long methacrylate chains carrying the functional ligand, offering a greater surface 





Figure 2.7 Comparison of commercial strong cation exchangers. Schematic representation of a conventional 
cation exchanger (HiTrap SP XL from Life Sciences®, left) vs a “tentacle-like” cation exchanger (Fractogel® 
EMD SO₃⁻ (M) from Merck Millipore®, with its increased binding hence binding capacity. 
 
 
Protein was applied overnight at 4 °C to a strong Ni-Nta matrix (Protino 5 mL HisTrap from Merck 
Millipore®) via a peristaltic pump. The following day the protein of interest was eluted with 500 mM 
Imidazole (25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) Glycerol, 500 mM Imidazole), using 
the AKTA Prime® device.  
 
Conventional strong cation 
exchanger (HiTrap SP XL) 
Tentacle-like strong cation 






Fractions containing the protein of interest were pooled together and applied to a PD-10 desalting 
column (Life Sciences) to remove excess NaCl, EDTA, or imidazole. Samples were eluted in 3.5 mL of 
an elution buffer suitable for size exclusion chromatography (25 mM NaH2PO4/Na2HPO4 (pH 7.0), 100 
mM NaCl, 1 mM EDTA, 1 mM DTT, 10% (w/v) Glycerol, 0.115% (v/v) LDAO for VDACs, or 25 mM 
Tris-HCl (pH 7.0), 100 mM NaCl, 3% (w/v) Glycerol for mKlp2C-Ter). Finally, the sample was 
concentrated to final volume of 500 µL using 30K cut-off AMICON Ultra-15 Centrifugal Filter Units®. 
 
Purified and concentrated samples (maximum 500 μl) were applied to a prepacked Superdex 75 10/300 
GL (Life Sciences®) or Superose 6 10/300 GL (Life Sciences®) at the top of the column. Sample was 
then pushed through the column by the elution buffer (25 mM NaH2PO4/Na2HPO4 (pH 7.0), 100 mM 
NaCl, 1 mM EDTA, 1 mM DTT, 10% (w/v) Glycerol, 0.12% (v/v) LDAO for VDACs, or 25 mM Tris-
HCl (pH 7.0), 100 mM NaCl, 3% (w/v) Glycerol for mKlp2C-Ter), using the AKTA Prime® device. 
Proteins in the sample were then separated depending on their size, bigger proteins coming first and 
lower molecular weight proteins coming last. 
 
A mixture of purified proteins of known molecular weight (IgG, BSA, Alpha-amylase, Lysozyme and 
Ribonuclease A, 0.5 mg each) was applied to the Superdex 75 10/300 GL (Life Sciences®). The 
corresponding elution profile (Figure 2.8A) was used to build a standard curve (Figure 2.8B), allowing 
the extrapolation of the molecular weight of a protein depending on the volume at which the 
aforementioned protein is eluted. Separation of standards was attempted in both size exclusion buffers 
(25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 
0.12 % (v/v) LDAO for AtVDACs and 25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) Glycerol 
for mKlp2C-Ter). As no noticeable difference in the separation profiles of the standards was observed 





Figure 2.8 Superdex75 calibration. (A). Elution profile showing the absorbance (in mAU) at 280 nm wavelength 
versus the volume (mL) of the samples collected. A mixture of purified proteins of known molecular weight (IgG, 
BSA, Alpha-amylase, Lysozyme and Ribonuclease A, 0.5 mg each) was applied. (B). Their respective molecular 
weights were plotted against their peak elution volume (blue line). A trend line (black) was then established and 













































A mixture of purified proteins of known molecular weight (IgG, BSA, Alpha-amylase, Lysozyme and 
Ribonuclease A, 0.5 mg each) was applied to the Superose 6 10/300 GL (Life Sciences®). The 
corresponding elution profile (Figure 2.9A) was used to build a standard curve (Figure 2.9B), allowing 
the extrapolation of the molecular weight of a protein depending on the volume at which the 
aforementioned protein is eluted.  Again, both size exclusion buffer for VDACs (NaH2PO4/ Na2HPO4 
(pH 7.0) 25 mM, NaCl 1 M, EDTA 1 mM, DTT 1 mM, Glycerol 10 % (w/v), LDAO (Stock:30 %) 0.12 
% (v/v)) and mKlp2C-Ter (TrisHCl (pH 7.0) 25 mM, NaCl 100 M, Glycerol 3 % (w/v)) were used but 
did not lead to different pattern. Only one profile is shown in Figure 2.9, with the VDACs buffer. 
The column maintenance was performed on a run to run basis, and a cleaning in place (CIP) was 
performed on a regular basis, depending on the purification yields obtained. Calibration was reassessed 






Figure 2.9 Superose 6 calibration. (A). Elution profile showing the absorbance (mAU) at 280nm wavelength 
depending on the Volume (mL). A mixture of purified proteins of known molecular weight (IgG, BSA, Alpha-
amylase, Lysozyme and Ribonuclease A, 0.5 mg each) was applied. (B). Their respective molecular weights were 
plotted against their peak elution volume (blue line). A trend line (black) was then established and the 

















































The BCA assay is a colorimetric assay for the determination of protein concentrations using the capacity 
of reduced Copper to form tetradentate complexes with peptide bonds. The bicinchonic acid will form 
a complex with reduced copper, and further interact with aromatic amino acids, cysteines and cystines, 
exhibiting a maximal absorption wavelength at 562 nm. The absorbance recorded is proportional to the 
amount of protein present in the sample. 
50 µL of each sample were tested using the BCA assay Kit from Merck Millipore® following the 
manufacturer’s instructions. Some components such as reducing agent DTT (dithiothreitol) EDTA 
(Ethylenediaminetetraacetic acid) or Guanidinium can interfere with the process. In this case samples 
were acetone precipitated (section 2.5.8) and resuspended in TN buffer (50 mM Tris-HCl (pH 8.0), 100 
mM NaCl) prior to the assay. 
 
 
Acetone precipitation allowed the selective precipitation of proteins and the removal of buffer 
components that could potentially interfere with downstream applications.  
200 μL of each protein sample were mixed with 1 mL acetone and incubated for 1 hour at –20 °C. 
Samples were then centrifuged for 3 minutes at 13000 rpm and 4 °C. Supernatants were discarded and 
protein pellets were washed with 50 μL ice cold dH2O and then centrifuged for 3 minutes at 13,000 rpm 
and 4 °C. Supernatants were discarded and protein pellets were washed with 50 μL of ice cold ethanol 
(100%). Washed samples were then centrifuged for 3 minutes at 13000 rpm and 4 °C, supernatants were 
discarded, and protein pellets were air-dried. Protein pellets were finally resuspended in 50 μL TN buffer 






E. coli lipids (50 mg/mL in chloroform) were added in a molar ratio of 2000:1 (lipid to Membrane 
Protein) to the solubilized membrane protein (AtVDACs) and incubated at 30 °C for an hour (STEP A).  
In parallel (STEP B), 750 mg biobeads from Biorad® were washed in 10 mL of 100 % (v/v) methanol. 
After letting the biobeads settle down, the supernatant was discarded. This washing step was repeated 
three times with 10 mL of distilled water. Finally, the biobeads were washed twice in the buffer used 
for the detergent solution (SEC buffer without detergent; 50 mM NaH2PO4/ Na2HPO4 (pH 7.0), 100 
mM NaCl, 10 % (v/v) Glycerol). Biobeads were then pre-saturated with lipids: 100 µl of the lipid 
suspension were added to 1 mL of washed biobeads in 10 mL of detergent buffer (SEC buffer without 
detergent, 50 mM NaH2PO4/ Na2HPO4 (pH 7.0), 100 mM NaCl, 10 % (v/v) Glycerol) and incubated 
for 30 min at room temperature. 
Once both prepared (STEP C), lipid-presaturated biobeads (step B) were added in a ratio 
biobeads:detergent of 100:1 (w/w) to a vial containing the lipids and the refolded protein solution (step 
A). The detergent was let to adsorb to the biobeads by incubation overnight on a shaker at 30°C. 
Next morning, the vial was removed from the shaker and biobeads were left to settle down. The 
supernatant was then transferred into a new vial. Then a new incubation step was initiated with a second 
aliquot of lipid-presaturated biobeads for 6 h at 30°C on a shaker. Following incubation, the supernatant 
containing the proteoliposomes was harvested. Pellet was resuspended in dialysis Buffer without 
detergent (25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10% (w/v) 
Glycerol), the proteoliposomes can be stored at 4°C until or frozen in liquid nitrogen until further 







SDS PAGE gels were either purchased from Invitrogen® or made in house. Precast gels were treated 
according to manufacturer’s instruction. Home-made gels recipe is detailed in Table 2.9. 
Table 2.9 Lower gel (10%, resolving) recipe. Components (left) and their corresponding volumes when making 
two resolving gels (middle) or one (right) based on Laemmli buffer gel composition (He 2011). 
Solution 2 Gels (mL) 1 Gel (mL) 
H2O 2.250 1.125 
Acrylamide/Bisacrylamide 40% (29:1) (v/v) 3.125 1.560 
Tris-HCl 1.5M (pH 8.5) 4.700 2.350 
SDS 10% (w/v) 0.125 0.063 
Sucrose 50% (w/v) 2.000 1.000 
Ammonium Persulfate (APS) 10% (w/v) 0.156 0.078 
TEMED 0.004 0.002 
 
Ammonium Persulfate and TEMED were added last since they are responsible for the catalysis of the 
acrylamide polymerization. Immediately after adding TEMED, the solution was pipetted between glass 
plates in a caster-device, filling at least two third of the container. Then pure ethanol or pure isopropanol 
was layered (1 to 2 mL) on top of the resolving gel to insulate the gel from air, even the surface of the 
resolving gel and remove any bubbles.  
After an hour, ethanol was poured away, and the top of the gel was gently dried with Whattman paper. 




Table 2.10 Upper gel (4%, stacking) recipe. Components (left) and their corresponding volumes when making 
two stacking gels (middle) or one (right). 
Solution 2 Gels (mL) 1 Gel (mL) 
H2O 3.000 1.500 
Acrylamide/Bisacrylamide 40% (29:1) (v/v) 0.625 0.312 
Tris-HCl 1M (pH 6.8) 2.100 1.050 
SDS 10% (w/v) 0.063 0.031 
Ammonium Persulfate (APS) 10% (w/v) 0.250 0.125 
TEMED 0.0025 0.00125 
 
 “Homemade” gels were stored for up to one week in the fridge (2 to 8°C), wrapped in paper towels 
soaked in 1x SDS-PAGE running buffer (recipe) and sealed in cling film.      
       
 
Protein samples were prepared for loading with SDS sample buffer (0.25 M Tris-HCl (pH 6.8), 0.5 M 
DTT, 10 % (w/v) SDS, 50 % (v/v) Glycerol, 0.5 % (w/v) Bromophenol blue) with the corresponding 
dilution and heated between 60-80oC for 10 minutes. In parallel, gel assembly was put into tank, and 
filled with 1xSDS run buffer (25 mM Tris, 200 mM Glycine, 0.1 % (w/v) SDS), ensuring wells were 
covered adequately. Combs were removed, and samples were loaded into the wells (each could 
accommodate a maximum volume of 25 µL). Run was performed at 200 V (around 110 mA) for 60-85 
minutes. 
Once the run finished, gels were gently removed from their cassettes and placed in Coomassie Blue 
staining solution (50 % (v/v) Methanol, 10 % (v/v) Glacial Acetic Acid, 0.25 % (w/v) Coomassie R-
97 
 
250), shaking for one hour. Gel was then rinsed with water three times to remove high excess of staining 
solution, and finally placed in destaining solution (50 % (v/v) Methanol, 10 % (v/v) Glacial Acetic Acid) 
for 30 minutes. Finally, gels were photographed and left in deionised water overnight. Gels were 
photographed the next day.  
Solutions and Reagents were routinely prepared in the laboratory, ensuring a constant availability of 
gels ready-to-use. For preparation of SDS-PAGE gel and buffer components, the following recipes were 
used (Table 2.11):  
Table 2.11 SDS PAGE buffer recipes. Typical day-to-day recipes of main solutions used in SDS PAGE. 
Solution Component Final Weight/Volume 
10x SDS Run Buffer 
SDS 10g 






Coomassie R-250 1.25g 
Methanol 225ml 
H2O 225ml 
Glacial Acetic Acid 50ml 
SDS-PAGE              
Destaining Solution 
 
Methanol 100% (v/v) 500ml 







Western Blotting is multi-step process. Routinely, samples were loaded in duplicates on SDS-PAGE 
gels, allowing for one side of the gel to be stained with Coomassie Blue or by silver staining, and the 
other to be probed by Western Blotting. Following completion of electrophoresis, gels were removed 
from their casting plates, and soaked in Blot-transfer buffer (1X blotting buffer from Novex® in 20 % 
(v/v) Methanol) for 5 minutes.  
In parallel, PVDF (Life sciences) membranes were soaked in 100% (v/v) Methanol for ten to thirty 
minutes to reduce its hydrophobicity and activate its protein binding capability. Whattman filter papers 
and blotting pads of the XCell SureLock Mini-Cell blot module, were placed in a tray containing Blot-
transfer buffer for30 minutes. Following the activation of the PVDF membrane by Methanol, the 
membrane was briefly soaked in Blot-transfer buffer for 2 minutes.  
For assembling the blot sandwich (Figure 2.11), two to three pre-soaked blotting pads, as well as two 
filter papers, were placed onto the cathode (-) core of the module. Then, the Blot-transfer buffer-pre-
soaked gel was gently placed on top, followed by the Blot-transfer buffer-pre-soaked PVDF membrane, 
ensuring no air bubbles were trapped between them. Then two more filter papers as well as two blotting 
pads were placed on top of the setup, enough to rise over 0.5cm rim of the cathode core. Finally, the 
anode core was placed on top of the pads, securely holding the two halves of the blot module (Figure 
2.11). Once assembled, the system was transferred into a tank unit. Blot module was then filled with 
Blot-transfer buffer until the gel/membrane sandwich was fully covered in buffer. Any potentially 
remaining air bubbles were again removed, by firmly pressing the anode and cathode against each other. 
Outer chamber was then filled with cold deionized water, to help dissipating heat during the run. Lid 




Figure 2.10 Western Blot sandwich Assembly. Gel (in blue) is sandwiched against a PVDF membrane (blue 
open rectangle), between two filters and three blotting pads on each side. 
 
At the end of the run, the sandwich was disassembled and the PVDF membrane was placed in Blocking 
buffer (5 % (w/v) Western blot Blocking reagent from Novex® in 10 mM Tris-HCl (pH 7.5), 150 mM 
NaCl, 0.05 % (v/v) Tween 20) overnight at 4 °C. 
The next morning, the membrane was washed twice for 10 minutes in TBS-Tween/Triton buffer at room 
temperature (15-25 oC). This step was then repeated with TBS buffer. Once washed the membrane was 
incubated with either rabbit anti-AtVDAC1 (Agrisera®), or penta-His-HRP (Qiagen®, for mKlp2C-
Ter) antibodies in blocking buffer at room temperature (15-25 oC) for 1 hour at specific dilutions (Table 
2.12). 
Table 2.12 Antibodies. Antibodies used for Western Blotting and their respective dilution factor. 
Solution Final dilution Supplier Function Protein 
Rabbit polyclonal 1:1000 Agrisera Antibodies Primary antibody AtVDAC1 
Anti-Rabbit IgG  1:1000 Agrisera Antibodies Secondary antibody AtVDAC1 























After incubation with a primary antibody, the membrane was again washed twice for 10 minutes in 
TBS-Tween/Triton buffer at room temperature (15-25 oC), followed by one additional wash in TBS 
buffer at room temperature (15-25 oC). The membrane was then either a) soaked in chemi-luminescence 
substrate (if using anti-His conjugated antibody) or b) incubated with a secondary antibody (if using the 
rabbit-AtVDAC1 antibody) as reported in Table 2.12.  
The incubation with a secondary antibody (mouse anti-rabbit IgG-HRP) was then performed for one 
hour at room temperature (15-25 oC). Following incubation, the membrane was washed three to four 
times in TBS-Tween/Triton buffer, and one wash in TBS buffer, at room temperature (15-25 oC). Once 
washed, the membrane was soaked in chemi-luminescence substrate.  
Preparation of the chemi-luminescence substrate was carried out according to Mruk and Cheng 
(2011)(Mruk and Cheng 2011). Briefly, 22 µl of p-coumaric acid (90 mM in DMSO), 50 µl of luminol 
(250 mM in DMSO) and 3 µl H2O2 were mixed in 10 mL of 0.1 M Tris-HCl (pH 8.6). Once prepared, 
single drops were applied to cover the entire membrane, then the rest of the reagent was poured in, and 
the membrane was incubated for 2 minutes at room temperature, without shaking. Excess reagent was 
then discarded, and the membrane gently wrapped in a thin layer of Clingfilm. 
In a dark room, wrapped membrane was placed in an X-Ray proof cassette, and covered by an auto-
radiographic film (Life sciences). Cassette was then closed firmly for 10 seconds to 2 minutes. The 
photographic film was then removed and placed in developing solution (Kodak) or 10 to 20 seconds, 
until bands of desired intensity started appearing. The film was then washed with water and immediately 





A beaker was set-up with 10 to 20 mL of TLC solvent (63: 35: 5, v/v/v chloroform: methanol: 
ammonium hydroxide) and the level of solvent was checked with filter paper, ensuring origin point 
was not submerged into solvent (Eriks, Mayor et al. 2003). 
In parallel, the origin points and loading positions for samples were gently marked on a TLC plate () 
using a pencil, leaving enough space for samples to run (0.5 to 1 cm). Samples were then “spotted” on 
the TLC plate drop-wise (1 µL of each sample at the time), with 30 seconds waiting time, between 
additions, to ensure effective and uniform adsorption of the sample at the corresponding position. Once 
dried, the TLC plate was gently placed into the beaker, and covered with aluminium film (to avoid 
vapour coming out). Samples were then allowed to run until reaching the top of the TLC plate (1cm 
from the top of the plate). 
Once samples reached the top, the TLC solvent was discarded, and the plate left to dry for two minutes. 
The TLC plate was then placed back in a beaker with one (or two) iodine crystals and covered with 
aluminium foil. The beaker was warmed up using a heating block (50-60oC), allowing the iodine vapour 
to stain the migrated samples on the plate, giving a brown tinge to the organic spots on the plates. Once 
the spots were revealed, the plate was removed from the beaker, dried, and pictures were taken at 
different intervals (important if samples were saturated, giving them a dark brown to black colour, that 
faded after a few minutes).  
Conventionally, the Rf would be calculated and used for each sample (see formula below). 
𝑅𝑓 =
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑡𝑟𝑎𝑣𝑒𝑙𝑙𝑒𝑑 𝑏𝑦 𝑐𝑜𝑚𝑝𝑜𝑛𝑒𝑛𝑡
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑡𝑟𝑎𝑣𝑒𝑙𝑙𝑒𝑑 𝑏𝑦 𝑠𝑜𝑙𝑣𝑒𝑛𝑡
 
However, since only the concentration of LDAO in purified and refolded AtVDAC samples was 
investigated, the analysis was performed using surface calculation (area covered by the sample) on 
ImageJ®. Using a standard curve designed with samples of known concentrations, unknown samples’ 
areas were compared to those of the standard curve, and the concentrations of the unknown samples 





Developed in the late 30s by Guinier (Rice 1956), this technique allows nanoscale density differences 
in a sample to be measured. As a result, the nanoparticle size distribution can help modelling the surface 
or overall shape of a macro-molecule. The technique uses an X-ray monochromatic beam which is 
brought to the sample by a series of mirrors (Figure 2.12).  
 
Figure 2.11 Representation of Small Angle X-Ray scattering experiment. Taken from (Tuukkanen, Spilotros 
et al. 2017) A monochromatic beam of X-rays is directed to a sample. Upon passing through the sample, some of 
the X-rays will scatter at specific angles (2θ). The scattered X-rays form a radially developed pattern of elastic 
scattering which is then acquired by a detector which is typically a 2-dimensional flat X-ray detector situated 
behind the sample perpendicular to the direction of the primary beam that initially hit the sample. The scattering 
pattern is a radially organised positioning of detected intensities. Those intensities are a function of scattering 
angles which feed information to the momentum transfer vector q. 
 
The scattered X-rays form a radially developed pattern of elastic scattering which is then acquired by a 
detector which is typically a 2-dimensional flat X-ray detector situated behind the sample perpendicular 
to the direction of the primary beam that initially hit the sample (Figure 2.12). The scattering pattern is 
a radially organised positioning of detected intensities. Those intensities are a function of scattering 







Samples were dialysed for three (mKlp2C-Ter) to seven days (AtVDAC proteins) and centrifuged 
briefly (6,000g for 10 minutes) to remove high molecular weight aggregates. SAXS data were first 
acquired in-house using a Bruker Nanostar ®, with 70 µL samples (concentration ranging from 
1.2mg/mL to 4.0mg/mL for VDACs, and from 1.4 mg/mL to 6.0 mg/mL for mKlp2C-Ter) in their 
respective dialysis buffers (25 mM NaH2PO4/Na2HPO4 (pH 7.0), 100 mM NaCl, 1 mM EDTA, 1 mM 
DTT, 10% (w/v) Glycerol, 0.12% (v/v) LDAO for VDACs, or 25 mM Tris-HCl (pH 7.0), 100 mM 
NaCl, 3% (w/v) Glycerol for mKlp2C-Ter). 
For in-house experiments, the distance of the sample from the detector was set to 106.850 cm. Samples 
were exposed to X-rays for 7,500 seconds, resulting in roughly 500,000 counts per image. A full data 
set consisted of 10 to 13 images of the sample at 7,500 seconds each (maximum of 97,500 seconds in 
total). Collection of excess frames would allow the discarding of some aberrant frames. SAXS 
experiments were conducted on protein solutions and buffers alone (blank) to enable subtraction of the 
solvent’s component ambient scattering and to eventually reveal the density contributions of the solute 
molecules. This scattering data were then integrated using the circular integration method (rotation 
around Chi) to obtain a raw scattering curve. Primus software (ATSAS)(Petoukhov, Franke et al. 2012, 
Franke, Petoukhov et al. 2017) was then used to take the average of the 10 scattering curves from both 
sample and blank, and buffer effects were subtracted from the protein-buffer mixture. 
Data generated, helped awarding time at the Beamline B21 in the Diamond Light Source in Oxford. 
Samples were treated as above, dialyzed prior to transport and brought to the site frozen at -20 °C. 
Again, different dilutions (50 µL samples with a concentration ranging from 1.2mg/mL to 4.0mg/mL 
for VDACs, and from 1.4 mg/mL to 6.0 mg/mL for mKlp2C-Ter) were subjected for 1 to 2 seconds in 
their respective dialysis buffer (25 mM NaH2PO4/Na2HPO4 (pH 7.0), 100 mM NaCl, 1 mM EDTA, 1 
mM DTT, 10% (w/v) Glycerol, 0.12% (v/v) LDAO for VDACs, or 25 mM Tris-HCl (pH 7.0), 100 mM 
NaCl, 3% (w/v) Glycerol for mKlp2C-Ter). The strength of the beam allowed the capture of millions of 
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frames for each individual protein, which were collected and partially analysed on-site for integrity. Rest 
of the analysis was carried out in-house (see section 2.6.1.2 and 5.2.2).   
 
Guinier and Kratky plots were generated in Primus software or Scatter Software (BioIsis) (Rambo and 
Tainer 2013). GNOM (ATSAS) (Petoukhov, Franke et al. 2012, Franke, Petoukhov et al. 2017) was 
used to generate the P(r) function (pair-distance distribution function). Ab initio shape determination 
using dummy atoms was performed using the online ATSAS package (Petoukhov, Franke et al. 2012, 
Franke, Petoukhov et al. 2017) with default settings. DAMMIF (Franke and Svergun 2009) automated 
analysis allowed the generation of 20 models through DAMMIN, which were then aligned and averaged 
by DAMAVER. Outliers were removed, and an average model was generated in DAMFILT. PDB 
envelopes (as dummy atoms) were generated in PyMOL (L DeLano 2002). 
 
Electrophysiology experiments were conducted at the University of Brighton, under the supervision of 
Dr Marcus Allen. The activity of lipid-reconstituted porins was monitored via the planar lipid bilayer 
assay (or Black Lipid Membrane BLM). The protein was inserted in a lipid bilayer made of a 1:1 mixture 
of POPE (1-Palmitoyl-2-Oleoyl-sn-glycero-3-phosphoethanolamine, Avanti Polar Lipids®) and POPS 
(1-Palmitoyl-2-Oleoyl-sn-glycero-3-[phosphor-L-serine], Avanti Polar Lipids®) resuspended in N-
Decane, using BLM buffer (10 mM Tris/HCl (pH 7.4), 150 mM KCl, 50 mM CaCl2) on each side of 
the bilayer. Data were recorded using a Warner Instruments PC-501A amplifier, capable of bilayer 





Figure 2.12 The black lipid membrane set-up. Two chambers (or a lipid bilayer cups) for bilayer formation 
(Warner Instruments chamber BCH-13A and cup CP13A-250) were connected via potassium chloride (KCl) agar 
bridges and silver/silver chloride (Ag/AgCl) electrodes to the amplifier head stage. The amplifier used (Warner 
Instruments PC-501A) was capable of bilayer recordings and single channel currents were digitised using an 
analogue to digital converter (CED micro1401 MkII), controlled by single channel analysis software (WinEDR®, 
University of Strathclyde, UK). A Faraday cage was used to minimize external interferences. 
 
Typically, this type of assay is carried out in two steps, firstly the membrane elevation and then the 
protein insertion (reconstitution). 
The membrane elevation is the process by which the lipid bilayer (generally a mixture of Phosphatidyl-
choline and Phosphatidyl-ethanolamine) is raised between a Teflon-lined hole (few microns) at the 
interface of two joined compartments, each filled with buffer (10 mM Tris-HCl (pH 7.4), 150 mM KCl, 
50 mM CaCl2). A small volume of lipid mixture would be applied (painting) on the small hole (aperture) 
between the upper and lower chamber of the setup, and buffer would be added on both sides (Figure 
2.13 step I and II). Correct elevation of the membrane is monitored on screen, since its presence would 
prevent ion movement across compartments, with or without applied current. The optimal width of the 
bilayer would be monitored via its capacitance, as the most stable and thinnest possible membrane is 




Figure 2.13 Schematic representation of the Teflon-cross section (I) between compartments. First, a stable 
lipid bilayer is set by “painting” lipids across the aperture, or by successively raising a lipid solution level, applied 
on either side of the aperture (step II); then the porin is introduced (step III). In the presence of an applied voltage, 
ions align in the direction of the applied field, and can cross the bilayer, through the reconstituted porin. In absence 
of a set current, ions are flowing on each side of the bilayer.   
 
Once a thin and stable bilayer is set, a small volume (typically one or two microliters) of lipid-
reconstituted membrane protein was added in the trans chamber. Ideally, one protein is inserted into the 
bilayer by vesicle fusion with the lipid bilayer. The protein insertion is monitored on screen when 
applying a current. Indeed, once inserted the porin will allow the flux of anions across the membrane 
(Figure 2.13 Step IV), leading to the recording of a specific current trace.  
Data were recorded for as long as possible (generally few minutes to few hours depending on the stress 
applied to the membrane). Application of different voltages, ranging from -60V to +60V (can be 
stretched to ±130mV), were explored, for ten seconds to a minute per step (generally with a 10mV step 















Figure 2.14 Schematic representation of a gating event. The channel is open (O) then closes (C) for a few 
moments (typically milliseconds) and re-opens again. The resulting current in pA from both open and closed states, 
as well as the time of opening/closing, the current applied can be recorded and further analysed.  
 
Analysis was performed using a combination of tools. Win-EDR ® free software to detect the signal 
and map the main raw data, Excel ® was used for data storage as well as the main analysis and 
Magicplot® Software was used for the Gaussian fitting on the channel conductance profile and statistical 









Iso-thermal titration calorimetry (ITC) is a method used to probe interactions between molecules, using 
thermodynamic parameters measured in solution. Experiments were performed at the University of 
Huddersfield, using a Malvern Microcal VP-iTC ®. Typically, a sample of protein would be left mixing 
in a thermo-regulated chamber and small amount of titrant containing the binding partner would be 
injected at regular intervals (see Figure 2.15A). The difference in energy resulting from the addition of 
titrant would be reported and used to calculate different parameters such as dissociation/association 
constants, the stoichiometry or the enthalpy of the reaction (see Figure 2.15B). The main 
Thermodynamic law formula driving this experiment is presented in equation 2.2, where T is the 
absolute temperature in Kelvin and R is the gas constant. 
∆𝐺 =  −𝑅𝑇 ln 𝐾𝑎 =  ∆𝐻 − 𝑇∆𝑆 
Equation 2.2 Thermodynamic laws defining the Gibbs free energy. T is the temperature, ∆G is the variation 
of free energy, ∆H is the variation of enthalpy and ∆S is the variation of entropy within the system. 
 
Analysis of the raw data was performed using a combination of Originlab®, Excel and Magicplot®. 
The initial recordings were monitored using Originlab® and the resulting traces were transferred via 









Figure 2.15 Iso-Thermal Calorimetry (ITC): basic principle. (A). Schematic representation of the instrument 
(Microcal VP-iTC from Malvern ®) used for the ITC study. The sample is mixing in the sample cell, and the titrant 
solution is delivered through a syringe via a specific volume at regular intervals. (B). Taken from Malvern 
Panalytical. Typical curve obtained in ITC (left) and the corresponding analysis (right). The binding mechanism 
(ΔH), the affinity (Kb) and the stoichiometry are shown in red. 
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Circular Dichroism (CD) is a widely used technique to probe the secondary structure composition of 
macromolecules (proteins, DNAs, RNAs), as a consequence of the interaction of polarised light with 
their chiral nature.  
A linearly polarised monochromatic light is defined by having its oscillations confined to a single plane. 
All polarised light states can be described as a sum of two linearly polarised states at defined angles to 
each other, usually referred as vertically and horizontally polarised light. In fact, a monochromatic 
linearly polarised light can be turned into either left‐ or right‐circularly polarised light (LCP and RCP 
respectively) by passing it through a quarter‐wave plate whose unique axis is at 45 degrees to the linear 
polarisation plane. A molecule that absorbs LCP and RCP differently is deemed optically active (or 
chiral). Hence, circular dichroism relies on the difference in light absorbance between left‐ (L‐CPL) and 
right‐ circularly polarised light (R‐CPL) by the molecule under investigation. It is generally described 
as the difference in absorption of ER (R-CPL absorption signal) and EL (L-CPL absorption signal), 
known as Δε (Purdie 1996, Snyder 1996) : 
Δε = ΔA(λ) = A(λ)LCPL - A(λ)RCPL 
Molecules containing chromophores will display singular patterns of differential absorption, in 
correlation with their structural composition. Therefore, proteins provide really good study-subjects 
using this technique. This is due to the fact that most of the amino acids (19 of the 20) that form proteins 
are themselves chiral. However, the CD spectrum of a protein is not merely a sum of the CD spectra of 
the individual residues or bases. Instead, the tertiary structure of the molecule can influence the signal 
obtained by CD (van Stokkum, Spoelder et al. 1990).  
It has been shown that a specific CD-signature is attributed to a precise secondary structure. following 
consequence, structural conformational changes in the tested macromolecules can be followed, through 
changes in these signatures (Kelly, Jess et al. 2005). The most widely studied circular dichroism 
signatures of proteins are those corresponding to their secondary structural elements (see Figure 3.21). 
111 
 
Particularly, CD spectra in the far‐UV (below 260nm) can be used to predict the percentages of each 
secondary structural element in the structure of a protein (Kelly, Jess et al. 2005).  
 
Figure 2.16 Representative examples of CD spectra of main secondary structural elements. Representative 
Circular Dichroism spectra of molecules with high beta-sheet content (red line), high alpha helical content (green 
line) and random coiled molecules (black line). 
 
Experiments were conducted at the Astbury Centre for Molecular Biology at the University of Leeds 
and data were collected using a Jasco J715 spectropolarimeter. The difference of absorption between 
left- and right-polarized light are measured for air, buffer, and up to 5 samples. The process is repeated 
at wavelengths ranging from 180 nm to 260 nm with a 1 nm increment. The instrument can also perform 
temperature ramping, allowing measurements at increasing temperature and probe their structure 
recovery after heating up and cooling down for example. Additional parameters such as the temperature 
or the voltage are also recorded and can help monitoring the integrity of the sample throughout the 
experiment.  
CD data outputs are generally given in millidegree (mDeg), or ellipticity θ. Using the molar 
concentration (in mole/L) and the path length (in cm), the Molar ellipticity [θ] can then be calculated 
and used for comparison with other proteins. In addition, using also the Mean Residual Weight of a 
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Using dedicated software (Dichroweb) and algorithms (CONTINLL or CDSSTR for 
example)(Sreerama and Woody 2000), the structural content (in percentages of beta, alpha helix and 
random coil) can be calculated for a specific protein in a specific condition (temperature or buffer for 
example)(Kelly, Jess et al. 2005).  
 
 
DNA sequences were retrieved from Pubmed® (Sayers, Barrett et al. 2009), either by direct search via 
the accession number or keywords, or by using BLAST alignment tool (McGinnis and Madden 2004) 
from NCBI® webserver. Multiple sequences alignments were also performed on the NCBI platform. 
The basic properties of the proteins used in this study such as the molecular weight or the homology 
modelling were performed using the ExPASy platform (Artimo, Jonnalagedda et al. 2012) and SWISS 
modeller (Waterhouse, Rempfer et al. 2018) respectively (thought the latter is also accessible through 
the same platform).  
Most of the three-dimensional structural analysis of the SAXS envelopes, the crystal structures, the 
homology models were performed using Pymol®(L DeLano 2002) and Chimera® software (Pettersen, 
Goddard, Huang, Meng et al. 2014). The known crystal structures data-files (pdb files) were retrieved 
from the RCSB Protein Data Bank.    
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3. Chapter 3: AtVDAC1 
 
Cloning of AtVDAC1 into the pET-20b(+) was performed by Felix Brademann at the University of 
Marburg, as part of his master thesis (see 2.2) under the supervision of Dr Georgios Psakis. The pET-
20b(+)AtVDAC1 construct was kindly provided and would be used for the subsequent production of 
AtVDAC1 protein in OMP9 cells.  
Test expression were carried out to confirm the correct overexpression of the ATVDAC1 gene by auto-
induction (see section 2.3.4.2). A 12 % (v/v) SDS-PAGE was performed to monitor the production of 
the translated protein AtVDAC1 (Figure 3.1) by Coomassie Blue staining. Indeed, an additional band 
around 30 to 40 kDa would appear on gel after 6 to 12 hours of incubation (Figure 3.1 lane 7 and 8).  
 
 
Figure 3.1 Heterologous production of AtVDAC proteins in E.coli by auto-induction. Whole cell extracts, 
taken during the over-production of AtVDAC1 in OMP9 cells were analysed on 10 % (v/v) SDS-PAGE in 1x 
Laemmli running buffer. Lane 1 contains the ladder from Novex®. 1 µL of the pelleted fraction after 0.5, 1, 2, 3, 
4, 6, 12 and 18 hours (lane 2 to 9) of auto-induction were analysed. The position of the AtVDAC1 monomer is 




















Following auto-induction (see section 2.3.4.2) in Omp9 cells with the best possible clone, the production 
of AtVDAC1 in inclusion bodies and their subsequent washing were analysed by 12% (v/v) SDS-PAGE 
in 25 mM Tris, 200 mM Glycine, 0.1 % (w/v) SDS (Figure 3.2, see 2.5.2 for further details on the 
samples). Supernatants (Figure 3.2, lanes 2 to 3) after the first centrifugation were devoid of the protein 
of interest (~29.5 kDa as predicted with the ExPASy webserver (Artimo, Jonnalagedda et al. 2012)). 
Pellet fractions resuspended in TEN-Triton (50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10 mM EDTA, 
2% (v/v) Triton X-100), show distinctively a protein band around 30 kDa (Figure 3.2, lanes 4 to 7), most 
likely AtVDAC1 monomer (green arrow). After washing in buffer TN (50 mM Tris-HCl (pH 8.0), 100 
mM NaCl) the protein’s band intensity increased (Figure 3.2, lanes 8 to 10), to reach saturation after the 
final resuspension in a smaller volume (Figure 3.2, lane 12). The identity of the protein was later 
confirmed by Western Blot (Figure 3.2, @AtVDAC1) using a polyclonal antibody targeted at 
AtVDAC1 at a dilution of 1/1000.  
 
           
Figure 3.2 Production, washing and concentrating of AtVDAC1 inclusion bodies (IB). Samples taken during 
the production of AtVDAC1 were analysed on 12 % (v/v) SDS-PAGE in 1x Laemmli running buffer. 25 µL of 
each of the supernatant fraction from the first wash in TEN Triton (lane 2 to 3), 5 µL of each resuspended pellet 
in TEN Triton (lane 4 to 7) or TN buffer (lane 8 to 10), 5 µL of the pooled pellets (lane 11) and 2 µL of the finally 
resuspended and concentrated AtVDAC1 inclusion bodies (lane 12) were analysed. The identity of the protein was 
confirmed by Western Blotting (right) using an @AtVDAC1 polyclonal antibody (from Agrisera) at 1/1000 
dilution. The position of the AtVDAC1 monomer as well as a possible oligomer are indicated by green arrows. 
 


























The relatively low yield of protein generated (10 to 30 %, or 5 to 15 mg of purified protein for 50 mg of 
inclusion bodies) may be limiting for downstream applications (De Bernardez Clark 1998, Lilie, 
Schwarz et al. 1998). Therefore, different steps of the refolding and purification processes were 
optimized, to enhance the yield of purified protein as well as the robustness of the method. Firstly, use 
of different additives was considered in improving the refolding yields (see section 2.5.3.1) and 
subsequently different chromatographic solid supports were used in improving purification yields (see 
section 2.5.4 and 2.5.6).  
 
The refolding step is often regarded as the most limiting in membrane protein purification, leading 
generally to a dramatic loss of protein (generally 80 %)(De Bernardez Clark 1998, Lilie, Schwarz et al. 
1998). Thus, appropriate additive selection for protein stabilisation and subsequent refolding is pivotal. 
As described in section 2.5.3.1, a screen was performed on the buffer used in the first dilution step of 
the in vitro refolding (25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 100 mM NaCl, 1 mM EDTA, 10 % (v/v) 
Glycerol, 2.29 % (v/v) LDAO). Choice of additives tested was guided by investigations of Yamaguchi 
et al. (2014) (Yamaguchi and Miyazaki 2014) and the screening methodology was inspired from Bondos 
et al. (2003) (Bondos and Bicknell 2003). 
Results of the refolding screens performed on two different batches of AtVDAC1 Inclusion bodies 
(labelled AtVDAC1 and AtVDAC1b) were regrouped in Figure 3.3. More precisely, they were 
represented as the percentage of refolded AtVDAC1 protein out of the total amount initially denatured. 
Out of the eleven conditions tested, the refolding buffer containing NaCl and glycerol appeared to be 
the best for the refolding of AtVDAC1 and AtVDAC1b. The only components providing high AtVDAC 
refolding efficiency (high ratio) for both replicates were NaCl and Glycerol, (NH4)2SO4, Na2SO4, lactose 
and glucose. NaCl and Glycerol combination offered a ratio over 0.9 (or 90%) whereas the other four 
conditions provided slightly lower efficiencies (between 0.8 and 0.9 or 80% and 90%). 
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Interestingly, the different batches sometimes exhibited different behaviours in regard to specific 
components such as Magnesium sulphate (MgSO4) and inositol. The latter is the most intriguing as the 
difference appeared significant (53 % for AtVDAC1 against 92 % for AtVDAC1b). This was explained 
by the variable behaviour of the preparations when using inositol, which tended to precipitate upon 
dilution. Hence, significant variation was obtained when triplicating the measurements.     
Overall, the first refolding step appeared not to be as crucial as the second dilution step. Indeed, most of 
the protein is refolded and solubilized instead of aggregating in pellets and many of the conditions tested 
in Figure 3.3 worked with an efficiency of 80% to 90%. Unfortunately, a screen for the second dilution 
step of the in vitro refolding was not possible using this methodology, due to the higher dilution factor 
(over 100) and the increasing errors in the measurements.  
Nevertheless, the high refolding efficiency achieved with the chosen buffer (25 mM NaH2PO4/ Na2HPO4 
(pH 7.0), 100 mM NaCl, 1 mM EDTA, 10 % (v/v) Glycerol, 2.29 % (v/v) LDAO) gave us confidence 






Figure 3.3 Refolding screen of AtVDAC1 in RF1 and in the presence of different additives. The relative 
solubility effectiveness is normalised to the AtVDAC1 protein that is soluble in the denaturing buffer (25 mM 
NaH2PO4/ Na2HPO4 (pH 7.0), 100 mM NaCl, 1 mM EDTA, 10 mM DTT, 6 M Guanidinium chloride) . If not 
refolded, the protein will aggregate, and following centrifugation the amount of soluble protein will decrease. Two 
different batches of Inclusion bodies were used for this experiment (AtVDAC1 and ATVDAC1b). Ratios for 































Originally, a combination of Fractogel® EMD SO₃⁻ (M) and with Superdex75 ® was used to capture 
the AtVDAC1 protein via ion exchange chromatography and control its monodispersity via gel 
filtration, respectively (see sections 2.5.4.1 and 2.5.6).  
For cation exchange chromatography, using a 5 mL Fractogel® EMD SO₃⁻ (M), a NaCl gradient  of 1 
mM to 1 M (cation exchange chromatography elution buffer, Table 2.1) and the protocol described in 
section 2.5.4.1, the protein would elute within a single peak of approximatively 2 column volumes 
(CVs)), and a maximum absorbance (280 nm) of  100 mAU at around 12 mL (Figure 3.4). The main 
collection peak was determined to be eluting between 10 and 14 mL, or 280 mM to 600 mM salt 
concentration (using a 1 mM to 1 M NaCl gradient), peaking at 500 mM NaCl.  
 
Figure 3.4 Initial cation exchange chromatography of AtVDAC1 protein using an increasing gradient of 
NaCl. Purification profile (in mAU, in blue) of AtVDAC1 protein using a Fractogel® EMD SO₃⁻ (M) and a linear 
gradient (grey) of NaCl (25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 1 mM to 1 M NaCl, 1 mM EDTA, 1 mM DTT, 10 
% (w/v) Glycerol, 0.12 % (v/v) LDAO). Absorbance (280 nm) was recorded against the collected fractions. Elution 
was carried out in an Akta Start ® device. 
 
Fractions were pooled together Figure 3.4; yellow arrow), buffer exchanged and concentrated using an 
















































the previous step) was injected onto a Superdex 75 ® (Figure 3.5A) gel filtration column and eluted in 




Figure 3.5 Size exclusion chromatography (SEC) of AtVDAC1 using Superdex75 and Superose6 solid 
supports. (A) 500 µL of 0.84 µg/µL IEC purified and concentrated AtVDAC1 were injected onto a Superdex75 
column attached to an Akta Prime ® device. (B) 500 µL of 0.84 µg/µL (dark blue line), 0.42 µg/µL (light blue 
line) or 0.21 µg/µL (pink line) of IEC purified and concentrated AtVDAC1 were injected onto a Superose6 
Increase® column attached to an Akta Prime ® device. Experiments were carried out in elution buffer (25 mM 
NaH2PO4/ Na2HPO4 (pH 7.0), 100 M NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12 % (v/v) LDAO). 





























































































The chromatograph recorded (Figure 3.5A, blue curve) in mAU, indicated the presence of two main 
peaks. The first main peak eluted at its maximum at 9.6 mL after injection, corresponding to an 
approximate size of 28 kDa (based on the calibration curve, see section 2.5.6.1), in accordance with the 
expected size of 29 kDa (calculated from Expasy webserver (Artimo, Jonnalagedda et al. 2012)). The 
remaining protein fully entering the column eluted within a second peak, around 12 mL and an 
approximate size of or 14 kDa. Surprisingly, when fractions from both peaks were analysed on a 10 % 
(v/v) SDS-PAGE (Figure 3.6, lane 2 to 4), only the AtVDAC1 monomer could be detected at high purity 
(above 95 %). However, higher column pressure as well as precipitation would be observed occasionally 
during the run when loading concentrated samples on the Superdex75 size exclusion column. The first 
peak would elute in the void volume (7 mL as estimated with Dextran Blue). The protein’s purification 
yield, under these conditions was generally low (few hundred micrograms at best, Figure 3.6, lanes 2 to 
4), despite looking relatively pure. 
To ensure the sample would fully enter the size exclusion chromatography bed volume and increase 
purification yields, gel filtration was attempted using a Superose6 Increase® column (Figure 3.5B), 
under the same conditions in which the Superdex 75 experiment was conducted. The resulting 
chromatogram (Figure 3.5B, dark blue curve) showed a broad peak with a maximum absorbance 
recorded around 16.2 mL after injection (around 64 kDa), with an additional shoulder becoming 
prominent at 18 mL (around 32 kDa). Although exhibiting clear differences in size on size exclusion 
chromatography, no difference was detected between SDS-PAGE analysed fractions from the main 
elution peak (Figure 3.6 lane 5), and SDS-PAGE analysed fractions from the shoulder peak (Figure 3.6, 
lane 6). SDS-PAGE analysed fractions from both peaks revealed the presence of a putative AtVDAC1 
monomer around 30 kDa (Figure 3.6 green arrow). 
To further investigate possible protein and or detergent concentration effects on the quality of the 
collected profiles, two different protein dilutions (dilution factor of 2 and 4, in size exclusion buffer) of 
the same sample were also subjected to SEC. The resulting chromatograms (Figure 3.5B, light blue 
curve and pink curve for the dilution by 2 and 4, respectively) demonstrated a shift of the predominant 
peak towards the position of the shoulder peak of the concentrated sample (around 18 mL). This result 
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confirmed the concentration dependency of the purification profile as well as the potential 
oligomerization of AtVDAC1 monomer protein.      
Typically, the combination Fractogel EMD SO3 (M)/ Superose6 yielded generally 2 mL purified protein 
at a concentration of 1 mg/mL from a batch of 50 mg of Inclusion bodies. This was deemed acceptable 
although limiting for a certain number of assays such as Black lipid membrane (BLM) assay or Far 
Western Blotting. However, a significant percentage of contaminating proteins (10 to 25 %), especially 
of high molecular weight (above 60 kDa, Figure 3.6 lane 5 and 7), was still present in the main elution 
peaks. Additionally, the later fractions (Figure 3.6 lane 6 and 8), although purer, did not yield enough 
monomer per run for a single Small Angle X-Ray Scattering (SAXS) experiment. Consequently, SEC 





Figure 3.6 SDS-PAGE analysis of SEC-AtVDAC1 fractions. 10 µL of each fraction were loaded on 10 % (v/v) 
SDS-PAGE in 1x Laemmli running buffer. Lane 1; ladder from Novex®. Lane 2 to 4; samples collected at 9, 10 
and 12 mL respectively from the Superdex75 column, Lanes 5 to 6; samples collected at 16 and 18 mL respectively 
from 0.84 µg/µL AtVDAC1 injected onto the Superose6 column, Lane 7; sample collected at 16 mL, from a 0.42 
µg/µL AtVDAC1 loaded onto Superose6. Lane 8; sample collected at 18 mL from a 0.21 µg/µL AtVDAC1 loaded 


















Refolded AtVDAC1 was treated as described in section 2.5.4.1. Using a linear gradient of NaCl (Table 
2.1) for the protein elution from the support, the protein eluted as a relatively sharp peak with a tail at 
the end (Figure 3.7). Overall, the elution started around 300 mM NaCl, peaking at 400 mM salt and 
reaching completion around 600 mM salt. Fractions collected between 20 mAU (beginning of the peak) 
and 50 mAU (end of the peak) were pooled together, buffer-exchanged in SEC buffer (see Table 2.1) 
and concentrated using an Amicon ® concentrator with a 10 kDa cut-off. Out of the 50 mg of Inclusion 
bodies used per batch of purification, 5 to 7 mL (1- 1.5 CV on 5 mL prepacked Hitrap SP XL ®) of 
protein could be collected at a concentration of 1- 1.5 mg/mL. When the pooled and concentrated 
fractions were analysed on a 10 % (v/v) SDS PAGE (see 3.5.1.1, Figure 3.8A, lane 8), the AtVDAC1 
monomer exhibited a strong signal, with a reasonable purity (above 80 % of the total signal, using 
ImageJ Software ®). Compared to the previous purifications (see section 3.3.2), the number of 
contaminants and their concentration decreased greatly with this HiTrap resin. This was particularly true 
regarding the higher molecular weight contaminants observed in the analysis of previous samples 




Figure 3.7 Cation exchange chromatography of AtVDAC1 protein using a Hitrap SP XL® with an 
increasing gradient of NaCl. UV absorbance profile (in mAU, in blue) recorded during the elution of AtVDAC1 
protein using a linear gradient (grey) of NaCl (25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 1 mM to 1 M NaCl, 1 mM 
EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12 % (v/v) LDAO). Elution was carried out in an Akta Start ® device. 
The resin used was a HiTrap SP XL 5 mL ®. Collection area is represented by an orange arrow.  
 
HiTrap SP XL 5 mL ® prepacked columns would be used for up to 50 cycles before exhibiting small 
decrease in binding capacity. However, this was easily countered by replacing the column with a fresh 
one. Binding capacity (total amount of protein eluted per mL of resin) would then be monitored at 
























































A sample (500 µL of a 4 mg/mL eluate from IEC performed in section 3.4) was injected onto the column 
and the elution profile was recorded (Figure 3.8B), and recovered samples were analysed by 10 % (v/v) 
SDS PAGE in 1x Laemmli buffer (Figure 3.8A). AtVDAC1 eluted as a broad peak with a maximum 
absorbance recorded at 16.1 mL after injection (69 kDa), with an additional shoulder appearing around 
17-18 mL (50 to 30 kDa) fractions collected separately. 
The use of the HiTrap resin (as opposed the Fractogel resin) resulted in greater sharpness for the main 
peak (Figure 3.8B), resulting in a higher amount of AtVDAC1 monomer eluted, as well as a great 
reduction in the number and concentration of contaminants (higher molecular weight). Although 
exhibiting clear differences in size on analytical size exclusion chromatography, no difference could be 
found between a sample coming from the main elution peak (Figure 3.8A lanes 2 to 4), and a sample 
coming from the later shoulder of the peak (Figure 3.8A, lanes 5 to 7). Indeed, when loaded on SDS-
PAGE (Figure 3.8), the main protein eluted would be the same protein of interest, i.e namely the 
AtVDAC1 monomer around 30 kDa on SDS PAGE (Figure 3.8, green arrow), thus confirming the 








Figure 3.8 Size exclusion chromatography of AtVDAC1 using a Superose6 Increase®. SEC was carried out 
in an Akta Prime ® device in SEC buffer (25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 100 mM NaCl, 1 mM EDTA, 1 
mM DTT, 10 % (w/v) Glycerol, 0.12 % (v/v) LDAO). (A). 10 µL of each purified AtVDAC1 fractions from SEC 
were analysed on a 10 % (v/v) SDS PAGE in 1 x Laemmli running buffer. Lane 1; ladder from Novex®. Lane 2 
to 7; samples collected at 14, 15, 16, 17, 18 and 19 mL, from a 4 mg/mL AtVDAC1 loaded onto Superose6. Lane 
8; 2 µL sample of the 4 mg/mL AtVDAC1 solution injected. The AtVDAC1 monomer is indicated by a green 
arrow. (B). Elution profile (UV absorbance in blue) of the size exclusion chromatography performed on AtVDAC1 
after injection of partially purified sample (500 µL of a 4 mg/mL solution). The minimum working range (void 
































































Circular Dichroism (CD) experiments were performed at The University of Leeds, at the Astbury Centre 
for Molecular Biology on two different samples. Two sample from SEC (see section 3.5) were subjected 
to CD to monitor any conformational associated with the oligomerization of AtVDAC1. The first sample 
was collected 16 mL (labelled as AtVDAC1 oligomer) after injection and the second 18 mL after 
injection (referred as AtVDAC1 monomer). Protein concentration was determined by BCA assay (see 
section 2.5.7) and data were analysed using Dichroweb ® website (Lobley, Wallace et al. 2002, 
Whitmore and Wallace 2004) and algorithms CONTINLL (AtVDAC1 monomer) or CDSSTR 
(AtVDAC1 oligomer)(Sreerama and Woody 2000).  
CD data were collected for both oligomer and monomer fractions as described above and repeated twice 
to ensure robustness of the data. Parameters are summarized in Table 3.1 and the corresponding CD 
spectra are presented in Figure 3.9. 
Table 3.1 Selected parameters for AtVDAC1 Circular Dichroism experiments. 
Parameter AtVDAC1 oligomer AtVDAC1 monomer 
Temperature 20 °C 20 °C 
Path length 1 cm 1 cm 
Protein amount 15 µg 15 µg 
Concentration 1.525 mg/mL 1.26 mg/mL 
Wavelength range 180-260 nm 180-260 nm 
Wavelength increment 1 nm 1 nm 
Initial Wavelength 260 nm 260 nm 
Final Wavelength 180 nm 180 nm 
Analysis algorithm CONTINLL CONTINLL 
 
Replicate CD spectra from AtVDAC1 oligomer (Figure 3.9A) and monomer (Figure 3.9B) were similar 
(1 and 2). In both cases, the profile remained extremely consistent across the experiments.  
Oligomeric AtVDAC1 (Figure 3.9A), exhibited a typical CD spectrum of a beta-sheet rich protein (see 
Figure 2.16 in section 2.6.4), with its minimum reaching at 218 nm, consistent with previous findings 
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on β-barrel rich macromolecules (Greenfield and Fasman, 1969) (Greenfield and Fasman 1969). Data 




   
Figure 3.9 Circular Dichroism spectra of AtVDAC1. (A) CD spectra of AtVDAC1 oligomer (collected 16 mL 
after injection on SEC and buffer exchanged in 25 mM NaH2PO4/ Na2HPO4 (pH 7.0), 0.12 % (v/v) LDAO). Repeat 
1 and repeat 2 are represented in light and dark green respectively. (B) CD spectra of AtVDAC1 monomer 
(collected 18 mL after injection on SEC). Repeat 1 and repeat 2 are represented in light blue and dark blue 
respectively. (C). Comparison of normalized CD spectra from AtVDAC1 monomer (in green) and AtVDAC1 
oligomer (in blue). The maximum value at 190 nm was used to normalize both spectra. All experiments were 
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On the other hand, the monomeric fraction (Figure 3.9B) displayed a composite CD spectrum. In fact, 
the beginning of the profile (from 190 to 214 nm wavelength) is similar to the one observed for the 
oligomeric fraction and resembled a beta barrel protein. However, from 214 to 260 nm the putative 
oligomer exhibited an increased helicity in the overall structural composition. When the data were 
analysed using Dichroweb website (Lobley, Wallace et al. 2002, Whitmore and Wallace 2004) and 
CONTINLL algorithm (Provencher and Gloeckner 1981, van Stokkum, Spoelder et al. 1990), the sum 
of the secondary structure was calculated to be 9.5 % alpha helical, 36.7 % beta barrel and 53.8 % 
random or unordered (Table 3.2). This confirmed the increased helicity observed on the raw data 
between AtVDAC1 oligomer and monomer (from 6.3 to 9.5 % alpha helix). It is likely that the signal 
of the beta barrel is overwhelming when considering an oligomer as opposed to the monomer. This 
could also be explained by a destabilization of the alpha helix (first 15 to 25 amino acids of AtVDAC1 
protein), due to the oligomerization of AtVDAC1 monomers and the high dynamicity of the alpha helix 
(Hiller, Garces et al. 2008, Geula, Ben-Hail et al. 2012). 
Table 3.2 Secondary structure content from three CD-analysed AtVDAC samples. CD data were analysed 
using algorithms CONTINLL (Provencher and Gloeckner 1981, van Stokkum, Spoelder et al. 1990) (AtVDAC1 
monomer) or CDSSTR (Sreerama and Woody 2000) (AtVDAC1 oligomer). Secondary structure content of mouse 
VDAC1 (mVDAC1; based on 3EMN1) is indicated. Hypothetical structure content of VDACs based on their 
expected secondary structures is indicated as well (AtVDACs prediction). 
 Sample Alpha helix Beta barrel Random 
AtVDAC1 oligomer 6.3 % 42.4 % 51.7 % 
AtVDAC1 mono 9.5 % 36.7 % 53.8 % 
mVDAC1 3EMN1 3.7 % 62.7 % 33.6 % 
AtVDACs predictions 4.3 % 50 % 45.7 % 
 
In parallel, the secondary structure content of mouse VDAC1 (mVDAC1) was calculated based on its 
published crystal structure (3EMN1). Using a PDB to CD file converter (PDB2CD® (Mavridis and 
Janes 2016)), a hypothetical CD spectra was generated (based on SMP180 reference database for soluble 
and membrane proteins) and processed in Dichroweb (Lobley, Wallace et al. 2002, Whitmore and 
Wallace 2004) using CONTINLL algorithm (Provencher and Gloeckner 1981, van Stokkum, Spoelder 
et al. 1990). A similar approach was used to calculate an averaged structural content for AtVDACs (1 
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to 4), based this time on their expected secondary structure alone (no crystal structure available, see 
section 1.6.1).  
 
The structural composition of the samples probed by CD seemed numerically close to those of the 
AtVDACs predictions, although the helical content was lower (4.3 %) and the beta barrel content was 
slightly higher (50 % against 36.7 to 42.4 % for the monomer and oligomer respectively) in the 
predictions. This could be explained by the averaged values of the prediction, taking into account all 
Arabidopsis thaliana VDAC proteins (AtVDAC1 to AtVDAC4).  
Interestingly, the same trend could be observed for the structural content of mVDAC1, only on a smaller 
scale. Indeed, despite displaying a similar pattern (high beta barrel content with small helicity) to the 
AtVDAC1 proteins, the beta barrel percentage was significantly higher (from 36-42 % to 62.7 %) and 
the random structure lower (from 51-54 to 33.6%). This was attributed to the crystal form of the protein 
as opposed to its solubilized form, which is t more dynamic due to interactions with the solvent. In 
contrast, within the crystal lattice, the structure is a more compact (hence the possibility to be 
crystallized) and the secondary structure content is dictated by the tertiary resolved structure of the 
protein.   
To further investigate the compactness of the monomeric and oligomeric conformations of AtVDAC1 
and whether the oligomerization conferred a decreased stability of the N-Terminal alpha helix of 
AtVDAC1, experiments were repeated, but with different temperatures. Samples would be denatured at 
high temperature, cooled down and CD spectra were recorded at each stage. In summary, the sample 
would be scanned at 20 °C, heated at 90 °C and re-scanned, then finally cooled down back to 20 °C to 
be re-scanned again.  
The resulting spectra are presented in Figure 3.10 for both monomer (A) and oligomer (B). There is a 
very noticeable full denaturation of the AtVDAC1 oligomer after heating (Figure 3.10B, red line), and 
close to no refolding after cooling down (blue line). This complete loss of structure and difficulty to 
refold was expected, since the membrane protein needed an in vitro dilution for its refolding. 
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The monomer (Figure 3.10A) showed a more complex profile, with strong but incomplete denaturation 
after heating at 90 °C (Figure 3.10A, red line). Upon cooling, a small but noticeable amount of structure 
was recovered, although the refolding was far from achieved.  
This result confirmed an increased stability of the AtVDAC1 monomer in comparison to its oligomer 
form, in regard to the temperature. Noticeably, the oligomer sample recovered a small amount of 
structure after cooling down (Figure 3.10B, blue line), partially resembling the profile of the monomer. 
Indeed, two invaginations could be observed, similar to the combined profile of the AtVDAC1 
monomer, with the exception of the minima observed. This might be due to the difficulty of the multiple 
beta sheets to properly fold upon denaturation as opposed to a small alpha helix.   
   
 
Figure 3.10 Heat denaturation profile of AtVDAC1 samples. (A) CD spectra of AtVDAC1 monomer (collected 
18 mL after injection on SEC) at different temperature. Standard (20°C) measurement, denatured (90 °C) and 
measurement after cooling down to 20 °C are represented as a black, red and blue line respectively. (B) CD spectra 
of AtVDAC1 oligomer (collected 16 mL after injection on SEC) at different temperature. The same colouring 
scheme was used as in (A). All experiments were performed at a scanning speed of 40000 counts per seconds.  
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Planar lipid bilayer assays or Black lipid membrane (BLM) assays, together with patch-clamping are 
electrophysiological techniques designed to evaluate physical properties and characteristics of ion 
transport/diffusion (Hanke and Miller 2008). All methods enable the characterisation of the gating 
behaviour of single channels. BLM, specifically, permits  the study of gating properties of purified 
complexes in a well-controlled artificial lipid environment (Hanke and Miller 2008). Additionally, such 
techniques enable the investigation of direct effects of chemicals and enzymes on the channel’s gating 
behaviour, while excluding possible indirect effects stemming from the presence of regulatory proteins 
under native/in vivo conditions. A description of a typical BLM setup has been described in section 
2.6.2. 
Typically, an electrophysiology experiment is performed by monitoring the transport rates of ions across 
membranes through ion channels. The rate of transport is measured as an ionic current (recorded in pA). 
Potentials/voltages, or membrane potentials (Vm; in mV) can be generated across the membrane either 
electrically (e.g. by a battery with electrodes on either side of the membrane) or chemically by 
asymmetric distribution of ion concentration in solution. Recorded currents can then be analysed to 
characterise various parameters of the open and closed states of the ion channel under experimentation, 
such as their currents, their population distribution (one to multiple closed states), their conductance, 
and their dwell times (Maher and Allen 2018).  
 
Experiments were conducted at The University of Brighton, under the supervision of Dr Marcus Allen. 
Two chambers (or a lipid bilayer cups) for bilayer formation (Warner Instruments chamber BCH-13A 
and cup CP13A-250) were connected via potassium chloride (KCl) agar bridges and silver/silver 
chloride (Ag/AgCl) electrodes to the amplifier head stage. The amplifier used (Warner Instruments PC-
501A) facilitated the detection of bilayer recordings and single channel currents were digitised using an 
analogue to digital converter (CED micro1401 MkII), controlled by single channel analysis software 
(WinEDR®, University of Strathclyde, UK). 
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The lipid bilayer was prepared using a 1:1 mixture of POPE (1-Palmitoyl-2-Oleoyl-sn-glycero-3-
phosphoethanolamine, Avanti Polar Lipids®) and POPS (1-Palmitoyl-2-Oleoyl-sn-glycero-3-
[phosphor-L-serine], Avanti Polar Lipids®) resuspended in N-Decane. A small volume (1 to 2 µL or 
7.5 to 15 µg) was applied on the aperture (or pinhole, 200 µm wide) between the cis and trans chambers 
and the buffer (10 mM Tris-HCl (pH 7.4), 150 mM KCl, 50 mM CaCl2) was added on each side of the 
bilayer. The correct elevation of the membrane was controlled through the absence of current across the 
chambers, and its limits were tested via mixing the solution while monitoring its capacitance. Because 
of mixing, the membrane size would decrease until reaching a breaking point (White and Thompson 
1973). Experiments were carried out using the thinnest possible bilayer (just before that breaking point 
was reached). 
 A few microliters of AtVDAC1 protein (1.15 mg/mL) resuspended in DMPC (1,2-
Dipalmitoylphosphatidylcholine) was applied to the trans chamber. The correct insertion of the porin 
into the bilayer was monitored on-screen by applying positive and negative potentials across the 
membrane (-40 and +40 mV). A current could be measured once the porin was properly incorporated, 
and its opening or closure was monitored at various membrane potentials.  
Observations were made quickly to assess the stability of the porin inside the bilayer using membrane 





Figure 3.11 Voltage ramp experiment of a single AtVDAC1 channel reconstituted on a POPE/POPS planar 
bilayer. Increasing voltages (Vm) ranging from -100 to +100 mV were applied across the bilayer in 10 mM 
Tris/HCl (pH 7.4), 150 mM KCl, 50 mM Ca2+. Currents (Im) resulting from AtVDAC1 ion gating were recorded 
in pA. 
 
Unfortunately, the current was highly unstable below -40 mV and above +40 mV, despite the porin 
displaying activity in all range of voltages applied. Consequently, experiments were generally 
performed between -40 and +40 mV membrane potentials. Mostly, the number of channels inserted into 
the bilayer needed to be kept to a minimum to prevent bilayer disruption. To further maintain the bilayer 
integrity, the DMPC-AtVDAC1 liposomes were filtered using two Hamilton gas tight 200 μL syringes 
coupled together by a two R nut prior to the assay. Conventional methods such as mixing (with a vortex), 
sonication or freeze-thawing did not prove as efficient. Filtering improved the effectiveness of 
AtVDAC1 insertion into the bilayer and facilitated recording of measurements up to an hour.  
Following the primary observation of the data collected on AtVDAC1 via BLM, gating events were 
detected using WinEDR® software analysis tool. In essence, the software can automatically detect 
events by setting a predefined threshold and defining an initial opening conductance (open state S0). 
Following the detection, parameters such as the average current (in pA), the voltage applied (in mV), 




Figure 3.12 Representative recordings of single AtVDAC1 channels reconstituted on a POPE/POPS planar 
bilayer at 40 mV. Three different currents corresponding to three different states (1 open and two closed states) 
were observed for the inserted AtVDAC1 channel in the planar bilayer in 10 mM Tris/HCl (pH 7.4), 150 mM KCl, 
50 mM CaCl2) The open S0 and the closed states S1 and S2 are indicated by a blue, red and green line.  
  
Interestingly, different closed states could be identified since they displayed obvious differences in these 
parameters (Figure 3.12). At least two different closed states could be identified (S1 and S2; Figure 
3.12) shaping the gating of AtVDAC1. Each of these states exhibited unique current signatures with 
variable opening times. More specifically, the S1 and S2 states conducted currents of approximatively 
80 % and 50 %, respectively, with respect to the fully open state S0 (Figure 3.12, blue).  This specific 
pattern of closure confirmed the identity of the channel, since this behaviour was already characterized 
in other VDACs such as the human hVDAC1 (Engelhardt, 2007) (Engelhardt, Meins et al. 2007) or 




Figure 3.13 Typical BLM recordings of single AtVDAC1 channels reconstituted on a POPE/POPS planar 
bilayer. The protein (1.15 mg/mL) was inserted into the bilayer in 10 mM Tris/HCl (pH 7.4), 150 mM KCl, 50 
mM Ca2+. Currents measurements (in pA) were recorded for 100 seconds at four different voltages (-40, -30, -20 
and -10 mV) in WinEDR® software. The open state S0 and the two closed states S1 and S2 are indicated blue, red 
and green arrows. 
 
A typical BLM profile for the ATVDAC1 channel at different applied voltage (-40 to -10 mV) using 
the WinEDR® software is shown in Figure 3.13. Generally, the overall frequency of gating increased 
with the voltage applied across the membrane (Figure 3.13). This was reflected by an increasing number 
of channel opening and closing events at higher voltages (Figure 3.13, -40 mV) compared to lower 
voltages (Figure 3.13, -30 mV). A change in the duration and conductance of the closed states was 












state). Furthermore, occupancy of the closed states varied with applied voltage. For example, S2 states 
were mostly absent below ±20 mV (Figure 3.13, -20 mV).  
Finally, based upon previous observations on VDAC channels (Mertins et al. 2012), intermediate open 
states were identified most often at the beginning of the recording (Figure 3.14), and generally resulted 
from reverse potential application between the different voltage steps. These states can be described as 
transitional open states of higher conductance (black arrow), of generally few seconds (up to 20 seconds 
at lower voltages, below ±20 mV). 
 
Figure 3.14 Intermediate open states of AtVDAC1 channel. First 40 seconds recordings of AtVDAC1 channel 
at -30 mV in a POPE/POPS lipid bilayer in 10 mM Tris/HCl (pH 7.4), 150 mM KCl, 50 mM Ca2+. A transitional 
state (black arrow) can be observed at the beginning of the voltage pulse, preceding the “normal” opening state 
(blue arrow).  
 
Using Ohm’s law (equation 3.1), the relationship between Voltage applied and current recorded can be 
examined to further understand the porin’s symmetric (or asymmetric) gating behaviour.  







Equation 3.1 Ohm’s Law. The conductance G (in Siemens S) is the reverse of the resistance R (in Ohm Ω) and 
is defined by a relationship between current I (in Amperes A) and voltage V (in Volts V). 
  
The different currents recorded were plotted against the applied voltage (Figure 3.15) for both closed 
states (S1 and S2) as well as the open state (S0). Over short periods of applied voltages (10 seconds per 
voltage), all three states displayed symmetric behaviour for their current recorded (Figure 3.15A). 
However, more asymmetric gating events were observed when exposing the porin for longer period of 
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time at specific membrane potentials (Figure 3.15B). This was mainly due to the appearance of 
intermediate states at longer exposure times as opposed to short bursts of 10 seconds. Therefore, the 
resulting graph (at longer voltage) resembled a kinetic curve, with linear behaviour at negative voltages, 
and logarithmic behaviour at positive voltages, indicating a probable outward rectification of the 






Figure 3.15 I/V (Ohm) plots used for the determination of the conducting AtVDAC1 states. Currents for the 
AtVDAC1 channel (in a POPE/POPS lipid bilayer in 10 mM Tris/HCl (pH 7.4), 150 mM KCl, 50 mM CaCl2) 
were recorded for 10 seconds bursts (A) or 100 seconds (B) bursts at different voltages. The two observed closed 
states S2 (yellow) and S1 (green) as well as the open state (red) are represented. Recording and detection of gating 






Since apparent correlations between current and voltages were identified (Figure 3.15), conductance 
values were calculated for each opening and closure of the channel. The analysis of the occurrence of 
individual conducting states was performed in MagikPlot®, as WinEDR® package offered a limited 
panel of graph. Conductance values were sorted by how often they occurred during the gating events. 
The resulting histogram (Figure 3.16, in light blue) confirmed the previous observations made on the 
raw data. Indeed, at least two clear closed states, corresponding to the identified S2 state (yellow line) 
and S1 state (green line) of the channel, as well as the fully open state S0 (red line) could be fitted with 
gaussian curves. The combined curve (black dashed line) residual R2 (or goodness of fit) was calculated 
to be 0.9243, thus explaining most of the variance associated with this model.  
 
Figure 3.16 Overall conductance profile of AtVDAC1 channel. Combined graph of AtVDAC1 conductance 
measurements (light blue histogram) with the Gaussian fit for the closed states S2 (yellow line) and S1 (green line) 
as well the open state S0 (red line). The combined fitting model (black dashed line) residual R2 was calculated to 
be 0.9243 (N=960), and the conductance for S2, S1 and S0 were established at 306,17 pS (±1.49), 428.55 pS (±1.3) 






























Although this initial fitting model was deemed acceptable (R2 > 0.9) when all states were considered, 
the total variance was not fully explained (ideally R2 > 0.99). This was visually obvious for the S1 state 
as the single Gaussian fit lacked smoothness (Figure 3.16, green line), since the distribution potentially 
comprised additional sub-states. Further analysis was performed on the closed states only to further 
understand the distribution of possible sub-states under S1. When only the closed states were considered 
an initial single Gaussian fit analysis (Figure 3.16) covered 72 % of the data (R2 = 0.7231). However, 
the fit with two additional Gaussians, resulted in a better fitting curve (Figure 3.17, black dashed line) 
with greater coverage (R2 = 0.9195). 
 
Figure 3.17 Conductance profile for the closed states of AtVDAC1 channel. Combined graph of AtVDAC1 
conductance measurements (light blue histogram) with the gaussian fit for the closed states S2 (yellow line), S1a 
(red line), S1b (green line) and S1c (blue line). The combined fitting model (black dashed line) residual R2 was 
calculated to be 0.9195, and the conductance for S2, S1a, S1b and S1c were established at 306,17 pS (±1.13), 




























As advised, when considering multiple series, an ANOVA test was performed on the data series and 
confirmed (p = 0.0087, N=960) the significance of the model. Additionally, T-Tests were performed to 
ensure the statistical relevance of this model by comparing the sub-state variances. Results are regrouped 
in Table 3.3. 
Table 3. 3 Statistical analysis of ATVDAC1 closed states.  
State Conductance (pS) P value (T-test) 
for S1a 
P value (T-test) 
for S1b 
P value (T-test) 
for S1c 
S2 306,17 (±1.13) >0.001 >0.001 >0.001 
S1a 431.57 (±0.81)  0.042 0.028 
S1b 415.93 (±7.1289)   0.039 
S1c 366.92 (±1.92)    
Conductance (in pS) was calculated for each state as well as their standard deviation. Series for each state were 
compared to each other using Student T-test. A p value > 0.05 is considered significant. 
 
The S2 (N=187) state was not affected at all during this additional analysis, as reflected by the p values 
when compared to those of each sub-state. Sub-state S1c (N=26) and S1a (N=151) had the most 
significant difference amongst the S1 states, albeit their p values were overall relatively close. 
Unfortunately, the low number of events recorded for these sub-states greatly affected the statistical 
outcome. Further experiments are needed to strengthen the statistical relevance of the fit for the S1b 






Interestingly, S1 and S2 states had comparable occurrences (Figure 3.17) despite the primary 
observations made on the raw data (Figure 3.13, -40 and -20 mV), suggesting a bias possibly toward S2 
state at higher voltage, and certainly towards S1 state (or sub-states) at lower voltages (below ±20 mV). 
Consequently, dwell times were investigated for the S1 state at -40 and -20 mV (100 seconds pulse 
each), both of which had extremely different profiles. The S2 state, although present at -20 mV, was not 
identified often enough to guarantee a significant relevance for this comparative analysis. This 
confirmed the early suggestions of population bias toward S2 state at lower voltages, as opposed to the 
relatively similar distribution of S1 and S2 closure events at -40 mV (Figure 3.13). 
Dwell times for the S1 AtVDAC1 states depended on the applied voltage and/or its duration. Noticeably, 
the S1 states were populated at short pulses of high voltages, e.g. -40 mV (Figure 3.18, orange dots; 
mostly below 1 ms). In contrast, long pulses (of half a second to one or two seconds) of lower voltages, 











Figure 3.18 Analysis of S1 dwell times at -40 mV and -20 mV. Graph representing the distribution of the dwell 
times for the S1 state of the AtVDAC1 channel at -40 mV (orange) and -20 mV (grey). The median value was 
calculated to be 0.3 and 305 ms at -40 mV and -20 mV respectively. For convenience the same graph was shown 







Table 3.4 Probabilities of AtVDAC1 opening and closure channel at -40 and -20 mV. The sum of each dwell 
time was calculated for the open state S1 and the closed state (S1+S2). Results are presented as a percentage of 
the total recorded time.  
State -40 mV -20 mV 
Open 91.37 % 90.57 % 
Close 8.63 % 9.43 % 
 
To further examine possible voltage dependency of gating transitions, the open and closed probabilities 
for the channel’s gating were determined (Table 3.4). Surprisingly, the channel was closed for a longer 
period at -20 mV. Although the difference in percentage of closure between -20 and -40 mV was only 
0.80 %, the perspective of having a 110 % longer (9.43 % against 8.63 %) closure despite a twice lower 
voltage applied (-20 mV against -40 mV) greatly amplified the significance of this small variation.  
Considering the activity of a channel is greatly dependent on the number of events, this last result 
unveiled a more complex gating behaviour for the AtVDAC1 channel (in a POPE/POPS lipid bilayer in 
10 mM Tris-HCl (pH 7.4), 150 mM KCl, 50 mM CaCl2). Indeed, the increase in number of events 
observed at higher voltages should theoretically involve a longer closure of the channel, unless 
additional mechanisms are involved. Further investigation was undertaken to fully understand this 
behaviour and characterize the channel’s gating activity further. Since the activity is usually described 
as function of the current recorded and the dwell time, the total charge (in Coulomb) can be calculated 
using the relationship in equation 3.2. 
𝑄 = 𝐼 × 𝑡 
Equation 3.2 Definition of a coulomb. A coulomb can be defined as the charge (Q) transported by a constant 
current (I) of one ampere in a time (t) of one second. 
 
Moreover, VDACs are known to display a preference for cations (Colombini, Blachly-Dyson et al. 
1996) (see section 1.7.1). Therefore, the variation of current between the closed and the open state was 
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calculated for each gating event at -20 and -40 mV. Values were then multiplied by their corresponding 
recorded dwell times following the relationship in Equation 3.2 and summed up together. The 
calculation of the area covered by the closure event would provide information on the total variation of 
charge (between the open and the closed states) and could be used as a measure of the “power of 
closure”. Theoretically, the number of ions passing through the channel could also be calculated using 
the elementary charge of an electron e- (1.602x10-19). However, the closure of the channel is 
characterized by a decrease in affinity for anions, an increased affinity for cations. Although largely in 
favour of cations in the closed state, this ratio between anions and cations should be included in the 
calculation of the number of ions. Hence, the use of the total charge or total number of charges Q can 
be useful in comparing similar states at different voltages.   
Table 3.5 Total variation of charge for the AtVDAC1 channel. Variations of current were calculated between 
the open state and the closed states at -40 and -20 mV and multiplied by their corresponding dwell time.    
Parameters -40 mV -20 mV 
Total variation of charge (in pC) 67.21 168.57 
 
The result was astounding as the total variation of charge was more than two-fold at -20 mV than -40 
mV (Table 3.5). Despite the lower applied voltage, the lower number of events (Figure 3.13, -20 mV), 
the lower current recorded (Figure 3.15A), the displacement of charge generated by the closure event 
was greater at -20 mV. In other words, the surface covered by the closed states was greater at -20 mV 
than -40 mV, which was unexpected since the difference in activity (number of events) was 
overwhelming (see Figure 3.13). 
In conclusion, the AtVDAC1 channel exhibited at least two closed states, namely S2 and S1, with 
conductances of 306.17 pS (±1.49) and 428.55 pS (±1.3) respectively. The channel exhibited its highest 
activity at -40 mV and was highly unstable at higher voltages. In addition, the channel exhibited a 
symmetric behaviour on Ohm plots over short voltage pulse (10 seconds) but became highly 
asymmetrical when exposed for 100 seconds, suggesting an outward rectification (Hedrich, Moran et al. 
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1995). Furthermore, a heterologous distribution of the closed states could be observed depending on the 
applied voltage, with a shift toward the S1 state at lower voltages. This led to a surprising finding as the 
S1 state (46:1 against the S2 state at -20 mV) was sufficiently present at low voltages to provide a 
comparable if not higher total power than all other closed states at -40 mV, despite greater number of 






The first step required to facilitate the regular production of adequate amounts of protein for downstream 
applications was the optimization of the gene expression.  
The successful cloning of AtVDAC1 gene into the expression plasmid pET-20b(+) as well the 
preliminary work on the expression of the AtVDAC1 protein was performed by Felix Brademann at The 
University of Marburg. This set the ground for the use of a robust and reproducible expression system, 
suitable for all the proteins produced in this work. Although initial over-expression attempts utilised 
IPTG, we quickly reverted into using auto-induction. This decision was not only based on practicality, 
but on efficiency, as well, since it increased the overall yield of protein by at least a factor of 5. Indeed, 
as the OMP9 E. coli cells lacked most porins required for their survival, their growth rate was slower 
than other experimental strains (40 minutes to 1 h per generation). Thus, overnight shaking in a highly 
rich media instead of a 4-hour induction was preferable, to ensure adequate cell densities.  
The washing of inclusion bodies and their concentration yielded around 300 to 500 mg of partially 
folded protein per two litres of cell culture. Also, the washing of inclusion bodies served as a pre-
purification step due to the removal of major contaminants from the overall mixture. 
Protein refolding yields are generally low (Yamaguchi and Miyazaki 2014), often % less than 40 % 
(Zhi, Landry et al. 1992), leading to great loses of total protein material, particularly for membrane 
proteins. In consequence, detergent choice, as a refolding aid, is critical in ensuring adequate refolding 
yields. An initial screen was performed by Felix Brademann as well and helped to determine LDAO as 
the best detergent (results not shown). The additional additive screen described in this work (section 
3.3.1), around the refolding buffer used in the first dilution step of the in vitro refolding, guaranteed the 
best condition for minimizing protein loss during the step. Time and resource constraints outweighed 
the usefulness of further additive screens. Nevertheless, alternative methods of high-throughput 
screening combined with Size exclusion-High Performance Liquid Chromatography (SEC-HPLC), may 
prove more useful in probing aggregate concentration (Hong, Koza et al. 2012).    
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The capture of the refolded AtVDAC1 protein via Ion Exchange Chromatography proved difficult and 
required further optimisation. Despite providing reasonable purification yields (overall around 10 %), 
the Fractogel® EMD SO3 and Superdex75® solid support combination did not provide a clear 
separation of the monomer from contaminants. It seemed that these contaminants interacted strongly 
with the Ion exchange chromatography matrix and were carried over in downstream experiments. The 
presence of LDAO in the mixture can explain their reluctance to be excluded as they might be embedded 
or encapsulated in micelles (Hayashi and Ikeda 1980, Thiyagarajan and Tiede 1994, Hiller, Garces et 
al. 2008, Hiller and Wagner 2009, Raschle, Hiller et al. 2009, Yu, Raschle et al. 2012). Luckily, most 
of these contaminants degraded faster than the AtVDAC monomeric protein over time, and the overall 
high concentration of the AtVDAC1 monomer ensured purer preparations.  
Due to the propensity of VDAC to oligomerise and/or aggregate, large molecular weight species were 
completely excluded from the Superdex75®. In consequence, for successive gel-filtration experiments, 
Superose 6 Increase® was used as it was shown to successfully resolve membrane protein oligomers 
and/or aggregates (Hall and Huang 2012). Overall, the protein generally eluted as two relatively broad 
peaks around 16-17 mL to 18-19 mL, or 27-36 kDa to 62-70 kDa according to the calibration curve 
(section 3.5). The relatively large size of early-eluting-species suggested the protein could form 
oligomers. The confirmation by SDS-PAGE of the identity of the main protein eluting (AtVDAC1) 
within that volume supported that hypothesis. The presence of. LDAO micelles, surrounding the protein 
species, would further impact on the total size of the complex. LDAO is known to form micelles of 17 
to 21 kDa (Herrmann 1962, Strop and Brunger 2005). However, the larger size (above 60 kDa) 
compared to AtVDAC1 embedded in a LDAO micelle (29 + 17) suited more the oligomerization 
scenario (section 3.5). Besides, dilution of the protein led to a shift towards the second peak (believed 
to be associated with the monomer), suggesting equilibrium monomer-oligomer equilibrium (Josse, Ebel 
et al. 2002). This negated the possibility of a slightly larger micelle, as no variation in size was ever 
observed which does not fit the relatively dynamic behaviour of detergent micelles in general (Garavito 
and Ferguson-Miller 2001).  
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The major breakthrough came when a new set of solid support, known as the HiTrap 5 mL SP XL, was 
tested and did improve the yield of monomer purified, as well as allowing more concentrated samples 
to be subjected to size exclusion chromatography. Contrary to HiTrap SP XL, the increased binding 
capacity of the the Fractogel EMD SO3 (M), stems from the cross-linked poly-methacrylate, a long 
linear polymer chain where the ion exchanger groups are bonded, offering more binding sites (A. Sewell 
2010). This was probably the reason additional contaminants were taken up, thus making the HiTrap a 
better choice for the purification of untagged proteins. 
Obviously, the absence of a conventional purification tag such the His-tag required the protein to be 
purified using ion exchange chromatography rather than a conventional affinity-chromatography step. 
However, on occasion the presence of a purification tag was shown to interfere with both the affinity 
purification and the functionality of proteins studied (Carson, Johnson et al. 2007). Although 
optimisations around the solid support used for ion exchange chromatography where time consuming, 





The first structural experiment conduced on AtVDAC1 was the definition of its secondary structure 
content by Circular Dichroism, following its purification by size exclusion chromatography. For this 
assay, two different fractions, collected at 16 and 18 mL from a Superose6 Increase® purification 
(section 3.5) and subjected to CD experiment (section 3.6). These two different fractions eluted at 
specific volumes, that were in accordance with a size of a putative AtVDAC1 monomer (around 30 
kDa) and an oligomer (around 60 kDa). Thus, it was possible to investigate the effect of oligomerization 
on the secondary structure of the AtVDAC1 channel. 
Primary analysis of the CD spectra at 20 °C showed a typical beta barrel rich protein profile for the 
oligomer, whereas the monomer displayed a combination of beta barrels with a small alpha helical 
content. The subsequent analysis using Dichroweb website and algorithms CONTINLL and CDSSTR 
(Lobley, Wallace et al. 2002, Whitmore and Wallace 2004) confirmed the observations made on the raw 
profiles. Indeed, both samples would exhibit similar structural content, composed mainly of beta barrels 
(36 to 42 %) and random coils (around 50 %), with a small alpha helical content (6.3 % to 9.5%). Again, 
the difference between the monomer fraction and the oligomer fraction showed an increased helicity in 
the monomer, or a decreased helicity in the oligomer, depending on the approach. The decrease in 
helicity in the oligomer could be explained by the overwhelming signal of the beta-barrels in this 
configuration. More likely, the presence of detergent is known to affect the CD signal, creating what is 
referred as the solvent shift effect (Cascio and Wallace 1995, Chen and Wallace 1997, Miles and 
Wallace 2016). To support this hypothesis, a comparative Thin layer Chromatography was performed 
on AtVDAC1 oligomer and monomer fractions (see Appendix 9.5). Although the concentrations were 
too low to accurately measure the detergent concentration, a noticeable difference could be observed 
between the oligomer and monomer samples, suggesting a higher concentration of LDAO in the 
oligomer fractions. This is in accordance with our previous hypothesis, indicating a shift effect due to 
the higher concentration of LDAO in the oligomer samples. Consequently, the calculation of the 
NRMSD (normalized-root-mean-square deviation) by the Dichroweb webserver (Lobley, Wallace 
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et al. 2002, Whitmore and Wallace 2004), which is a measure of the statistical relevance of the model, 
yielded values above 0.1 for this sample, considered not statistically relevant.  
Nevertheless, the structural determination of AtVDAC1 monomer fraction confirmed the correct 
refolding of the protein using the in vitro dilution, since it displayed typical content of a VDAC channel 
(see section 1.6), and CD spectra is in agreement with previous reports on S.cerevisae scVDAC in 1% 
LDAO (Koppel, Kinnally et al. 1998). Interestingly, it seems the type of detergent, the pH and 
temperature can also influence the CD spectra, as illustrated by the increased helicity of VDAC in the 
presence of LDAO and its decreased helicity in Octyl-glucoside (OG) (Shao, Kinnally et al. 1996).  
The heating cooling process indicated a great degree of denaturation for the monomer. Upon cooling, a 
small amount of structure is recovered, and the profile remained highly comparable to the unheated 
protein spectra (section 3.6 Figure 3.10). On the opposite, the oligomer displayed an almost complete 
loss of structure following heating, and barely any recovery upon cooling (section 3.6, Figure 3.10). 
Furthermore, the profile for the latter seem to include an alpha helical content, similar to the one 
observed for the monomer. This result was expected since the alpha helix is shorter and easier to refold 
than beta sheets (Vijayakumar, Vishveshwara et al. 1993). Finally, a small increase in the HT spectrum 





AtVDAC1 was successfully incorporated into a POPS/POPE lipid bilayer, and the channel exhibited 
gating activity in 10 mM Tris-HCl (pH 7.4), 150 mM KCl, 50 mM CaCl2 (section 3.7).  
Ramp experiments allowed the characterization of the optimum conditions for recording the activity of 
the channel. A clear instability was observed when a current above 40 mV was applied, often leading to 
bilayer disruption. This result was surprising since the VDAC channel has been reportedly capable of 
sustaining voltages up to 100 mV (Colombini 1989, Colombini 2004, Tan and Colombini 2007, 
Colombini 2016). However, the different composition in lipids (POPS/POPE instead of POPC)(Renne 
and de Kroon 2018) as well as the lower concentration of salt used in these experiments (Böckmann, 
Hac et al. 2003) might contribute to the instability of the bilayer.  
Typically, the channel opened and closed rapidly, displaying at least three conductance states. The open 
state denoted S0 was identified with a conductance of 540.16 pS (±0.35). Two closed states, referred to 
as S1 and S2, exhibited conductances of 428.55 pS (±1.3) and 306.17 pS (±1.49), respectively. The S2 
state conductance was around 60 % of that of the open state S0, in accordance with previous findings 
(Colombini 1989, Tan and Colombini 2007, Mertins, Psakis et al. 2012, Colombini 2016).  
Surprisingly, the S1 state exhibited a relatively high conductance, corresponding to 80 % of the open 
state S0. Different sub-states were potentially identified (S1a, S1b and S1c), but insufficient data 
prevented the generation of statistically relevant models. Additional experiments could provide the 
necessary amount of gating events to strengthen the model. The difference in the conductance of S1 and 
S2 could be explained by the fact that the channel can act as a sensor, alternatively switching preference 
to calcium or potassium cations in its closed state (Pavlov, Grigoriev et al. 2005, Tan and Colombini 
2007).  
 Overall, the electrophysiology of the AtVDAC1 channel, fitted the gating behaviour of previously 
characterised orthologues, concerning the unique partial gating of the channel and the diversity of its 
closed states and/or the intermediate states (Figure 3.12). Hence, this experiment was very successful at 
characterizing the main conducting state (S0, S1 and S2) of the channel AtVDAC1.  
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Table 3.6 Famous VDACs Gating conductance. 
Protein  Open state (nS) Closed state (nS) Salt 
concentration 
Reference 
mVDAC1 3.70±0.40 1.70±0.20 1 M KCl Ujwal et al., 2008 
mVDAC1 3.94±0.04 2.61±0.01 (S1), 
1.90±0.06 (S2) 
1 M KCl Mertins, Psakis, et al. 
2012 
hVDAC1 4.50±0.50  1 M NaCl Shanmugavadivu et 
al., 2008 
hVDAC1 3.90±1.50  1 M KCl Hiller et al., 2008 
NcVDAC1 4.0 2.0 1 M KCl Popp et al., 1996 
AtVDAC3 0.500 0.2 to 0.65 100 mM/300 
mM KCl 
Berrier et al., 2015 
rVDAC 4.50  1 M KCl Colombini et al., 1989 
rVDAC 0.48  0.1 M KCl Colombini et al., 1989 
ScVDAC 4.5  1 M KCl Colombini et al., 1989 
ScVDAC 0.45  0.1 M KCl Colombini et al., 1989 
AtVDAC1 0.54 0.31±0.0049 (S2), 
0.43±0.0013 (S1) 
150 mM KCl  
 
The lower conductance reported in this study, between 0.3 and 0.54 nS, can be correlated with the lower 
concentration of salt used in the BLM buffer (150 mM), compared to previously reported conductances 
of VDAC channels (see Table 7.1). Indeed, experiments conducted at concentrations lower or equal to 
150 mM KCl generally revealed conductances 10-fold lower than those reported at higher 
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concentrations of salt, namely 1 M KCl. A perfect example is illustrated by the yeast VDAC (ScVDAC), 
which exhibits a conductance of 4.5 nS at 1 M KCl, and 0.45 nS at 0.1 M KCl (Colombini 1989). 
Therefore, it is very likely that the AtVDAC1 channel’s conductance would be higher at 1 M KCl. 
Most importantly, both AtVDAC1 and AtVDAC3 channels (Berrier, Peyronnet et al. 2015) exhibited 
highly similar conductance values for their open and closed states, potentially confirming the 
conservation of the ion gating function amongst AtVDAC isoforms. Considering these two isoforms are 
both residing largely in the mitochondrion (section 1.5.3), this similarity is to be expected, contrary to 
AtVDAC2 and AtVDAC4, whose expression and sub-cellular localization differs from the previous two 
isoforms (Tateda, Watanabe et al. 2011). The slight differences in the values reported (Table 7.1) might 
either arise from the different methodology used (symmetric versus asymmetric salt concentration) or 
small evolutionary divergence between the isoform 1 and 3 from A.thaliana. AtVDAC1 is known to be 
ubiquitous and essential for plant survival whereas AtVDAC3 is not essential and is restricted to leaf 
tips of seedlings, shoot meristems, and anthers (Tateda, Watanabe et al. 2011). It is possible that 
AtVDAC3 expression is only upregulated under specific conditions, where its gating activity might 
favour a certain biochemistry. Further research on the role of AtVDAC1 gating in plants could help 
unveiling more precisely the role of AtVDAC3 by designing chimeric constructs of AtVDAC1 and 
AtVDAC3. The chimeric channels would behave differentially to the application of a current depending 
on their relative composition in AtVDAC1 and AtVDAC3. This type of study can broaden our 
comprehension of the gating phenomenon and ultimately enlighten us on the structures responsible for 
the modulation of the conductance states. Finally, the study of AtVDAC3 offered an interesting insight 
into the cationic properties of the closed states at low voltages, which were highly similar to the S1 
closed state trace patterns showed for AtVDAC1 in this work. As mentioned previously, the sensing 
ability of the channel might dictate which type of ions will pass through (Pavlov, Grigoriev et al. 2005, 
Tan and Colombini 2007). Various BLM experiments could be designed to confirm this ability, and 
potentially attribute a state to a specific ion for AtVDAC1. The use of different cations or asymmetric 
salt solutions, to replace the calcium or the potassium ions, would be useful tools for this type of 
investigations. Furthermore, considering new plant tissues such as the tips of the roots, and young leaves 
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can't properly form without a decent concentration of calcium (White and Broadley 2003), it would be 
interesting to test whether any of the AtVDAC isoforms has a strong preference for calcium ions. For 
example, since AtVDAC3 is highly restricted to the leaf tips of seedlings, shoot meristems, and anthers 
(Tateda, Watanabe et al. 2011), possible variation in the sensing ability could be expected with 





Additional investigations of the S1 state gating at “low” (-20 mV) and “high” applied voltages (-40 mV) 
allowed a deeper comprehension of the AtVDAC1 channel’s activity. Mostly under-looked, the gating 
at voltages above -20 mV and below 20 mV lacks characterization and the VDAC channel is often 
deemed “most active” at 40 mV (Colombini 1989, Tan and Colombini 2007, Mertins, Psakis et al. 2012, 
Colombini 2016). In the case of AtVDAC1, at low voltages, the distribution of the closed states was 
directed toward long closure events of relatively high conductance (or low variation from the open state), 
as exemplified by the acquisition of S1 state. Surprisingly, the channel was closed for a longer period 
of time (Table 3.3) at -20 mV, despite a higher number of closure events at -40 mV.  
Finally, the use of the total variation of charge between the open and closed states allowed quantifying 
the “power” delivered during a 100 pulse at both -40 and -20 mV (or indirectly, the number of 
ions/charges concerned by the closure event). This confirmed the channel was still exhibiting a 
comparable processing of charges across the membrane at both voltages.  
Furthermore, this preference for the S1 state at -20 mV could be further explored by modulating the 
concentration or the composition of ions present in the solution. As mentioned above, the sensing ability 
and preference for a specific ion at specific voltage could unveil mechanisms of calcium uptake from 
the mitochondria, well known to mediate cell fate (see section 1.7.3). Finally, it would also be interesting 
to investigate whether any other VDAC channel might be exhibiting similar pattern using this parameter.    
In the end, the different issues encountered such as the rectification observed at long voltage exposure 
(100 s) prevented the collection of significant amounts of data for positive currents. The use of different 
concentration of salt could help explore and understand this rectification process, as demonstrated for 





In summary, the Planar Lipid Bilayer assay was a powerful tool, rapidly generating a great amount of 
data for the AtVDAC1 channel, reconstituted in DMPC and inserted into a POPE/POPS lipid bilayer in 
10 mM Tris-HCl (pH 7.4), 150 mM KCl, 50 mM CaCl2. Nevertheless, a great number of challenges 
had to be overcome to enable the production of quality data.  
First and foremost, the AtVDAC1 reconstitution in DMPC, albeit successful, enabled the generation of 
large GVO proteoliposomes which proved difficult to homogenize using conventional methods such as 
freeze/thawing, sonication and mixing (Scotto, Goodwyn et al. 1987, Winterstein, Kukovetz et al. 2018). 
Consequently, the early experiments were heavily affected by large micelles fusing with the bilayer. 
Thus, lots of channels were inserted at once, often causing the membrane to fall apart almost instantly. 
The determining factor in improving the proteoliposome homogenization came from using two 
Hamilton gas tight 200 μl syringes coupled together by a two R nut. In fact, this instrument improved 
immensely the quality of the data generated and is worth mentioning as it is typically used in 
crystallography.    
Once the preparative work was optimized, experiments were conducted as described above, and early 
observations had to be made to distinguish specific behaviours that might affect data processing. In 
particular, the asymmetry observed at longer voltage exposure prevented the capture of multiple batches 
of 100 seconds. The logarithmic trend led to a great instability in the lipid bilayer as for bigger micelles, 
which generally resulted in the loss of the membrane. This behaviour is typical of outward rectifiers, 
who display a preference in their response to the orientation of the current (Molleman, Thuneberg et al. 
1993, Hedrich, Moran et al. 1995), a feature VDACs are known to exhibit (Tan and Colombini 2007). 
Although the composition in lipids can affect the channel behaviour, the use of POPS and POPE 
minimized this phenomenon, as opposed to anionic lipids such as phosphoinositides (Tucker and 
Baukrowitz 2008).  
Sporadically, porins would be inserted in opposite directions (Figure 7.1, green and blue arrows). 
Although being an interesting feature to explore, it affected relatively the quality of the data, as the open 
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state S0 would be a combination of both cis and trans channels working together. Hence, data had to be 
treated separately or simply discarded.  
 
 
Figure 3.19 Example of AtVDAC1 channels in opposite directions. Two channels were inserted, in the direction 
of the current (green arrow) and in the opposite direction of the current (blue arrow). This is reflected by their 
closed states pointing in opposite directions. Fortunately, this phenomenon was relatively rare. 
 
Another great challenge that needed to be resolved, was the correct detection of the gating events. The 
S1 state proved extremely difficult to correctly identify due to its close proximity to the open state 
conductance (around 80 % of the open state conductance). Data had to be scouted heavily and checked 
for the correct recording. Additional states had to be deleted manually to produce a final corrected signal 




   
Figure 3.20 Repetitive issue in event detection of S2 state. Schematic representation of the refinement of the 
data obtained during the detection of gating events via WinEDR® software. As the S2 state was too close to the 
baseline and the detection threshold (dashed line), its initial profile looked odd (upper right, red line), and had to 
be readjusted by deleting the excess events (bottom right, green line).   
 
The abrupt interruption of the recorded closure events above 440 pS (Figure 3.17 and 3.18) could be an 
additional consequence of the detection threshold being almost adjacent to the S1 state. Consequently, 
the lack of statistical relevance in the Gaussian models (section 3.7.2) is likely influenced by an 
incomplete Gaussian curve fit for the S1 state, due to the lack of closure events above 440 pS. Assuming 
the tail of the S1 Gaussian fit was absent, a broad Gaussian could be fitted and would potentially 
encompass both the S1a and S1b sub states.  
 
Figure 3.21 Representative recordings of single AtVDAC1 channels reconstituted on a POPE/POPS planar 
bilayer at -40 mV. Three different currents corresponding to three different states (1 open and two closed states) 
were observed for the inserted AtVDAC1 channel in the planar bilayer in 10 mM Tris/HCl (pH 7.4), 150 mM KCl, 
50 mM Ca2+. The open S0 and the closed states S1 and S2 are indicated by a blue, red and green line. A potential 








The S1c states however, displayed strong statistical relevance despite the low number of counts 
compared to the other two states (section 3.7.2). an additional closed state of really short pulses (Figure 
7.3; S3, in purple) can be found between S1and S2 states, although rarely identified as previously 
mentioned. As a result, it will be called S2c (and not S3), until further data can strengthen the statistics.  
Unfortunately, due to the limited time available for the electrophysiology work, effects of lipid 
composition as well as buffer concentration on the channel’s gating were not fully explored. For 
example, AtVDAC1 proteins were reconstituted in DMPC and in Asolectine (a relatively crude mixture 
of plant lipids, potentially closer to the natural conditions of a plant bilayer). The Asolectine-AtVDAC1 
mixture was originally tested but did not produce acceptable data as the insertion into the artificial 
bilayer was very difficult. Future experiments might focus on the use of these preparations, but they first 
require great optimization to ensure the channel can incorporate into the bilayer.   
Similarly, use of high salt concentrations for BLM work was previously described to be effective 
(Colombini 1989, Blachly-Dyson, Peng et al. 1990, Blumenthal, Kahn et al. 1993, Hodge and Colombini 
1997, Tan and Colombini 2007), but in this work appeared to compromise the stability of the bilayer.   
Consequently, it was deemed wise to use 150 mM KCl, to allow the formation of a stable lipid bilayer, 
and to maintain a slat environment closer to physiological conditions.       
Incidentally, the use of such buffer might as well explain the low conductance observed for all states 
considered in comparison with previous findings on VDACs in similar experiments (Table 7.1). Indeed, 
the conductance values reported are around 5- to 10-fold lower on average in comparison with previous 
findings at 1 M KCl. Recent studies on VDAC from Phaseolus coccineus (soya seeds) highlighted a 
potential effect of the salt concentration on the overall conductance of the VDAC1 channel (Saidani, 
Grobys et al. 2016), and early studies (Colombini 1989) already reported similar values at 0.1 M KCl to 
those described in this work (see Table 7.1). However, testing higher concentrations of salt in BLM 
experiments with AtVDAC1 would allow direct comparisons with previous reports and characterize the 




4. Chapter 4: AtVDAC1 mutants D177N, T156C and D258N 
 
Considering previous data on the interaction of mammalian VDACs with hexokinase and/or glucokinase 
(Ahmad, Ahmad et al. 2002, Bryson, Coy et al. 2002, John 2003, da-Silva, Gómez-Puyou et al. 2004, 
Kim, Lim et al. 2006, Abu-Hamad, Zaid et al. 2008, Pastorino and Hoek 2008), hypothetical docking 
models were generated between the predicted AtVDAC1 structure (NP_186777) and that of Nicotiana 
benthamiana hexokinase 1 (AAP40021). Indeed, previous experiments (Kim et al., 2006) highlighted 
the role of this Mitochondria-associated Hexokinase in the control of Programmed cell death (PCD) in 
plants (see section 1.10) (Kim, Lim et al. 2006).   
  
Figure 4.1 Example of docking experiment of the Nicotiana benthamiana Hexokinase 1 on AtVDAC1 (based 
on 3EMN1). Docking was carried out by Cluspro 2.0 software (Comeau, Gatchell et al. 2004, Kozakov, Beglov 
et al. 2013) between AtVDAC1 hypothetical structure (in green) and the Hexokinase 1 from N.benthamiana (in 
blue), both were generated using SWISS-MODELLER (Artimo, Jonnalagedda et al. 2012). Results were then 
analysed to putatively identify amino acids involved in hexokinase binding and provided the targets for further 
mutagenesis. Protein sequence of AtVDAC1 (NP_186777) with location of selected mutations showed by red 
arrows is indicated. Position 156T is shown in red, position 177D in white, position 180D in orange, position 256E 





Multiple binding configurations were produced (an example is shown in Figure 4.1) and amino acids 
involved in protein-protein interaction were reported. The same approach was used for docking 
N.benthamiana Hexokinase 1 with isoforms AtVDAC2 and AtVDAC4, to highlight similarities and 
redundancies in the amino acid positions identified by this in silico study (see Appendix 9.3). In fact, 
AtVDACs are known to exhibit differential expression and cellular as well as sub-cellular localization 
patterns in A.thaliana (Tateda, Watanabe et al. 2011), thus potential differences in the interaction to the 
Hexokinase could be expected. Due to the relatively high sequence similarities between AtVDACs 
(from 62 to 80 %, see Table 1.1), amino acid substitution could be guided through this analysis. 
Table 4.1 Redundant amino acid positions involved in the docking of N.benthamiana Hexokinase 1 to 
AtVDAC isoforms 1, 2 and 4. The amino acid identity corresponding to each isoform is also included. 
Amino acid position Amino acid 
AtVDAC1 AtVDAC2 AtVDAC4 
48 K K K 
50 D G D 
156 T K T 
177 D D D 
180 D E E 
205 K T S 
256 E E E 
258 D D D 
Docking was carried out by Cluspro 2.0 software (Comeau, Gatchell et al. 2004, Kozakov, Beglov et al. 2013) 
between AtVDAC1, 2 and 4 hypothetical structure and the Hexokinase 1 from N.benthamiana, both were 
generated using SWISS-MODELLER(Waterhouse, Rempfer et al. 2018) (Artimo, Jonnalagedda et al. 2012). 
Amino acid positions reported in at least on binding model (Appendix 9.3) for each isoform are indicated, as well 




Amino acids positions present in at least one binding configuration for AtVDAC1, AtVDAC2 and 
AtVDAC4 binding to Hexokinase 1 were identified and regrouped in Table 4.1. Amino acids at positions 
48, 50, 156, 177, 180, 205, 256 and 258 were systematically predicted to be involved in the binding of 
Hexokinase 1 to AtVDACs. Furthermore, positions 48, 177, 256 and 258 harboured the same amino 
acid for all AtVDAC isoforms, namely a lysine (K48), an aspartic acid (D177), a glutamic acid (E256) 
and another aspartic acid (D258), indicating a conserved feature between AtVDAC1, AtVDAC2 and 
AtVDAC4. Finally, all amino acids involved in the binding of AtVDACs to Hexokinase 1 are positioned 
on the loops exposed to the external surface.   
Interestingly, the binding of Hexokinase 1 to AtVDACs mostly involved the first 50 to 100 amino acids 
of the former. This observation is in accordance with previous data suggesting the involvement of the 
N-Terminal domain of the Hexokinase 1 as an anchor for its mitochondrial targeting (Kim, Lim et al. 
2006, Abu-Hamad, Arbel et al. 2009, Arzoine, Zilberberg et al. 2009).  
On the basis of the docking data (Figure 4.1, Appendix 9.3 and Table 4.1), eight putative AtVDAC1 
amino acid residues were identified for mediation of protein-protein interactions. Additionally, sequence 
alignments were generated between AtVDAC1 and other orthologues (Appendix 9.4). Protein sequences 
of human, mouse, and zebrafish were chosen and aligned against AtVDAC1, AtVDAC2 and AtVDAC4. 
Human and mouse VDACs are the most studied eukaryotic porins to date, and the zebrafish VDAC 
offered a more evolutionary distant organism, as well as a known VDAC dimer structure (PDB ID: 
4BUM)(Schredelseker, Paz et al. 2014). VDAC orthologues of distantly related organisms were also 
included in the alignment, to identify the most conserved amino acids, and variable amino acids which 
may be associated with organism-specific functions. 
Overall, positions 177 and 258 on AtVDAC1 protein proved interesting since they were conserved in 
most of the analysed sequences. Interestingly, an Aspartic acid is present at both positions. This amino 
acid is not known for its propensity to be part of beta-sheets formation, thus leaving the possibility of 
being part of a binding platform for potential partners (see section 1.6).  
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The Aspartic acids of positions 177 and 258 (negatively charged) would be changed to Asparagine (polar 
and uncharged). In a similar fashion, E256 was changed to glutamine, whereas D180 was changed to 
serine, for its reduced steric hindrance. This last two positions (D180 and E256) were chosen based on 
their proximity to D177 and D258, respectively. Additionally, T156 was identified as being the ideal 
candidate for potential labelling experiments of cysteine with fluorophores (Puljung and Zagotta 2012), 
due to the reduced structural difference between the serine and cysteine residue (a sulphur atom replaces 
the oxygen on the lateral chain of the residue). Moreover, its close proximity to the N-Terminal alpha 
helix of AtVDAC1 could as well provide the basis for a cross linking-experiment for BLM assays, as 
highlighted in the mVDAC1 (Mertins, Psakis et al. 2012).  
 
After performing mini-preps on batches of 4 to 6 clones, purified mutant plasmids (section 2.4.5) were 
screened by restriction endonuclease analysis with their respective restriction enzymes (see Table 4.2) 
for the identification of putatively positive clones.  
Table 4.2 Mutant screening patterns. Table containing mutations used in this study, the enzyme used for the 
screening of positive colonies, as well as the expected Wild-Type (WT) and Mutant DNA fragments size. 
Mutation Enzyme WT pattern (bp) Mutant pattern (bp) 
D258N HpaI/XmnI 2517+1934 1036+1482+1934 
D177N HincII 384+71+3996 144+240+71+3996 
E256Q XmnI 2517+1934 1041+1476+1934 



















Figure 4.2 Screening of D258N, D177N, E256Q and D180S AtVDAC1 mutant constructs by restriction 
endonuclease digests. 5 µL of digested pET-20b(+) plasmid, harbouring the corresponding AtVDAC mutant were 
analysed on a 1.5% (w/v) agarose gel  in 1xc TBE. with a 1 kb DNA ladder from NEB® loaded on lane 1. Expected 
digestion pattern is displayed by the right side of each gel. Plasmids sent for DNA sequencing are marked with a 
green star. (A) 4 potential AtVDAC1 D258N clones were analysed (lane 3 to 6). (B) Wild-type AtVDAC1 (lane 
3) or AtVDAC1 D177N clones (lane 4 to 7) were analysed. (C) Wild-type AtVDAC1 (lane 2) or AtVDAC1 E256Q 
clones (lane 3 to 5) were analysed. (D) Wild-type AtVDAC1 (lane 4) and AtVDAC1 D180S clones (lane 5 to 8) 
were analysed. Green star indicates successful mutant construction. 
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Only one positive construct (green star) was generated during E256Q and D180S mutagenesis, and both 
were sent for DNA sequencing (Figure 4.2C and 4.2D). D258N mutagenesis yielded 4 positive 
constructs (Figure 4.2A lanes 3 to 6), whereas two D177N constructs were screened positives (Figure 
4.2B lanes 4 and 7). Constructs were sent for DNA sequencing (See Appendix 9.1) alongside few T156C 
potential clones identified with the same method. Mutants D258N, D177N, T156C and D180S had their 
sequences confirmed by DNA sequencing. These constructs would be maintained (as described in 





For analysis, D177N, D258N and T156C AtVDAC1 mutants were produced in inclusion bodies, 
completely denatured and refolded in vitro using the same conditions as for the native-like AtVDAC1 
(see 3.4.1 for the refolding screen), prior to purification using the Fractogel ® EMD SO3 (M) and the 
Superose 6 Increase®. Fractions containing the proteins of interest were pooled together and loaded on 




Figure 4.3 SDS-PAGE analysis of preliminary SEC purifications of AtVDAC1 T156C, D258N and D177N 
mutants. Fractions eluted from size exclusion chromatography using a Superose6 Increase® were pooled together 
and concentrated. 10 µL of each purified AtVDAC1 mutant were analysed on a 10 % (v/v) SDS PAGE in 1 x 
Laemmli running. Lane 1; ladder from Novex®, Lane 2 to 4; samples from fractions 10, 11 and 12 mL respectively, 
on undiluted injection (0.5 mg/mL) of T156C. Lanes 5; additional sample collected at 10 mL during a second 
undiluted injection (0.5 mg/mL) of T156C. Lane 6; sample from a single purification of D258N mutant. Lane 7 to 
8; samples collected at 10, and 12 mL respectively, on undiluted injection (0.5 mg/mL) of D177N. Lane 9 to 10; 
samples collected at 10, and 12 mL respectively, on diluted injection (0.25 mg/mL) of D177N. The monomeric 
AtVDAC is indicated by a green arrow. Possible oligomers (lane 2 and 5) are indicated by black arrows. 
 
A similar electrophoresis profile to that of native AtVDAC1 was observed repeatedly for each mutant 
purified. However, it soon became apparent the mutants exhibited different behaviour to that of the 
Native-like AtVDAC1 (Figure 3.6). Whereas most of the mutant preparations do contain similar 
contaminants to those present in the native AtVDAC1, the yield of mutant monomers was variable and 
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4.3, lanes 7 to 10) contained the highest amount of monomeric AtVDAC1 mutant compared to other 
contaminants in the same fractions (Figure 4.3, green arrow), amongst all mutants. Surprisingly, two 
proteins, both having an apparent molecular weight of 60-70 kDa (black arrows), were the major 
proteins present in mutant T156C fractions (Figure 4.3, lane 2 and lane 5). Finally, mutant D258N 
(Figure 4.3, lane 6) yielded the least monodisperse samples, with a barely detectable amount of 
monomer. 
The diverse composition in terms of contaminants and the very low amount of monomer present in each 
mutant fraction, despite no issues detected at earlier stages (expression, Inclusions bodies preparation 
and refolding, results not shown); the amount and number of contaminants present in the AtVDAC1 
mutant purified fractions, as well as the low yield, (Figure 4.3) deemed those preparations unsuitable 
for further works. 
Finally, we attempted using the prepacked Hitrap SP XL ® 5 mL from Life Sciences® exchanger as it 
was successfully tested on the Native AtVDAC1 protein (see section 3.4). Fortunately, this solid support 
would guarantee a constant yield of AtVDAC mutant proteins for  characterization studies (Black Lipid 





Using the previously optimized refolding methodology (see section 3.3.1), the mutant protein D177N 
was tested for its ability to bind to the new resin (Hitrap SP XL ® 5 mL from ThermoFisher ®). Using 
a linear gradient of NaCl (from 1 mM to 1 M), the protein would elute as a relatively sharp peak with 
tailing at the end of the run (Figure 4.4B). Overall, the elution started around 250 mM NaCl, peaking at 
400 mM and reaching completion around 700 mM salt. Samples from collected fractions were analysed 
on a 10 % (v/v) SDS PAGE gel in 1x Laemmli running buffer (Figure 4.4A, lanes 2 to 10). The majority 
of the mutant protein appeared to have eluted between 300 mM and 600 mM sodium chloride (Figure 
4.4, lanes 3 to 6) and contained mostly the protein of interest (around 30 kDa), with a purity around 75 
to 80 % of the total signal (using ImageJ® Software (Schneider, Rasband et al. 2012, Schindelin, Rueden 
et al. 2015)). Some minor contaminants were detected (low and high molecular weight) in the main 
fractions, whereas the tail fractions collected between 600 and 750 mM NaCl largely contained lower 
molecular weight (below 30 kDa) contaminants (Figure 4.4A, lanes 7 to 10).  
Use of Hitrap SP XL 5 mL greatly improved the purification yield of the AtVDAC1-D177N mutant, in 
comparison to previously used solid supports. Fractions between 7 and 12 mL (after the start of the 
gradient) were pooled together, buffer-exchanged and concentrated using an Amicon ® concentrator 
with a 10 kDa cut-off in SEC buffer. Out of the 50 mg of inclusion bodies used per batch of purification, 
5 to 8 mL (1 to 1.6 CV on 5 mL prepacked Hitrap SP XL ®) of protein could be purified at a 









Figure 4.4 Hitrap SP XL cation exchange chromatography of D177N mutant protein with an increasing 
gradient of NaCl. Elution was carried out in an Akta Start ® device using a gradient of NaCl (IEX Buffer). (A). 
10 µL of each purified D177N mutant fractions were loaded on 10 % (v/v) SDS PAGE in 1x Laemmli running 
buffer. First lane; Ladder from Novex®. Lanes 2 to 10; samples collected 8, 9, 10, 11, 12, 13, 14, 15 and 16 mL 
respectively after the start of the gradient (between 250 and 700 mM salt concentration). Monomer protein is 
indicated by a green arrow (B). Purification profile (in mAU, in blue) of D177N protein using a Hitrap SP XL and 
a linear gradient (grey) of NaCl (IEX Buffer). Absorbance (280 nm) was recorded against the collected fractions. 
































































500 µL of a 3.5 mg/mL AtVDAC1-D177N from IEX using an Hitrap solid support (See section 4.4) 
was injected onto the Superose6 Increase® column and the elution profile was recorded (Figure 4.5B). 
Recovered sec fractions were analysed by 10 % (v/v) SDS PAGE in 25 mM Tris, 200 mM Glycine, 0.1 
% (w/v) SDS (Figure 4.5A). The mutant protein AtVDAC1-D177N eluted in a broad peak with a 
maximum absorbance recorded around 16.3 mL after injection (64 kDa), with a slight shoulder starting 
at 18 mL (28 kDa), which was collected separately. 
For this mutant, no difference was detected between fractions of the main elution peak (Figure 4.5A 
lanes 3 to 6), and fractions belonging to the later shoulder (Figure 4.5A, lanes 7 to 8), upon SDS-PAGE 
analysis. Indeed, the main protein eluted was the D177N monomer around 30 kDa on SDS PAGE 
(Figure 4.5A, green arrow). However, an additional protein of approximatively 28 kDa (on SDS PAGE) 
was present at decent concentration (5 to 10 % of the total signal). This pattern is similar to the one 
observed for the purification of Native AtVDAC1 protein (Figure 3.8, lane 5). Nevertheless, its presence 
in all the samples suggests a carry over or a degradation product. Further investigation by Western 
Blotting will be explored in section 4.7. 
None the less, the SEC purification using a Superose6 Increase® resulted in substantially purer and 
more monodisperse fractions when using an Hitrap SP XL® for the IEX step in comparison to the use 









Figure 4.5 Size exclusion chromatography of AtVDAC1D177N mutant protein. SEC was carried out in an 
Akta Prime ® device using a Superose 6 Increase® in SEC buffer. (A). 10 µL of each fraction were loaded on a 
10 % (v/v) SDS PAGE in 1x Laemmli running. First lane; ladder from Novex®. Lanes 2 to 8; samples collected 
at 13, 14, 15, 16, 17, 18 and 19 mL respectively from a 3.5 mg/mL AtVDAC1. The D177N mutant monomer is 
indicated by a green arrow. (B). Elution profile (UV absorbance in blue) of the size exclusion chromatography 
performed on D177N after injection of partially purified sample (500 µL of a 3.5 mg/mL solution). The minimum 































































AtVDAC1-D258N was refolded (section 2.5.3) and purified using a Hitrap SP XL 5 mL ® matrix 
(section 2.5.4). The protein eluted as a relatively sharp peak with tailing towards run completion (Figure 
4.6B). Overall, the elution started around 300 mM NaCl, peaking at 400 mM and reaching completion 
around 550 mM salt. Samples were analysed on 10 % (v/v) SDS PAGE in 1x Laemmli running buffer 
(Figure 4.6A, lanes 2 to 10) to monitor purification efficiency. Fractions collected between 320 mM and 
440 mM sodium chloride were rich in AtVDAC1-D258N (around 30 kDa) (Figure 4.6, lanes 3 to 5) 
and, with signal intensity suggesting a very good purity (90 to 95 % of the total signal, using ImageJ® 
Software (Schneider, Rasband et al. 2012, Schindelin, Rueden et al. 2015)). Some minor contaminants 
were detected (low and high molecular weight) in the main fractions, whereas tail fractions only 
contained lower molecular weight (below 30 kDa) contaminants (Figure 4.6A, lanes 6 to 10). Higher 
molecular weight contaminants detected in fractions 3 to 5 (Figure 4.6A) could be a potential oligomer 
due to their apparent molecular weight (around 60 kDa, or twice the size of AtVDAC monomer). 
Fractions collected from 7 to 11 mL (after the start of the gradient) were pooled together, buffer-
exchanged in SEC buffer and concentrated using an Amicon® concentrator with a 10 kDa cut-off for 
size exclusion chromatography (section 4.5.1). 
This experiment was a breakthrough towards purifying large amounts of AtVDAC1-D258N protein, as 
it allowed a massive increase of the overall capture and purity of the samples compared to previous 
experiments (Figure 4.3, lane 6). Out of the 50 mg of inclusion bodies used per batch of purification, a 
routine 4 to 6 mL (around 1 CV on 5 mL prepacked Hitrap SP XL ®) of protein could be purified at a 








Figure 4.6 Hitrap cation exchange chromatography of D258N mutant protein with an increasing gradient 
of NaCl. Elution was carried out in an Akta Start ® device using a gradient of NaCl (IEX buffer). The resin used 
was a HiTrap SP XL 5 mL ®. (A). 10 µL of each fraction were analysed on a 10 % (v/v) SDS PAGE in 1x Laemmli 
running buffer (and Coomassie-stained). First lane; ladder from Novex®. Lanes 2 to 10; samples collected 7, 8, 9, 
10, 11, 12, 13, 14 and 15 mL respectively after the start of the gradient (between 300 and 600 mM salt 
concentration). Monomer protein is indicated by a green arrow (B). Purification profile (in mAU, in blue) of 
D258N protein using a Hitrap SP XL and a linear gradient (grey) of NaCl (IEX Buffer). Absorbance (280 nm) was 



































































500 µL of a 2.5 mg/mL IEC purified AtVDAC1-D258N (section 4.5) was injected onto the Superose6 
Increase® column and the elution profile was recorded (Figure 4.7B). Recovered fractions were 
analysed on a 10 % (v/v) SDS PAGE in 1x Laemmli running buffer (Figure 4.7A). AtVDAC1-D258N 
eluted within two sharp peaks with maximum absorbances recorded around 16.2 and 18 mL after 
injection (68 kDa and 28 kDa), respectively. A slight shoulder around 19 mL (22 kDa) following the 
second sharp peak was also observed. 
When analysed on 10 % (v/v) SDS-PAGE (Figure 4.7A lanes 2 to 9), most of the protein would be 
denatured, as previously described for AtVDAC1 (section 3.5). However, the presence of a 60 kDa 
protein (lanes 3 to 5) suggested potential oligomerization of the AtVDAC1-D258N protein, that would 
partially resist the denaturation. Finally, fractions belonging to the tail of the second peak showed a 
distinctive pattern of two bands (Figure 4.7A, lanes 8 to 9), the first being likely AtVDAC1-D258N and 
the second a similarly sized contaminant to the one observed in previous purifications (see section 3.5 
and 4.4.1), i.e a probable degradation product. As opposed to previous experiments, this contaminant 
was easily removed by size exclusion chromatography. As for D177N and T156C mutants, the 








Figure 4.7 Size exclusion chromatography of AtVDAC1-D258N mutant protein using a Superose6 
Increase®. SEC was carried out in an Akta Prime ® in SEC buffer. (A). 10 µL of each fraction were loaded on 
SDS PAGE 10 % (v/v) in Laemmli buffer. First lane; Ladder from Novex®. Lanes 2 to 9; samples collected 14, 
15, 16, 17, 18, 18.5, 19, and 20 mL respectively from a 2.5 mg/mL D258N. Lane 10; 2 µL sample of the 2.5 
mg/mL D258N solution. The D258N mutant monomer is indicated by a green arrow (B). Elution profile (UV 
absorbance in blue) of the size exclusion chromatography performed on 2.5 mg/mL D258N injection (500 µL). 
































































AtVDAC1-T156C was treated as the other mutants (see previous sections). Using a linear gradient of 
NaCl (from 1 mM to 1 M), the protein eluted under two unresolved peaks, with a noisy tail towards the 
completion of the run (Figure 4.8B). Overall, the protein elution started around 240 mM NaCl, peaking 
at 300 and 400 mM, for the first and second peak respectively, and reaching completion around 550 mM 
salt. Collected fractions were analysed on a 10 % (v/v) SDS PAGE in 1x Laemmli running buffer (Figure 
4.8A, lanes 2 to 10) to monitor purification yields. Fractions corresponding to the first peak (eluted 
between 240 mM and 350 mM NaCl) contained most of the protein (around 30 kDa), at a very good 
purity (around 80 to 85 % of the total signal, using ImageJ Software ®(Schneider, Rasband et al. 2012, 
Schindelin, Rueden et al. 2015)) (Figure 4.8A, lanes 3 to 5).  Minor contaminants (low molecular 
weight) were detected in fractions eluting after 5 mL (Figure 4.8A, lane 6 and 7), whereas tail fractions 
only contained lower molecular weight (below 30 kDa) contaminants (Figure 4.8A, lanes 8 to 10), as 
well as the previously identified 28 kDa species (sections 4.4.1, 4.5.1). In contrast to previous 
purifications, no clear potential oligomer (usually around 60 kDa) could be detected on 10 % (v/v) SDS-
PAGE. 
 Use of the Hitrap SP XL® solid support resulted in a 10-fold increase of the overall capture and 
particularly purity of the samples compared to previous experiments (Figure 4.3, lanes 2 to 5). Out of 
the 50 mg of inclusion bodies used per batch of purification, 3 to 5 mL (around 0.6 to 1 CV on 5 mL 









Figure 4.8 Cation exchange chromatography of AtVDAC1-T156C mutant protein using a HiTrap SP XL 5 
mL ® with an increasing gradient of NaCl. Elution was carried out in an Akta Start ® device using a gradient 
of NaCl (IEX buffer). (A). 10 µL of each fraction were analysed on a 10% (v/v) SDS PAGE in 1 x Laemmli 
Running buffer. First lane; ladder from Novex®. Lanes 2 to 10; samples collected 5, 6, 7, 8, 9, 10, 11, 12 and 13 
mL respectively after the start of the gradient (between 200 and 500 mM salt concentration). Monomer protein is 
indicated by a green arrow (B). Purification profile (in mAU, in blue) of T156C protein using a Hitrap SP XL and 
a linear gradient (grey) of NaCl (IEX Buffer). Absorbance (280 nm) was recorded against the collected fractions. 


































































500 µL of a 1.5 mg/mL IEC purified AtVDAC-T156C (section 4.6) was injected onto the using the 
Superose6 Increase® column and its elution profile was recorded (Figure 4.9B). Collected samples were 
analysed by 10 % (v/v) SDS PAGE in 1x Laemmli running buffer (Figure 4.9A). AtVDAC1-T156C 
eluted under two peaks with maximum absorbances recorded around 18 and 21 mL after injection (28 
kDa and 9 kDa respectively). A slight shoulder at the end of the first peak, around 18.5 mL (26 kDa), 
could be observed.  
When analysed on 10 % (v/v) SDS-PAGE, fractions corresponding to the peak with the maximum 
absorbance contained most of the mutant protein (around 30 kDa) (Figure 4.9A lanes 2 to 9), at a very 
good purity (around 85 to 90 % of the total signal, using ImageJ Software ®). As the elution progressed 
(Figure 4.9A lanes 5 to 7), additional low molecular weight contaminants co-eluted with the monomeric 
T156C mutant protein, with possible degradation products showing a signal just below 30 kDa). The 
later peak eluted around 21 mL after injection but did not contain significant amounts of the target 
protein (Figure 4.9A, lane 8 and lane 9). Instead, the increased viscosity of the sample when handled 








Figure 4.9 Size exclusion chromatography of AtVDAC1-T156C mutant protein using a Superose 6 
Increase®. SEC was carried out in an Akta Prime ® device in SEC buffer. (A). 10 µL of each fraction were loaded 
on SDS PAGE 10% (v/v) in 1x Laemmli buffer. First lane; ladder from novex®. Lanes 2 to 9; samples collected 
15, 16, 17, 18, 19, 20, 21 and 22 mL respectively from a 1.5 mg/mL T156C. Lane 10; 2 µL sample of the 1.5 
mg/mL T156C solution. The T156C mutant monomer is indicated by a green arrow (B). Elution profile (UV 
absorbance in blue) of the size exclusion chromatography performed on T156C after injection of partially purified 







































































A Western Blot experiment was conducted to assess the purity of the samples and test the mutants for 
antibody recognition. Native-like and mutant proteins were analysed on 10% (v/v) SDS-PAGE in 1x 
Laemmli running buffer (Figure 4.10 left side) and probed by Western Blotting using a rabbit-polyclonal 
Anti-AtVDAC1 antibody at a 1/2500 dilution (Figure 4.10 right side).  
  
 
Figure 4.10 Confirmation of identity of AtVDAC1 Native-like and mutant proteins by Western Blotting. 10 
µL of each purified Native-like and mutant AtVDAC1 proteins were loaded on 10 % (v/v) SDS PAGE, (left side) 
in 1x Laemmli running buffer. First lane is the ladder. Lanes 2, 4, 5, 6 and 7 contains samples from Native 
AtVDAC1(batch 1 and 1b), T156C, D258N and D177N protein respectively. A random construct RD2 (lane 3) 
and mKlp2 purified protein (lane 8) were used as negative controls. Lane 9 contains a 1 µL sample of a BSA 
solution at 5 mg/mL and served as a loading control. The samples were either stained by Coomassie Blue R250 
(left) or probed by Western Blot with a polyclonal anti-AtVDAC1 antibody (from rabbit) at a 1/2500 dilution. The 




























































































A strong signal was detected on the photographic film for the native-like AtVDAC1 monomer and all 
of its mutants (Figure 4.10 right side). As expected, the intensity of the signal generated through Western 
Blotting correlated with the band intensity on Coomassie Blue stained SDS-PAGE gels (Figure 4.10 
left). The mutations did not seem to affect (at least to a detectable threshold) the binding of the antibody 
to the protein. This result was expected since this antibody was supposed to bind the N-terminal segment 
of AtVDAC1 (according to manufacturer’s instructions). 
Native-like AtVDAC1 (AtVDAC1 and ATVDAC1b) and AtVDAC1-D258N samples, showed faint 
signals between 50 and 60 kDa on the photographic film, suggesting the presence of VDAC-oligomers 
(aggregates or specific dimers resisting SDS denaturation (Kumar, Gopalakrishna et al. 1993, Grigorian, 
Bustamante et al. 2005); Figure 4.10, blue arrow). This observation correlated with the SEC purification 
profiles of those proteins (section 3.5 and 4.5.1). Conversely, T156C mutant exhibited no higher 
molecular weight aggregate or oligomer which correlated with its SEC profile (single peak elution with 
a maximum absorbance at 18 mL or 28 kDa). However, no oligomer/aggregate was detected by WB in 
D177N fraction, despite its SEC profile suggesting a high tendency towards the higher molecular weight 
form.  
Overall, the identity of the AtVDAC1 Native-like and its mutant proteins was confirmed using the same 
@AtVDAC1 antibody. This successful recognition gave confidence that the antibody could be used in 
downstream processes such as Far Western Blotting, to probe the interaction of AtVDAC proteins with 





In parallel to the primary characterization of AtVDAC1, attention was given to prepare the groundwork 
for future experiments focusing on the interaction of the channel with potential binding partners. The 
Hexokinase-like 1 from Nicothiana Benthamania (formerly known as Hexokinase 3) was an early 
candidate considered for the design of AtVDAC1 mutants. These mutants would harbour mainly mild 
mutations that would affect (instead of completely abolishing) a potential interaction Mutants were 
designed not only with the aim of using them in binding assays with hexokinase, but also as general 
binding platforms with other cytosolic partners. By changing the overall charge in the cytoplasm8ically 
exposed part of the channel, the molecular basis for AtVDAC1-partner protein interactions could be 
unveiled.  Additionally, the extent of conservation of these amino acids in other eukaryotic orthologues, 
suggested common features in the VDAC-partner protein recognition and interaction.   
The PCR directed mutagenesis was overall successful and yielded multiple new constructs (pET-
20b(+)D258N, pET-20b(+)D177N and pET-20b(+)T156C). E.coli Omp9 cells were successfully 
transformed with the aforementioned constructs, and the corresponding mutant proteins were 
subsequently overproduced following the optimised protocols developed for the Native-like AtVDAC1 
(section 3.3).   
The AtVDAC1 mutants (T156C, D258N and D177N) were purified at least twice with the Fractogel 
solid support to ensure the process could be carried out reproducibly. Nevertheless, the yield of 
monomeric VDACs was low, overall, compared to the wild-type AtVDAC1 with the same setup (see 
section 4.3).  
However, the use of the HiTrap SP XL® again proved very successful, with adequate amounts (around 
5 to 10 mg of purified from a 50 mg inclusion bodies) produced for each protein, with relatively high 
purity (above 90-95 %) (section 3.3.1). The slight differences observed between the mutants and the 
wild-type concerning concentration and amounts could have simply arisen from their different refolding 
propensities. Indeed, these amino acids are well conserved across species (see Appendix 9.4), suggesting 
an importance in either the structural or functional properties of the VDAC.  
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Both mutants D258N and D177N were purified in reasonable amounts, suitable for downstream 
applications such as BLM or SAXS. However, mutant T156C concentration was deemed too low to 
produce robust data on SAXS. Nevertheless, this mutant could still be used in BLM assays or binding 
assays such as Far Western Blotting. The presence of a cysteine might explain its peculiar behaviour in 
comparison to the other two mutants. Indeed, the replacement of the aspartic acid by a cysteine residue 
might lead to greater structural and functional difference in comparison to substitutions where aspartate 
is exchanged for asparagine, e.g. in D258N and D177N mutants. 
Interestingly, the behaviour of the mutant proteins on size exclusion chromatography often correlated 
with their ability to show SDS-resistant oligomeric forms on denaturing 10 % SDS-PAGE in 1x 
Laemmli buffer (section 2.1). For example, T156C SEC revealed a single peak and no 
oligomer/aggregate could be revealed by Western Blotting (section 2.5.11), whereas, D258N SEC 
showed two peaks corresponding to the oligomer (around 60 kDa) and monomer (30 kDa), with Western 
Blotting signals appearing at higher molecular weights than the monomer (between 60 and 65 kDa; 
section 4.7, Figure 4.10).  
Surprisingly, D177N SEC was characterized by a single broad peak corresponding to the oligomer 
(around 16 mL after injection), but no higher molecular weight complexes could be identified on 
Western Blotting experiments (section 4.7).  
This variation in the behaviour of the mutants on SEC and Western Blotting could stem from the impact 
of the different mutations on the formation and maintenance of the oligomeric form of AtVDAC1. 
Indeed, Additional mutants could be designed in these specific amino acid positions, to further explore 
this hypothesis. 
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5. Chapter 5: Small Angle Scattering of AtVDAC proteins 
 
Small angle X-ray scattering (SAXS) is a renowned method for the structural characterization of both 
ordered and disordered proteins in solution. It provides low resolution information about the sizes and 
shapes of proteins and complexes (Petoukhov and Svergun 2013, Kikhney and Svergun 2015, 
Trewhella, Duff et al. 2017). Advances in SAXS instrumentation, especially using high intensity 
synchrotron sources, have been key in popularizing the technique (Mylonas and Svergun 2007). Possible 
to collect adequate amount of scattering data with short exposures, thus minimising the risk of radiation 
damage to the sample, as opposed to a conventional “in-house” instrument such as the Bruker 
Nanostar®. SAXS is often regarded as a secondary approach to structural characterization of proteins, 
compared to crystallography, due to its lower resolution (1-3 nm against few Angstroms). However, it 
has been predicted that more than 35% of human proteins have significant regions of disorder and about 
25% are likely to be completely disordered (Kikhney and Svergun 2015). Hence, the absence of stable 
tertiary structure often leads to difficulties in obtaining protein crystals, thus compromising the 
possibility for X-ray crystallography experiments to be performed. Under physiological conditions, 
these partially disordered proteins constantly fluctuate between different structural states, resulting in a 
dynamic mixture of structural variants. SAXS can then prove to be the powerful tool to explore the 
“actual” shape of a protein in solution. 
 
Typically, a monochromatic beam of X-rays is directed to a sample by a series of mirrors. For structural 
experiments hard X-rays with wavelengths (λ) of 0.10-0.15 nm and energies of around 10keV are used. 
Upon passing through the sample, some of the X-rays will scatter. Specific detectors are positioned to 
collect the scattered photons, and a scattering intensity pattern will be obtained (Petoukhov and Svergun 
2013, Kikhney and Svergun 2015, Trewhella, Duff et al. 2017). The scattered X-rays form a radially 
developed pattern of elastic scattering which is collected by a 2-dimensional flat X-ray detector situated 
behind the sample perpendicular to the direction of the primary beam that initially hit the sample (see 
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section 2.6.1). The scattering pattern is a radially organised arrangement of detected intensities. Those 
intensities are a function of scattering angles which feed information to the momentum transfer vector 
q (as the molecule tumbles in solution with a certain speed). The major challenge that must be overcome 
in SAXS instrumentation is the separation of the weak scattered intensities from those of the powerful 
main beam (Petoukhov and Svergun 2013, Kikhney and Svergun 2015, Trewhella, Duff et al. 2017). 
The smaller the forward scattering angle, the more difficult this separation becomes.  
Since the macromolecules are in solution and not “frozen” and immobile as in tight crystalline lattice, 
their orientation is supposed to be homogenous in all directions. Thus, scattering is usually presented as 
a radially averaged one dimensional curve (Petoukhov and Svergun 2013, Kikhney and Svergun 2015, 
Trewhella, Duff et al. 2017). The scattering curve is described by the intensity I(q) as a function of the 





Equation 5.1 Scattering Intensity I(q) as a function of the momentum transfer q (scattering vector). Where 
θ is the angle between the x-ray beam and the detector and λ is the wavelength of the x-rays. 
 
Due to the high scattering intensity of a sample due its buffer composition and heterogeneity, a certain 
number of parameters are important to ensure background scattering noise can be minimized (Petoukhov 
and Svergun 2013, Kikhney and Svergun 2015, Trewhella, Duff et al. 2017). First and foremost, the 
concentration of the macromolecules must be high enough so the contrast between the electron density 
of the molecule and those of the buffer can be distinguished from one another. If not, structural 
information will be lost during the subtraction of scattering profile of the buffer from the one of the 
analyte. 
Another parameter that needs to be controlled is the monodispersity of a sample, which has to be 
maximised in order to avoid scattering interference by contaminants. Thus, the purer the sample the 
greater the chances of achieving a robust structural model, as in X-Ray crystallography. Typically, 
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filtering and high-speed centrifugation are performed to ensure removal of heavy aggregates and ensure 
monodispersity, following gel filtration chromatography. 
Finally, it is of absolute importance that the buffer composition matches the one of the sample 
(Petoukhov and Svergun 2013, Kikhney and Svergun 2015, Trewhella, Duff et al. 2017). Indeed, a great 
deal in the generation of accurate data is the subtraction of the background intensities offered by the 
chosen buffer in which the desired molecule is solubilised. If buffers are not alike, troublesome variation 
will be obtained in the scattering profile, and the solvent might not be well excluded from the model. In 
the case of membrane proteins, dialysis is generally performed prior to the experiment, in the same 
buffer used for the background removal. It can be performed for an hour (soluble proteins) to days in 
the case of membrane proteins (due to the slower exchange kinetics of detergents) (Petoukhov and 
Svergun 2013, Kikhney and Svergun 2015, Trewhella, Duff et al. 2017).  
 
Scattering profiles are generated for both the buffer and protein of interest. The removal of the buffer 
baseline is then obtained by subtraction of the buffer scattering intensity from the overall data (protein 
scattering intensity). A number of parameters can be directly or indirectly (via additional curves such as 
the P(r) distribution function) identified from the resulting scattering intensity curve (I(q)) such as the 
radius of gyration (Rg), molecular mass (MM), the maximum diameter of the particle (Dmax) and the 
intensity at zero scattering angle I(0) (Trewhella, Duff et al. 2017). The software Primus ® (Petoukhov, 
Franke et al. 2012, Franke, Petoukhov et al. 2017) is generally used to assess these parameters, but 
Scatter® software (Förster, Apostol et al. 2010) offers a more “all in one” approach, which makes it 
more user-friendly and more adapted for high-throughput methods.   
The scattering intensity is then radially averaged to generate the pair distance function P(r). P(r) 
distribution relates the position of pairs of electrons within the scattering sample (Petoukhov and 
Svergun 2013, Kikhney and Svergun 2015, Trewhella, Duff et al. 2017). Electron distance is a one-
dimension function, but the calculation of all the paired-electron distances enables a consequential 
reconstruction of 2D and 3D maps. The P(r) distribution is a Fourier transformation of the scattering 
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profile l(q) vs q plot commonly shown as P(r) vs r (Petoukhov and Svergun 2013, Kikhney and Svergun 
2015, Trewhella, Duff et al. 2017). This is achieved through the use of GNOM program or module 
(Table 5.1) (Petoukhov, Franke et al. 2012, Franke, Petoukhov et al. 2017).  
The output file generated can be used to build a low-resolution model of the shape of the particles’ 
density, using programs such as DAMMIN or DAMMIF (Table 5.1) (Franke and Svergun 2009). The 
latter, a more recent algorithm, uses a more automated approach, but its high-throughput processing can 
increase the statistical robustness of the generated models. In summary, the modelling program will 
generate a crude shape or volume filled with dummy atoms, often bigger than the protein (Franke and 
Svergun 2009); this is partly due to the bound solvent being accounted for. DAMMIN then produces a 
compact model by assigning the dummy atoms as part of either the solvent or as particles (from the core 
structure) and uses simulated annealing (Franke and Svergun 2009), in order to fit the experimental data. 
This process is repeated multiple times (>20), each time generating a slightly different model.  
Statistical relevance is generally assessed through the Chi2 value, which can be defined 
as a measure of the goodness of fit character of the model (Franke, Petoukhov et al. 2017). For good 
relevance, the Chi2 must be at a minimum (below 0.5). DAMMIN generated volumes not fitting this 
criterion are not processed further. 
DAMAVER module (Table 5.1) will superpose the models and produce an averaged model and a refined 
model (smaller since variable areas are not accounted for) (Petoukhov, Franke et al. 2012, Franke, 
Petoukhov et al. 2017). 
Table 5.1 Table 5.1. Important SAXS ab initio Programs. List of Software used for SAXS envelope modelling 
and their corresponding function. Taken from Gemma Brown (PhD Thesis, 2016)(Brown 2016, Franke, Petoukhov 
et al. 2017). 
Program Function 
SCATTER  An interface for performing manipulations of the 
scattering data including, subtraction, averaging, 
merging, extrapolation to zero concentration.  
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Generation and evaluation of Guiner, Porod and 
Kratky plots.  
Build-in modules: GNOM, DAMMIN, DAMMIF, 
SUPCOMB, DAMSEL, DAMSUP, DAMAVER, 
DAMFILT 
GNOM  An indirect transform program which takes one 
dimensional scattering curves and evaluates the 
P(r) and prepares .out files for modelling.  
DAMMIN  A tool for ab-initio modelling of SAXS data based 
on bead modelling and simulated annealing.  
DAMMIF  An improved ab-initio modelling program based 
upon the foundations of DAMMIN but 
implementing a new algorithm to speed up 
reconstruction by a factor of 25-40.  
SUPCOMB  A program used to superimpose one 3D structure 
onto another and calculates a normal spatial 
discrepancy (NSD) which can be used to determine 
the best alignments between models.  
DAMSEL  The program takes all generated models in PDB 
format and superimposes all possible pairs using 
SUPCOMB then generates an output table which 
determines which models are outliers and selects a 
reference model. Models are considered as outliers 
if the NSD exceeds two standard deviations away 
from the calculated mean.  
DAMSUP  A program that aligns a set of models excluding the 
outliers to a selected reference model and calculates 
standard deviation from the NSD.  
DAMAVER  The program averages models that have been 




DAMFILT  Can take the DAMAVER file and filter the model 
by removal of low occupancy regions or loosely 
connected atoms, this model doesn’t always reflect 
the true size of the experimental data.  
 





Different parameters, such as the sample monodispersity or the buffer composition, are key to the 
success of a SAXS experiment on a macromolecule (Petoukhov and Svergun 2013). Nevertheless, the 
advance in technology and the use of powerful X-ray generators (synchrotrons) can minimize the impact 
of these parameters on the final scattering profile and still generate complete data sets. The electron 
beam strength will help generate enormous amount of data in few seconds and does not require multiple 
frames exposure as opposed to conventional “in-house” SAXS experiments. However, the strength of 
the beam can be deleterious to the protein integrity. Indeed, most samples decompose almost 
immediately (one to few seconds) during SAXS experiments. Hence, the first test performed when 
starting a SAXS experiment in the Diamond Light Source (Oxford, Oxfordshire) helps determine the 
“protective effect” of the buffer on the protein against radiation damage. A reference protein with known 
SAXS parameters as well as crystal structure must be used as a control to test the buffer protection 
against radiation damage and to relate radius of gyration to molecular weight and size of spherical 
envelopes. As a result, data were collected for 2 seconds at the Beamline B21 (see section 2.6.1) on 
buffer blank samples (dialysis buffer; 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 
1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO) and Bovine Serum Albumin at a concentration 
of 5 mg/mL in the same buffer. 
 
 
Raw scattering intensity data were obtained for both BSA (Figure 5.1; blue curve) and buffer (Figure 
5.1; red curve). Data from the buffer were then subtracted from the sample to generate the new scattering 
curve (Figure 5.1, pink curve), that would be used for further processing. Theoretically, this curve only 
reflects the scattering data from the solvated protein (surrounded by solvent), as most of the buffer 
intrinsic noise had been removed (Petoukhov and Svergun 2013, Kikhney and Svergun 2015, Trewhella, 




Figure 5.1 Raw Scattering Intensity plots of BSA at 5 mg/mL and its buffer. Scattering data recorded at the 
Beamline B21 and displayed as log of intensity over the scattering vector q (Ǻ) and created using ScAtter 
Software® (Förster, Apostol et al. 2010). Blue line is the scattering intensity curve for the sample (BSA at 5 
mg/mL in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 
0.12% (v/v) LDAO). Red line is the scattering profile recorded for the blank sample (25 mM NaH2PO4/Na2HPO4 
(pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO). The Pink line 
represents the adjusted scattering of BSA following buffer blank background subtraction. 
 
 
The initial approach when dealing with scattering data, is the primary evaluation of the radius of gyration 
(Rg) and the extrapolated intensity at zero scattering angle I(0), using the Guinier approximation 
(Petoukhov and Svergun 2013, Kikhney and Svergun 2015, Trewhella, Duff et al. 2017). This 
approximation is made at low q values, as most spherical molecules display a relative consistency 
between hypothetical (calculated) and real (following ab initio modelling) parameters.  Rg and intensity 
can be directly calculated by the Guinier plot using the equation below:  
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𝑅𝑔 = √−3𝑎 
Equation 5.2 Calculation of the Radius of gyration (Rg) by Guinier analysis. Where a is the slope of the 
scattering curve at low q values. 
 
One of the main phenomena interfering with the quality of SAXS experiments and the generation of 
clean scattering data is protein aggregation (Petoukhov and Svergun 2013, Kikhney and Svergun 2015, 
Trewhella, Duff et al. 2017). Protein aggregation can be assessed directly on the scattering profile, as it 
will lead to a high upturn of I(q) at low q values. In the case of BSA at 5 mg/mL (in 25 mM 
NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% 
(v/v) LDAO), more pronounced noise could be observed at low q values, but no high upturn of of I(q) 
was identified (Figure 5.1). Thus, there was no apparent aggregation of the samples and all scattering 
points could be used for the Guinier approximation.  
 
Figure 5.2 Initial Guinier analysis of the 5 mg/mL BSA scattering curve. (Top) First data points of the recorded 
scattering data displayed (in blue dots) as log of intensity over the scattering vector q (Ǻ) and created using ScAtter 
Software® (Förster, Apostol et al. 2010, Petoukhov and Svergun 2013, Kikhney and Svergun 2015, Trewhella, 
Duff et al. 2017). The first 130 data points were used to fit a linear curve (red) that would be used to calculate the 




The Scatter® software, developed by Dr Rambo from the Diamond Light Source (Oxford, Oxfordshire), 
was used for the calculation of the hypothetical Rg and I(0) as well as their “real” parameters using 
GNOM (Franke, Petoukhov et al. 2017). Values for Rg and I(0) are reported in Table 5.2. 
Table 5.2 Summary Table of Rg and I(0) values for BSA at 5 mg/mL.  
Parameter  Value calculated by Scatter® 
Rg (Reciprocal Space) 40.03 
Rg (Real space) 41.00 
I(0) (Reciprocal Space) 5.33 x10-2 
I(0) (Real space) 5.36 x10-2 
Rg and I(0) parameters were calculated by the Scatter Software® using the Guinier approximation (reciprocal 
space) and GNOM (Real Space). 
 
For the reference protein BSA, all values were similar for both Rg and I(0) (Table 5.2), regardless of the 
methodology of calculation. Surprisingly, Rg values for the monomer BSA protein available on sasbdb® 
website (SAXS and SANS general data platform) were reported to be close to 27 Å (SASDBT4, 
https://www.sasbdb.org/data/SASDBT4). However, the higher Rg values reported here (around 40-41 
Å) correlate with those of a BSA dimer, reported to be close to 39 Å (SASDBK3, 
https://www.sasbdb.org/data/SASDBK3) on SEC-SAXS (Size exclusion chromatography coupled with 
SAXS). This result is likely due to the detergent cooperative binding to BSA, leading to the formation 






Additional parameters can be derived from the Raw scattering data using another type of analysis. The 
Kratky analysis or Kratky plot will provide information on the folding or “unfolded-ness” of 
macromolecules. It has been evidenced (Putnam et al., 2007) that a globular molecule displays a bell-
shaped curve on this plot and the more unfolded the analyte is, the higher the  q2 x I(q) product at high 
q values (Figure 5.3A), and a more hyperbolic “structural signature” is evident as for completely 
unfolded proteins (Figure 5.3A, red curve). 
 
Figure 5.3 Kratky Analysis of the 5 mg/mL BSA scattering data. (A). Representative Kratky curves for a 
globular and folded (blue) molecule, partially unfolded (black) and completely unfolded (red). (B) Kratky plot (in 
pink) of the BSA protein at 5 mg/mL in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM 
DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO). The profile obtained corresponds to that of a relatively well 
folded protein with partial unfolding. 
 
Analysis of the Kratky Plot from BSA at 5 mg/mL in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM 
NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO) revealed a bell-shaped 
curve (see example of blue curve in Figure 5.3A) with slight upturn at high q values similar to the one 
of a partially unfolded protein (Figure 5.3A, black curve). Altogether, these data indicated a substantial 
degree of folding with slight disorganization. The level of disorganisation is hardly influenced by the 
relative noise of the scattering data at high q values which could indicate imperfect buffer subtraction. 




(Trewhella, Duff et al. 2017), thus giving confidence there was no mismatch but rather a lack of robust 
scattering intensities for BSA above this scattering angle. 
Porod plots (expressed in q4 x I(q)) follow a similar principle to Kratky plots, but instead of providing 
information on the “unfolded-ness”, they reveal information about the flexibility of the molecule 
(Petoukhov and Svergun 2013, Kikhney and Svergun 2015, Trewhella, Duff et al. 2017). In this case, a 
bell-shaped curve is indicative of a fairly compact protein, and its plateauing at high q values relate to a 
very flexible protein (which still display some level of folding). 
 
Figure 5.4 Porod plot analysis the 5 mg/mL BSA scattering data. Porod plot (in pink) of the BSA protein at 5 
mg/mL (in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 
0.12% (v/v) LDAO), generated through ScAtter Software ® (REF). The profile obtained (expressed in q4 x I(q)) 
corresponds to that of a partially flexible protein. 
 
In the case of BSA protein at 5 mg/mL in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM 
EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO), the Porod profile obtained resembled a 
bell-shaped curve at low q values, with decent upturn at high q values. This indicated the protein was 
relatively compact and lacked flexibility.  
Overall, the quality assessment of the Scattering intensity of the 5 mg/mL BSA sample in the buffer of 
choice, revealed a well folded protein with a great degree of flexibility. The initial analysis did not reveal 
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parameters preventing the subsequent modelling using these data sets, such as high aggregation or a 






Once the primary analysis on the data is performed (section 5.3), the P(r) distance distribution is 
calculated from the scattering curve and is processed through GNOM (Franke, Petoukhov et al. 2017). 
certain parameters need to be modulated, in order to obtain a representative P(r) function. For example, 
some scattering data points can be discarded at low and high q values (where the noise is at his highest), 
and the maximum distance between two pairs of electrons within the molecule (Dmax) can be adjusted 
to reflect the overall maximum distribution within the molecule. As with previous analyses, patterns can 
be identified and compared to those that had been generated from distinct and precise structural 
configurations (Figure 5.5A). Again, a bell-shaped curve corresponds to a spherical and globular 






Figure 5.5 P(r) distribution of BSA at 5 mg/mL. (A) Representative P(r) distribution function for a globular and 
spherical (green), multi-domain (red), cylindrical (orange) and a disk (blue) shaped proteins. (B) P(r) distribution 
function of 5 mg/mL BSA in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 
% (w/v) Glycerol, 0.12% (v/v) LDAO.  
 
The P(r) distribution function obtained for the 5 mg/mL BSA sample (in 25 mM NaH2PO4/Na2HPO4 
(pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO) fitted a 
well-defined bell-shaped curve, suggesting the presence of a relatively globular and spherical core. 
However, the tailing in the profile indicated the presence of a more cylindrical component or at least an 
elongated protein. Altogether these results confirmed previous analysis performed on the raw scattering 






Using the P(r) distribution function, output files are generated by Scatter® (through the GNOM module) 
and communicated to the DAMMIF ab initio modelling automated algorithm. As described in section 
5.3, the program defines a search volume of dummy atoms and will either assign each dummy atom as 
part of the solvent or as part of the macromolecule (Franke and Svergun 2009). A compact model will 
be generated (by simulated annealing) from an arbitrary starting model, which should theoretically fit 
the experimental scattering data. The process was repeated 23 times, generating each time a different 




Figure 5.6 Molecular envelopes of BSA at 5 mg/mL. Twenty-three independent models (A to W) were generated 
using the DAMMIF algorithm (Franke and Svergun 2009) for the BSA protein in 25 mM NaH2PO4/Na2HPO4 (pH 
7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO. 
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The DAMSEL program (Franke and Svergun 2009) will calculate a parameter known as the normal 
spatial discrepancy (NSD) for each envelope and will discard any values with a NSD above two standard 
deviation from the mean NSD. DAMSUP will superpose the accepted models and calculate a standard 
deviation from the reference NSD (lowest amongst all remaining models). This procedure will help 
refining the model and discard any potential outliers prior to averaging the models (Franke and Svergun 
2009).    
Table 5.3 Summary of DAMSEL and DAMSUP results for BSA at 5 mg/mL.  
Model DAMSEL NSD FATE DAMSUP NSD 
16 0.584 Reference 0.000 
18 0.584 Include 0.536 
3 0.585 Include 0.485 
23 0.589 Include 0.555 
21 0.592 Include 0.549 
17 0.592 Include 0.538 
13 0.594 Include 0.541 
15 0.596 Include 0.541 
4 0.599 Include 0.558 
7 0.600 Include 0.507 
10 0.601 Include 0.522 
2 0.602 Include 0.591 
6 0.604 Include 0.535 
5 0.608 Include 0.544 
9 0.609 Include 0.493 
1 0.611 Include 0.565 
19 0.613 Include 0.560 
12 0.620 Include 0.541 
11 0.621 Include 0.574 
22 0.641 Include 0.634 
8 0.671 Include 0.665 
20 0.704 Include 0.668 
14 1.102 Discard N/A 
The mean NSD value was calculated to be 0.631 with a standard deviation of 0.106. Models are sorted from the 
lowest to the highest NSD value. Model 16 had the best NSD at 0.584 and was taken as the reference for the 
superposition with DAMSUP. Model 14 had a NSD value of 1.102 and was subsequently discarded. DAMSUP 




The accepted BSA envelope models were aligned and averaged by DAMAVER (Franke and 
Svergun 2009). The resulting volume (or probability map) was further filtered by DAMFILT using 
a predefined cut-off. Low occupancy regions were discarded and only the core (of high occupancy) 
was retained. 
Both molecular envelopes (averaged and refined) can be visualized with software such as Pymol® 
or WMD® (Figure 5.7). A crystal structure of the reference protein is generally used to orient the 
envelope.  
Although the molecular envelopes generated for the 5 mg/mL BSA in 25 mM NaH2PO4/Na2HPO4 
(pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO) seemed 
adequate when compared the reference crystal structure of Bovine Serum Albumin (3V03), a certain 
portion of the latter is outside the volume defined by the SAXS analysis (Figure 5.7 blue ribbons). This 
might be due to the flexibility observed in the previous analyses (see 5.4.3) and the partial lack of 
folding, resulting in some part of the protein being considered as solvent and discarded in the earlier 






Figure 5.7 Predicted molecular envelopes for BSA at 5 mg/mL. Probability map (grey) and filtered (yellow) 
molecular envelope generated by DAMAVER on a BSA sample at 5 mg/mL in mL in 25 mM NaH2PO4/Na2HPO4 
(pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO. The crystal structure 
of Bovine Serum Albumin 3V03 was added (in blue) and retrieved from the Protein Data Bank. The front (A) and 






SAXS data were collected at the Beamline B21 for AtVDAC1 at five different concentrations. Sample 
(4 mg/mL) was diluted in a 96-well plate four times, each time by a factor of 2. The resulting samples 
(4, 2, 1, 0.5 and 0.25 mg/mL) were all subjected to SAXS for 2 seconds, and triplicated. Series of 
triplicates were then averaged to produce a final scattering profile for each of the different concentrations 
(Figure 5.8A). The buffer blank (25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 
mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO) was also subjected to SAXS measurements, and 
its scattering profile (Figure 5.8A blue line) was subtracted from the scattering data of the protein 
samples (Figure 5.8B). A high upturn of the scattering intensity at low q values could be observed for 
each sample, despite performing dilutions and centrifuging samples prior to the experiment. This 
indicates a degree of polydispersity in the samples, due to potential aggregation or oligomerization. The 
great level of noise observed on the scattering profile of the lowest dilution (0.25 mg/mL, Figure 5.8, 






Figure 5.8 Raw Scattering Intensity plots of AtVDAC1 at 4, 2, 1, 0.5 and 0.25 mg/mL. Scattering data recorded 
at the Beamline B21 and displayed as log of intensity over the scattering vector q (Ǻ) and created using ScAtter 
Software® (Förster, Apostol et al. 2010). Samples were dialyzed for 5 days in 25 mM NaH2PO4/Na2HPO4 (pH 
7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO. (A) Raw Scattering data 
of AtVDAC1. The buffer blank (as above) is represented by a blue line. The scattering intensity curves for the 
AtVDAC1 samples at 4 (red), 2 (purple), 1 (yellow), 0.5 (burgundy) and 0.25 mg/mL (grey) are shown. (B) 







Data analysis for AtVDAC1 at 4, 2, 1, 0.5 mg/mL was carried out as previously described for the 
control protein BSA (section 5.4.2). The Rg was calculated using the Guinier approximation (Figure 





Figure 5.9 Guinier analysis of AtVDAC1 at 4, 2, 1 and 0.5 mg/mL. First data points of the recorded scattering data displayed (in coloured dots) as log of intensity over the 
scattering vector q (Ǻ) and created using ScAtter Software® (Förster, Apostol et al. 2010). The first 200 points were used to fit a linear curve (red) that would be used to 
calculate the hypothetical Rg values. Residual analysis of the scattering data (black dots) from the tendency curve (red) is indicated at the bottom for each concentration. Guinier 







Table 5.4 Derived Rg values for AtVDAC1 samples at different concentrations.   
Sample Rg (Reciprocal Space) Rg (Real space) 
AtVDAC1 at 4 mg/mL 14.56 13.88 
AtVDAC1 at 2 mg/mL 14.64 14.05 
AtVDAC1 at 1 mg/mL 14.59 14.04 
AtVDAC1 at 0.5 mg/mL 14.57 13.74 
Rg parameters were calculated by the Scatter Software® (Förster, Apostol et al. 2010) using the Guinier 
approximation (reciprocal space) and GNOM (Real Space). 
 
All reciprocal Rg values were similar, and relatively close to their corresponding real values. A small 
decreasing trend in the GNOM derived Rg values was observed for the last dilution (0.5 mg/mL). 
However, the low concentration of the sample was not deemed suitable as possible buffer mismatch are 
likely to result in over-subtraction of the buffer scattering data from those of the sample, leading to a 
smaller Radius of gyration.   
 
 
Kratky and Porods plots (Figure 5.10) both showed bell-shaped curves for all concentrations of 
AtVDAC1 tested, indicating a great degree of folding compaction. However, only the scattering datasets 
from the 4 and 2 mg/mL AtVDAC1 samples were used for ab initio modelling since the other three 
dilutions (1, 0.5 and 0.25 mg/mL) did not produce envelope models of good quality, as their 





Figure 5.10 Quality assessment of collected AtVDAC1 scattering curves at different protein concentrations. 
(A) Kratky plot of AtVDAC1 samples at 4 (red), 2 (purple), 1 (yellow), 0.5 (burgundy) and 0.25 mg/mL (grey) 




Following the initial analysis of the scattering data from the tested AtVDAC1 concentrations, 
GNOM was used as an indirect transform program for the establishment of the P(r) function for 
further ab initio modelling (Figure 5.11). For convenience, the fit between the scattering data and 
the tendency curve representing the P(r) distribution is indicated.  The two highest concentrations 
(4 and 2 mg/mL) revealed similar bell-shaped curves with a small extension at high r values, 






Figure 5.11 P(r) distribution plots of AtVDAC1 scattering data. (A) P(r) distribution function of the AtVDAC1 
scattering data, collected from 4 mg/mL (red) and 2 mg/mL (purple) samples in 25 mM NaH2PO4/Na2HPO4 (pH 
7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO. (B) Scattering intensity 
of AtVDAC1 at 4 and 2 mg/mL. For each concentration, the tendency curve representing the P(r) distribution is 
indicated in red. 
 
 
Assessment of the quality of the generated envelopes was carried out by DAMSEL and DAMSUP 
(Table 5.5) as previously described for the BSA control protein (section 5.4.6). Outliers were identified 
using their NSD value (above two standard deviation from the calculated mean NSD) and removed from 
the superposition step. Envelopes 11 and 4 were chosen for AtVDAC1 at 4 mg/mL and 2 mg/mL 






Table 5.5 Summary of DAMSEL and DAMSUP results for AtVDAC1 at 4 mg/mL and 2 mg/mL.  
Model DAMSEL NSD FATE DAMSUP NSD 
AtVDAC1 at 4 mg/mL 
11 0.484 Reference 0.000 
5 0.489 Include 0.376 
12 0.490 Include 0.432 
22 0.491 Include 0.486 
17 0.492 Include 0.457 
23 0.493 Include 0.478 
13 0.493 Include 0.489 
6 0.494 Include 0.440 
15 0.495 Include 0.495 
9 0.496 Include 0.481 
1 0.496 Include 0.471 
20 0.499 Include 0.507 
10 0.499 Include 0.501 
21 0.499 Include 0.487 
2 0.500 Include 0.474 
14 0.503 Include 0.497 
16 0.503 Include 0.503 
4 0.506 Include 0.498 
3 0.508 Include 0.515 
8 0.512 Include 0.514 
19 0.519 Include 0.508 
18 0.519 Include 0.495 
7 0.533 Discard N/A 
AtVDAC1 at 2 mg/mL 
4 0.479 Reference 0.000 
13 0.485 Include 0.484 
12 0.487 Include 0.331 
20 0.492 Include 0.481 
11 0.494 Include 0.490 
7 0.494 Include 0.483 
1 0.495 Include 0.488 
14 0.497 Include 0.502 
8 0.498 Include 0.481 
23 0.499 Include 0.463 
2 0.503 Include 0.483 
16 0.505 Include 0.487 
3 0.506 Include 0.514 
5 0.506 Include 0.374 
6 0.507 Include 0.443 
17 0.507 Include 0.501 
10 0.507 Include 0.507 
21 0.510 Include 0.504 
213 
 
18 0.513 Include 0.508 
9 0.513 Include 0.509 
19 0.515 Include 0.517 
22 0.527 Discard N/A 
15 0.527 Discard N/A 
The mean NSD value was calculated to be 0.501 with a standard deviation of 0.012 (4 mg/mL), and 0.503 with a 
standard deviation of 0.012 (2 mg/mL). Models are sorted from the lowest to the highest NSD value. Models 11 
and 4 had the best NSD at 0.484 and 0.479 (for 4 and 2 mg/mL respectively) and were taken as reference for the 
superposition with DAMSUP. On the opposite model 7 had an NSD value of 0.533 (AtVDAC1 at 4 mg/mL) and 
was subsequently discarded. In a similar manner, models 22 and 15 (NSD of 0.507 for both) were discarded for 
AtVDAC1 at 2 mg/mL. DAMSUP superposed the models and calculated a deviation from the reference NSD. 
 
Following models’ refinement by DAMAVER, the averaged probability map was generated, then 
filtered by DAMFILT which removed regions of low occupancy, to finally generate the final 
molecular envelopes for both AtVDAC1 tested concentrations (Figure 5.12).  
Primary analysis of the molecular envelopes for AtVDAC1 using Pymol and the crystal structure of the 
mouse VDAC1 (3EMN1; reference) proved difficult. The generated model had a smaller density volume 
than expected, which lead to a significant number of residues being excluded from the envelope. Thus, 
the molecular structure of AtVDAC1 was generated by homology modelling using SWISS 
MODELLER (Waterhouse, Rempfer et al. 2018) and fitted into the SAXS molecular envelopes using 
UCSF-Chimera  (Pettersen, Goddard Td Fau - Huang et al. , Huang, Meng et al. 2014). The average 
map values for AtVDAC1 at 4 mg/mL and 2 mg/mL calculated by UCSF-Chimera were reported to be 
0.2782 (293 out of 2039 atoms outside contour) and 0.2798 (314 out of 2039 atoms outside contour) 







Figure 5.12 SAXS derived 3D molecular envelopes for AtVDAC1. AtVDAC1 probability maps (grey) and 
filtered (blue) molecular envelopes generated by DAMAVER from samples at 4 mg/mL (A) and 2 mg/mL (B) in 
25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12 % (v/v) 
LDAO. The crystal structure of mouse voltage-dependant anion channel (3EMN) (in dark blue) was fitted to the 
envelopes (A) and (B). Molecular structure of AtVDAC1 (in blue) generated using SWISS MODELLER 
(Waterhouse, Rempfer et al. 2018) and fitted into the AtVDAC1 SAXS molecular envelopes from at 4 mg/mL (C) 
and 2 mg/mL samples (D), using the Chimera software (Pettersen, Goddard Td Fau - Huang et al. , Huang, Meng 





















SAXS data were collected for AtVDAC1 D177N at four different concentrations. The protein sample 
(2 mg/mL) was diluted in a 96-well plate three times, each time by a factor of 2. The resulting samples 
(2, 1, 0.5 and 0.25 mg/mL) were all subjected to SAXS for 2 seconds, and triplicated. Triplicate 
measurements were then averaged to produce a final scattering profile for each of the different 
concentrations tested (Figure 5.13A). The buffer blank (25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM 
NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO) was subjected to SAXS 
measurements and its scattering profile (Figure 5.13A blue line) was subtracted from the scattering data 
of the protein samples (Figure 5.13B). A high upturn of the scattering intensity at low q values could be 
observed for each sample, despite performing dilutions and centrifuging samples prior to the experiment. 





Figure 5.13 Raw Scattering Intensity plots of mutant D177N at 2, 1, 0.5 and 0.25 mg/mL. Scattering data 
recorded at the Beamline B21 and displayed as log of intensity over the scattering vector q (Ǻ) and created using 
ScAtter Software® (Förster, Apostol et al. 2010). Samples were dialyzed for 5 days in 25 mM NaH2PO4/Na2HPO4 
(pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO. (A) Raw Scattering 
data of D177N. The buffer blank (as above) is represented by blue line. The scattering intensity curves for the 
D177N sample at 2, 1, 0.5 and 0.25 mg/mL are represented by a red, grey, yellow and green line respectively. (B) 








Data analysis for AtVDAC1 D177N at 2, 1, 0.5 and 0.25 mg/mL was carried out as previously 
described for the control protein BSA and AtVDAC1 (sections 5.4 and 5.5). The Rg was calculated 
using the Guinier approximation (Figure 5.14) and GNOM for all concentrations. Results are 





Figure 5.14 Guinier analysis of D177N at 2, 1, 0.5 and 0.25 mg/mL. First data points of the recorded scattering data displayed as log of intensity over the scattering vector q 
(Ǻ) and created using ScAtter Software® (Förster, Apostol et al. 2010). The first 200 points were used to fit a linear curve (red) that would be used to calculate the hypothetical 
Rg. Guinier plots of D177N at 2 (A), 1 (B), 0.5 (C), and 0.25 mg/mL (D) are represented by red, grey, yellow and green dots respectively. Residual analysis of the scattering 







Table 5.6 Summary Table of Rg values for D177N.  
Sample Rg (Reciprocal Space) Rg (Real space) 
D177N at 2 mg/mL 15.31 13.96 
D177N at 1 mg/mL 15.40 14.25 
D177N at 0.5 mg/mL 16.42 14.49 
D177N at 0.25 mg/mL 18.78 14.53 
Parameters Rg calculated by Scatter Software ® using approximation (reciprocal space) and GNOM (Real Space). 
 
Reciprocal Space Rg values increased with the dilution factor and were relatively higher than their 
corresponding real values (overall more than 1 unit difference). A similar trend was observed for the 
Real Rg values, calculated by GNOM, indicating an effect of the dilution on the real Rg. The high upturn 
at low q values identified on scattering profile indicated a possible aggregation (for all of them), which 
was likely the cause of this trend.  
  
 
Kratky and Porods plots (Figure 5.15) both showed bell-shaped curves for all the tested AtVDAC1 
D177N samples, indicating a great degree of folding and compaction. Nevertheless, only two datasets 
(2 mg/mL and 1 mg/mL samples) of D177N protein was used for ab initio modelling since the other two 
dilutions (0.5 and 0.25 mg/mL) did no produce envelope models of good quality, as their concentrations 





Figure 5.15 Quality assessment of D177N scattering curves at different protein concentrations. (A) Kratky 
plot of samples at 2, 1, 0.5 and 0.25 mg/mL are represented by a red, grey, yellow and green line respectively. (B) 









Following the initial analysis of the scattering data from D177N at various concentrations, GNOM 
was used as an indirect transform program for the establishment of the P(r) function for further ab 
initio modelling (Figure 5.16). For convenience, the fit between the scattering data and the tendency 
curve representing the P(r) distribution is indicated.  Only two concentrations of D177N protein (2 
mg/mL and 1 mg/mL) were used and revealed a similar bell-shaped curve with a small extension, 






Figure 5.16 P(r) distribution plots of D177N scattering data. (A) P(r) distribution function of the D177N 
scattering data, collected from 2 mg/mL (red) and 1 mg/mL (purple) samples in 25 mM NaH2PO4/Na2HPO4 (pH 
7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO. (B) Scattering intensity 
of D177N at 2 and 1 mg/mL. For each concentration, the tendency curve representing the P(r) distribution is 







Assessment of the generated envelopes (Table 5.7) was carried out by DAMSEL and DAMSUP as 
previously described for the BSA control protein and AtVDAC1 (see 5.4 and 5.5). Outliers were 
identified (model 4 and 2 for the 2 mg/mL and 1 mg/mL sample respectively) as two standard deviation 
units  away from the calculated mean NSD, and excluded from the superposition step. Envelopes 17 in 
(both cases) were used by DAMSEL as the reference envelopes for D177N at 2 mg/mL and 1 mg/mL 
respectively. 
Table 5.7 Summary of DAMSEL and DAMSUP results for D177N at 2 mg/mL and 1 mg/mL.  
Model DAMSEL NSD FATE DAMSUP NSD 
D177N at 2 mg/mL 
17 0.461 Reference 0.000 
12 0.465 Include 0.429 
14 0.472 Include 0.477 
3 0.473 Include 0.447 
20 0.474 Include 0.486 
6 0.474 Include 0.464 
21 0.474 Include 0.439 
5 0.477 Include 0.460 
8 0.478 Include 0.305 
10 0.480 Include 0.461 
7 0.480 Include 0.451 
11 0.480 Include 0.476 
18 0.482 Include 0.463 
16 0.489 Include 0.471 
13 0.489 Include 0.445 
1 0.489 Include 0.471 
19 0.490 Include 0.476 
22 0.490 Include 0.516 
2 0.490 Include 0.504 
9 0.493 Include 0.489 
23 0.495 Include 0.455 
15 0.506 Include 0.516 
4 0.552 Discard N/A 
D177N at 1 mg/mL 
17 0.468 Reference 0.000 
18 0.473 Include 0.259 
14 0.477 Include 0.407 
13 0.478 Include 0.439 
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1 0.483 Include 0.490 
6 0.483 Include 0.477 
22 0.473 Include 0.371 
21 0.488 Include 0.498 
19 0.489 Include 0.482 
20 0.490 Include 0.465 
9 0.490 Include 0.484 
23 0.491 Include 0.471 
4 0.491 Include 0.457 
8 0.498 Include 0.519 
3 0.499 Include 0.496 
5 0.504 Include 0.496 
12 0.505 Include 0.479 
7 0.507 Include 0.498 
15 0.509 Include 0.553 
10 0.510 Include 0.523 
11 0.511 Include 0.539 
16 0.547 Include 0.503 
2 0.583 Discard N/A 
The mean NSD value was calculated to be 0.485 with a standard deviation of 0.018 (2 mg/mL), and 0.498 with a 
standard deviation of 0.025 (2 mg/mL). Models are sorted from the lowest to the highest NSD value. Models 17 
had the best NSD at 0.461 and 0.468 (for 2 and 1 mg/mL respectively) and were taken as reference for the 
superposition with DAMSUP. On the opposite model 4 had an NSD value of 0.552 (D177N at 2 mg/mL) and was 
subsequently discarded. In a similar manner, model 2 (NSD of 0.583) was discarded for D177N at 1 mg/mL. 
DAMSUP superposed the models and calculated a deviation from the reference NSD.  
 
Following models’ refinement by DAMAVER, the averaged probability map was created, then 
filtered by DAMFILT which removed regions of low occupancy to give a final molecular envelope 
for D177N at both 2 and 1 mg/mL (Figure 5.17).  
Primary analysis of the molecular envelopes for D177N using Pymol ® and the crystal structure of the 
mouse VDAC1 (3EMN1; reference) proved difficult. The generated model had a smaller density volume 
than expected, which lead to a significant number of residues being excluded from the envelope. Thus, 
the molecular structure of D177N was generated by homology modelling using SWISS MODELLER 
(Waterhouse, Rempfer et al. 2018) and fitted into the SAXS molecular envelopes using UCSF-Chimera  
(Pettersen, Goddard Td Fau - Huang et al. , Huang, Meng et al. 2014). The average map values for 
D177N at 2 mg/mL and 1 mg/mL calculated by UCSF-Chimera were reported to be 0.282 (307 out of 




Figure 5. 17 Generated molecular envelopes for D177N at 2 and 1 mg/mL. Probability map (grey) and filtered 
(blue) molecular envelope generated by DAMAVER on D177N samples at 2 mg/mL (A) and 1 mg/mL (B) in 25 
mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) 
LDAO. The crystal structure of Voltage-dependant Channel 1 from mouse 3EMN1 was added (in dark blue) and 
retrieved from the Protein Data Bank. (C) Molecular structure of D177N (in blue) generated using SWISS 
MODELLER (Waterhouse, Rempfer et al. 2018) and fitted into the SAXS molecular envelopes using Chimera 
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SAXS data were collected for D258N at four different concentrations. Sample (2 mg/mL) was diluted 
in a 96-well plate three times, each time by a factor of 2. The resulting samples (2, 1, 0.5 and 0.25 
mg/mL) were all subjected to SAXS for 2 seconds, and triplicated. Series of triplicates were then 
averaged to produce a final scattering profile for each of the different concentrations (Figure 5.18A). 
The buffer blank (25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % 
(w/v) Glycerol, 0.12% (v/v) LDAO) was subjected to SAXS and its scattering profile (Figure 5.18A 
blue line) was removed from the samples data sets (Figure 5.18B). As for most previous AtVDAC 
proteins (section 5.5 and 5.6), a high upturn of the scattering intensity at low q values could be observed 
for each sample, despite performing dilutions and centrifuging samples prior to the experiment. This 





Figure 5.18 Raw Scattering Intensity plots of mutant D258N at 2, 1, 0.5 and 0.25 mg/mL. Scattering data 
recorded at the Beamline B21 and displayed as log of intensity over the scattering vector q (Ǻ) and created using 
ScAtter Software® (Förster, Apostol et al. 2010). Samples were dialyzed for 5 days in 25 mM NaH2PO4/Na2HPO4 
(pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO. (A) Raw Scattering 
data of D258N. The buffer blank (as above) is represented by blue line. The scattering intensity curves for the 
D258N sample at 2, 1, 0.5 and 0.25 mg/mL are represented by a red, grey, yellow and green line respectively. (B) 






Data analysis for D258N at 2, 1, 0.5 and 0.25 mg/mL was carried out as previously described 
(sections 5.4 to 5.6). The Rg was calculated using the Guinier approximation (Figure 5.19) and 





Figure 5.19 Guinier analysis of D258N at 2, 1, 0.5 and 0.25 mg/mL. First data points of the recorded scattering data displayed as log of intensity over the scattering vector q 
(Ǻ) and created using ScAtter Software® (Förster, Apostol et al. 2010). The first 200 points were used to fit a linear curve (red) that would be used to calculate the hypothetical 
Rg. Guinier plots of D258N at 2 (A), 1 (B), 0.5 (C), and 0.25 mg/mL (D) are represented by red, grey, yellow and green dots respectively. Residual analysis of the scattering 







Table 5. 8 Summary Table of Rg values for D258N.  
Sample Rg (Reciprocal Space) Rg (Real space) 
D258N at 2 mg/mL 13.29 13.70 
D258N at 1 mg/mL 13.69 13.77 
D258N at 0.5 mg/mL 14.00 13.96 
D258N at 0.25 mg/mL 14.33 14.00 
Parameters Rg calculated by Scatter Software ® using approximation (reciprocal space) and GNOM (Real Space). 
 
Reciprocal Space Rg values increased with the dilution factor and were very close to their corresponding 
real values (overall less than 0.5 units difference). A similar trend can be observed for the Real Rg 
values, calculated by GNOM, indicating an effect of the dilution on the real Rg. As with previous SAXS 
analyses on AtVDACs (section 5.5 and 5.6), the high upturn at low q values identified on scattering 
profile indicated a possible aggregation (for all of them), which was the likely cause of this trend.  
 
 
Initial assessment of the data quality was performed on D258N samples at 2, 1, 0.5 and 0.25 mg/mL 
(Figure 5.20). Kratky and Porods plots both showed a bell-shaped curve for all D258N samples, 
indicating a great degree of folding and compaction. However, only two datasets (2 mg/mL and 1 mg/mL 
samples) of D258N protein was used for ab initio modelling since the concentrations and profile were 
reasonable. The other two dilutions (0.5 and 0.25 mg/mL) did no produce final models of good quality 
to guarantee statistically relevant molecular envelopes, as their concentrations were too low and their 





Figure 5. 20 Quality assessment of D258N scattering curves at different protein concentrations. (A) Kratky 
plot of samples at 2, 1, 0.5 and 0.25 mg/mL are represented by a red, grey, yellow and green line respectively. (B) 
Corresponding Porod plots for D258N samples. Colours are as above.  
 
 
Following the initial analysis of the scattering data from D258N at various concentrations, GNOM 
was used as an indirect transform program for the establishment of the P(r) function for further ab 
initio modelling (Figure 5.21). For convenience, the fit between the scattering data and the tendency 
curve representing the P(r) distribution is indicated. Only two concentrations of D258N protein (2 
mg/mL and 1 mg/mL) were used and revealed a similar bell-shaped curve with a small extension, 








Figure 5. 21 P(r) distribution plots of D258N scattering data. (A) P(r) distribution function of the D258N 
scattering data, collected from the 2 mg/mL (red) and 1 mg/mL (purple) samples in 25 mM NaH2PO4/Na2HPO4 
(pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO. (B) Scattering 
intensity of D258N at 2 and 1 mg/mL. For each concentration, the tendency curve representing the P(r) distribution 








Assessment of the generated envelopes (Table 5.9) was carried out by DAMSEL and DAMSUP as 
previously described for the previous proteins (sections 5.4.5, 5.5.5 and 5.6.5). Outliers were identified 
(model 2 and 2 for the 2 mg/mL and 1 mg/mL sample respectively) as two standard deviations away 
from the calculated mean NSD and removed from the superposition step. Envelopes 17 in (both cases) 
were used by DAMSEL as the reference envelopes for D177N at 2 mg/mL and 1 mg/mL respectively. 
Table 5.9 Summary of DAMSEL and DAMSUP results for D258N at 2 mg/mL and 1 mg/mL.  
Model DAMSEL NSD FATE DAMSUP NSD 
D258N at 2 mg/mL 
5 0.446 Reference 0.000 
6 0.448 Include 0.308 
13 0.455 Include 0.386 
12 0.461 Include 0.471 
19 0.462 Include 0.489 
8 0.462 Include 0.497 
3 0.468 Include 0.474 
4 0.470 Include 0.308 
21 0.475 Include 0.499 
22 0.477 Include 0.459 
23 0.479 Include 0.494 
9 0.480 Include 0.488 
16 0.481 Include 0.464 
17 0.481 Include 0.464 
14 0.484 Include 0.494 
20 0.485 Include 0.443 
10 0.486 Include 0.493 
15 0.486 Include 0.492 
18 0.486 Include 0.491 
7 0.491 Include 0.501 
11 0.500 Include 0.485 
1 0.500 Include 0.532 
2 0.532 Discard N/A 
D258N at 1 mg/mL 
6 0.472 Reference 0.000 
9 0.473 Include 0.259 
7 0.475 Include 0.407 
13 0.479 Include 0.439 
22 0.481 Include 0.490 
19 0.481 Include 0.477 
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14 0.482 Include 0.371 
21 0.482 Include 0.498 
18 0.485 Include 0.482 
4 0.485 Include 0.465 
20 0.487 Include 0.484 
16 0.489 Include 0.471 
17 0.490 Include 0.457 
2 0.491 Include 0.519 
23 0.492 Include 0.496 
1 0.493 Include 0.496 
3 0.493 Include 0.479 
15 0.493 Include 0.498 
10 0.494 Include 0.553 
8 0.494 Include 0.523 
12 0.494 Include 0.539 
11 0.520 Include 0.503 
5 0.600 Discard N/A 
The mean NSD value was calculated to be 0.478 with a standard deviation of 0.019 (2 mg/mL), and 0.492 with a 
standard deviation of 0.025 (2 mg/mL). Models are sorted from the lowest to the highest NSD value. Models 5 
and 6 had the best NSD at 0.446 and 0.472 (for 2 and 1 mg/mL respectively) and were taken as reference for the 
superposition with DAMSUP. On the opposite model 2 had an NSD value of 0.532 (D258N at 2 mg/mL) and was 
subsequently discarded. In a similar fashion, model 5 (NSD of 0.600) was discarded for D258N at 1 mg/mL. 
DAMSUP superposed the models and calculated a deviation from the reference NSD. 
 
Following models’ refinement by DAMAVER, the averaged probability map was created, then 
filtered by DAMFILT which removed regions of low occupancy to give a final molecular envelope 
for D258N at both 2 and 1 mg/mL (Figure 5.22).  
Primary analysis of the molecular envelopes for D258N using Pymol and the crystal structure of the 
mouse VDAC1 (3EMN1; reference) proved difficult. The generated model had a smaller density volume 
than expected, which lead to a significant number of residues being excluded from the envelope. Thus, 
the molecular structure of D258N was generated by homology modelling using SWISS MODELLER 
(Waterhouse, Rempfer et al. 2018) and fitted into the SAXS molecular envelopes using UCSF-Chimera  
(Pettersen, Goddard Td Fau - Huang et al. , Huang, Meng et al. 2014). The average map values for 
D258N at 2 mg/mL and 1 mg/mL calculated by UCSF-Chimera were reported to be 0.2666 (344 out of 





Figure 5.22 Generated molecular envelopes for D258N at 2 and 1 mg/mL. Probability map (grey) and filtered 
(blue) molecular envelope generated by DAMAVER on D258N samples at 2 mg/mL (A) and 1 mg/mL (B) in 25 
mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) 
LDAO. The crystal structure of Voltage-dependant Channel 1 from mouse 3EMN1 was added (in dark blue) and 
retrieved from the Protein Data Bank. (C) Molecular structure of D177N (in blue) generated using SWISS 
MODELLER (Waterhouse, Rempfer et al. 2018) and fitted into the SAXS molecular envelopes using Chimera 
software (Pettersen, Goddard Td Fau - Huang et al. , Huang, Meng et al. 2014) for AtVDAC1 at 2 mg/mL and 1 
mg/mL (D).  
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Primary analysis of the molecular envelopes for AtVDAC proteins using Pymol and the crystal structure 
of the mouse VDAC1 3EMN1 or their respective structures generated in silico revealed a smaller density 
volume than expected, with a substantial number of residues (15 % on average) left out of the envelope 
(section 5.5.5; 5.6.5 and 5.7.5,). Thus, the molecular structure of AtVDAC1 and its D258N and D177N 
mutants (created using homology modelling) were used to compute a theoretical SAXS profile using 
the Fox webserver (Schneidman-Duhovny, Hammel et al. 2010)  (Figure 5.23, A to C). As expected, 
almost no difference was observed between the native-like AtVDAC1 and its mutant, although 
D258N showed a slight variation at very high q values (around 35 to 38 Å). However, a clear 
difference was evident between the calculated and the actual AtVDAC SAXS scattering profiles 
(Figure 5.23E). This difference can be accounted by the fact that the computational calculations 
were performed on a hypothetical 3D-model,  as opposed to experimental data reflecting the 






Figure 5.23 Computed SAXS profiles based on AtVDAC predicted 3D-models. Theoretical intensity curves 
using the constructed homology models of AtVDAC1 (A), D177N (B) and D258N (C) superposed (D) and 
generated by Chimera. (E) Theoretical intensity curve of AtVDAC1 (red) and actual SAXS scattering from 
AtVDAC1 (yellow), D177N (grey) and D258N (light blue), each at 2 mg/mL in 25 mM NaH2PO4/Na2HPO4 (pH 










Overall, measurements for AtVDAC proteins in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 
mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol, 0.12% (v/v) LDAO are summarized in Table 5.10. 
Distances and diameters of the molecular envelopes were calculated using the Pymol distance 
measurement tool. AtVDAC1 molecular envelopes, generated through SAXS experiments, showed 
similar features to those of the D177N and D258N AtVDAC1 mutants for all parameters listed, with 
some minor differences in the lengths and diameters. Most noticeably, the measured diameters of the 
predicted 3D-models were consistently larger than those of their SAXS envelopes.  
Table 5. 10. Summary of parameters for the SAXS envelopes and predicted 3D models of AtVDAC proteins.  





D177N      
2 mg/mL 
D177N      
1 mg/mL 
D258N      
2 mg/mL 




13.88 14.05 13.96 14.25 13.70 13.77 
Dmax 40 40 39 39 40 40 
Diameter of the 
molecular 
envelope 
27.3-42.9 31.9-42.7 36.5-39.3 33.5-42.1 37.0-37.8 35.4-36.2 
Diameter of the 
homology model 
38.3-54.9 38.3-54.9 39.5-53.4 39.5-53.4 37.3-50.7 37.3-50.7 
Height of the 
molecular 
envelope 
21.2-23.0 19.9-23.3 16.4-19.2 16.2-19.0 14.4-19.5 11.2-20.9 
Height of the 
homology model 







All AtVDAC proteins were refolded with the aid of LDAO at a final concentration of 0.12 % (v/v), at 
about 5 times of its critical micellar concentration (CMC). Further investigation was undertaken to 
properly distinguish between a free empty micelle and an AtVDAC1 generated envelope, possibly 
embedded within a micelle. Hence, four different LDAO samples were prepared at 0.01, 0.0575, 0.115 
and 0.23 % (v/v) concentration in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 
mM DTT, 10 % (w/v) Glycerol. These samples were prepared to monitor the Scattering pattern of 
LDAO below, at 2.5, 5 and 10 times its CMC respectively. SAXS data were collected for LDAO at the 
four different concentrations with series of triplicates that were averaged to produce a final scattering 
profiles for each concentration (Figure 5.24). The buffer blank (25 mM NaH2PO4/Na2HPO4 (pH 7.0), 
50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol) was subjected to SAXS and its scattering 
profile was subtracted from the scattering data of the LDAO samples. No high upturn of the scattering 
intensity at low q values could be observed for each sample above the CMC (Figure 5.24, red, grey and 
yellow curve), indicating a great degree of monodispersity in the samples. In contrast, the LDAO sample 
below the CMC showed a high degree of noise in the low q regions, due to a potential lack of structure 





Figure 5.24 Scattering Intensity plots of LDAO at 0.01, 0.0575, 0.115 and 0.23 % (v/v). Scattering intensity 
data recorded and displayed as log of intensity over the scattering vector q (Ǻ) and created using ScAtter® 
Software (Förster, Apostol et al. 2010). The scattering intensity curves for the LDAO at 0.23, 0.115, 0.0575 and 
0.01 % (v/v) (in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) 
Glycerol) are represented by an orange, grey, yellow and green line respectively. 
 
 
Data analysis for LDAO at 0.01, 0.0575, 0.115 and 0.23 % (v/v) was carried out as previously 
described for the control protein BSA (sections 5.4). The Rg was calculated using the Guinier 
approximation (Figure 5.25) and GNOM for all concentrations except for the lowest (below the 
detergent’s CMC). This last sample proved difficult as there was no apparent Rg due to the lack of 




Figure 5.25 Initial Guinier analysis of LDAO at 0.0575, 0.115 and 0.23 % (v/v). First data points of the recorded scattering data displayed as log of intensity over the 
scattering vector q (Ǻ) and created using ScAtter Software® (Förster, Apostol et al. 2010). The first 200 points were used to fit a linear curve (red) that would be used to 
calculate the hypothetical Rg. Guinier plots of LDAO at 0.23 (A), 0.115 (B) and 0.0575 % (v/v) (C) are represented by orange, grey and yellow dots respectively. Residual 





Table 5.11 Summary Table of Rg values for LDAO. 
Sample Rg (Reciprocal Space) Rg (Real space) 
LDAO at 0.23 % (v/v) 12.90 13.28 
LDAO at 0.115 % (v/v) 12.27 12.92 
LDAO at 0.0575 % (v/v) 12.07 12.85 
Parameters Rg calculated by Scatter® Software using approximation (reciprocal space) and GNOM (Real 
Space). 
 
Reciprocal Space Rg values increased with LDAO concentration and were slightly higher than their 
corresponding real values (overall less than 0.8 units difference). A similar trend can be observed for 
the Real Rg values, calculated by GNOM, indicating an effect of the LDAO concentration on the real 
Rg and the micelles’ size.   
 
 
Initial assessment of the data quality was performed on LDAO at 0.01, 0.0575, 0.115 and 0.23 % (v/v) 
(Figure 5.26). Kratky plots confirmed the correlation between degree of “unfoldness” and LDAO 
concentration; as the concentration increased the profile resembled more and more a bell-shaped curve 
(Figure 5.26A), indicating an increasing level of compaction. This is to be expected as the micelle size 
increases and stabilizes with the detergent concentration. Porod plots showed a similar trend, with the 
flexibility increasing with decreasing detergent concentration, although a great degree of flexibility was 
evident in all samples (Figure 5.26B). The absence of an actual compact core was noticeable, as opposed 





Figure 5.26 Quality assessment of LDAO scattering curves at different protein concentrations. (A) Kratky 
plot LDAO at 0.23, 0.115 and 0.0575 % (v/v) are represented by a red, grey, yellow and green line respectively. 








Following the initial analysis of the scattering data from LDAO at various concentrations, GNOM 
was used as an indirect transform program for the establishment of the P(r) function for further ab 
initio modelling (Figure 5.27). For convenience, the fit between the scattering data and the tendency 
curve representing the P(r) distribution is indicated (Figure 5.27B, red line). Considering the 
concentration of LDAO in AtVDAC samples (0.12 % (v/v)), two datasets (LDAO 0.115 and 0.23 % 
(v/v)) were used for the ab initio analysis, as their concentrations were the most representative of those 
of AtVDAC samples (0.115 < 0.12 <0.23). Both analyses revealed a similar bell-shaped curve with a 






Figure 5.27 P(r) distribution plots of LDAO scattering data. (A) P(r) distribution function of the LDAO 
collected from the 0.23 % (v/v) (red) and 0.115 % (v/v) (grey) samples in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 
50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % (w/v) Glycerol. (B) Scattering intensity of LDAO at 0.115 and 









Assessment of the generated envelopes (Table 5.12) was carried out by DAMSEL and DAMSUP as 
previously described for the BSA control protein and AtVDACs (sections 5.4.5, 5.5.5, 5.6.5 and 5.7.5). 
Outliers were identified (model 4 and 2 for the 2 mg/mL and 1 mg/mL sample respectively) as two 
standard deviation units away from the calculated mean NSD and removed from the superposition step. 
Envelopes 19 and 21 were used by DAMSEL as the reference envelopes for LDAO at 0.23 % (v/v) and 
0.115 % (v/v) respectively. 
Table 5.12 Summary of DAMSEL and DAMSUP results for LDAO at 0.23 and 0.115 % (v/v).  
Model DAMSEL NSD FATE DAMSUP NSD 
LDAO at 0.23 % (v/v) 
19 0.515 Reference 0.000 
3 0.518 Include 0.481 
20 0.518 Include 0.488 
21 0.522 Include 0.494 
12 0.522 Include 0.495 
15 0.525 Include 0.500 
18 0.526 Include 0.509 
5 0.528 Include 0.502 
9 0.528 Include 0.482 
6 0.532 Include 0.465 
1 0.532 Include 0.497 
16 0.533 Include 0.514 
14 0.537 Include 0.496 
17 0.538 Include 0.522 
8 0.540 Include 0.516 
23 0.550 Include 0.486 
4 0.552 Include 0.506 
10 0.564 Include 0.516 
11 0.572 Include 0.550 
13 0.572 Include 0.560 
2 0.606 Include 0.608 
22 0.607 Include 0.557 
7 0.625 Discard N/A 
LDAO at 0.115 % (v/v) 
21 0.484 Reference 0.000 
17 0.486 Include 0.470 
10 0.487 Include 0.494 
1 0.489 Include 0.471 
247 
 
4 0.490 Include 0.458 
8 0. 490 Include 0.471 
15 0. 490 Include 0.372 
20 0.491 Include 0.471 
16 0.493 Include 0.475 
19 0.497 Include 0.469 
9 0.498 Include 0.509 
2 0.502 Include 0.493 
6 0.505 Include 0.429 
18 0.506 Include 0.499 
3 0.509 Include 0.498 
7 0.511 Include 0.503 
12 0.512 Include 0.472 
22 0.513 Include 0.489 
11 0.516 Include 0.542 
14 0.516 Include 0.510 
5 0.516 Include 0.510 
13 0.517 Include 0.498 
23 0.529 Discard N/A 
The mean NSD value was calculated to be 0.546 with a standard deviation of 0.031 (0.23 % (v/v)), and 0.502 with 
a standard deviation of 0.013 (0.115 % (v/v)). Models are sorted from the lowest to the highest NSD value. Models 
19 and 21 had the best NSD at 0.515 and 0.484 (for 0.23 and 0.115 % (v/v) respectively) and were taken as 
reference for the superposition with DAMSUP. On the opposite model 7 had an NSD value of 0.625 (LDAO at 
0.23 % (v/v)) and was subsequently discarded. In a similar manner, model 23 (NSD of 0.529) was discarded for 
LDAO at 0.115 % (v/v). DAMSUP superposed the models and calculated a deviation from the reference NSD.  
 
Following models’ refinement by DAMAVER, the averaged probability map was created, then 
filtered by DAMFILT which removed regions of low occupancy to give a final molecular envelope 





Figure 5.28 Generated molecular envelopes for LDAO at 0.23 and 0.115 % (v/v). Probability map (grey) and 
filtered (blue) molecular envelope generated by DAMAVER on LDAO samples at 0.23 % (v/v) (A) and 0.115 % 














SAXS experiments conducted at the Diamond Light Source at the Beamline B21 under the supervision 
of Dr Rambo proved very successful in capturing relatively good quality data for all AtVDAC samples. 
Aggregation of membrane protein is a common phenomenon, often affecting the quality of the collected 
scattering curves which is generally assessed through examination of the scattering profile at low q 
values (Trewhella, Duff et al. 2017). In this instance, AtVDAC1 and its D177N and D258N mutants all 
exhibited a small upturn of the scattering intensity at low q values (section 5.5.1, 5.6.1 and 5.7.1, Figure 
5.8, 5.13 and 5.18). Despite the scattering intensities indicating a certain level of aggregation within the 
samples, data were deemed acceptable as they did not affect the overall quality of the scattering curves 
in a critical manner. Specific care was taken when centrifuging samples prior to the experiment, but this 
did not seem to drastically improve the quality of the SAXS scattering profiles. Feedback provided by 
Dr Rambo form the Diamond Light Source (Oxford) supported the hypothesis that small upturn might 
not always be a sign of aggregation but rather a sign of higher oligomer formation (often disordered).  
Primary analysis of all the AtVDAC SAXS data revealed a compact, well folded envelope with 
relatively small flexibility, consistent with previous studies on β-barrel porins (Dyer, Brown et al. 2015). 
This compactness was accompanied with a relatively low Rg for a ~30 kDa protein as opposed to the 
reference protein BSA (~66 kDa) (section 5.4.2). The Rg was fairly consistent across individual 
experiments for all AtVDACs, albeit increasing very slightly upon dilution (section 5.5.1, 5.6.1 and 
5.7.1, Figure 5.8, 5.13 and 5.18). This might be due to the dilution, potentially stabilizing the micelles 
in which the proteins are embedded (Yu, Raschle et al. 2012) by increasing the ratio between detergent 
and protein, and putatively reducing the natural aggregation propensity of membrane proteins. 
The P(r) distribution function of all the examined AtVDACs revealed bell-shaped curves with a small 
tail, suggesting a globular-type envelope with a relatively spherical shape. No significant differences 
could be observed between the native-like AtVDAC envelope and those of its mutants, (consistent Dmax 





Figure 5.29 P(r) distribution plots of AtVDACs scattering data. P(r) distribution function of the 
AtVDACs samples in 25 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 % 
(w/v) Glycerol. The Native AtVDAC1 is shown in red, mutant D258N and D177N are shown in black and blue 
respectively. 
Processing of data through GNOM lead to the generation of multiple envelopes that were averaged and 
filtered by DAMSUP to produce final molecular envelopes for each protein. All AtVDAC proteins 
exhibited thick disk shapes with similar dimensions. AtVDAC1 appeared slightly more elongated than 
its mutants, which shares a more homogenous disk shape.  
When comparing the generated AtVDAC1 SAXS envelopes to the computed AtVDAC1 structures 
(generated by homology modelling; section 5.5.5), the filtered SAXS envelopes were smaller than 
expected and most of the amino acids forming the loops between each beta sheet were excluded from 
them. The relative flexibility of these secondary structures compared to beta sheets might explain why 
they were not included in the “core” density. Moreover, slight over-subtraction of the buffer might as 
well contribute to this smaller volume. As VDAC are likely embedded in micelles (Yu, Raschle et al. 
2012), part of the micelle could be subtracted from the scattering intensity, leading to a reduction in the 
size of the molecular envelope.   
Surprisingly, the computed SAXS profile generated via the Fox webserver (Schneidman-Duhovny, 
Hammel et al. 2010) revealed a completely different hypothetical scattering pattern. This pattern was 
strongly influenced by the crystal nature of the inputed PDB, thus producing a scattering profile 
indicative for the presence of an elongated tube (Svergun and Volkov, 2003). Even more surprising was 
the fact that in-house experiments often displayed a scattering profile closer to those of the simulated 
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experiments. Unfortunately, an incredibly high upturn of the scattering intensity at low q value prevented 
further analysis of these data. In conclusion, it is likely that the instrument and measurements made with 
a weaker X-ray beam (less sensitive) only revealed the internal core of the protein. This could be due to 
additional parameters such the lack of scattering of the sample due to possible X-ray absorption.  
The general consensus around protein refolding in detergent relies around the membrane protein being 
“embedded” into micelles. Therefore, LDAO SAXS profiles were recorded at various concentrations 
matching the concentration of the blank/dialysis buffer. In summary, the radius of gyration of LDAO 
was consistent  with a micelle size of 17 to 20 kDa (Herrmann 1962) and fairly close, although slightly 
lower, than the Rg values obtained for AtVDACs. The quality analysis of LDAO emphasized a partially 
folded, but definitely not compact envelope. This lack of proper compactness and folding in comparison 
to the AtVDAC envelopes was a key determinant in characterizing the main difference between a free 
empty micelle and a VDAC embedded in a micelle.  
Finally, final molecular envelopes for LDAO at five times and ten times the CMC revealed a bi- and 
trilobate shape respectively, nowhere close to those of AtVDAC1 or its mutant. Although the LDAO 
micelle was found to be best fitted as an ellipsoid in SANS experiments (Thiyagarajan and Tiede 1994), 
the analysis of the size distribution of the particles in the different LDAO by BSc Student Thomas 
Goodfellow at the University of Huddersfield using a zeta sizer Nano Z from Malvern ® revealed a slow 
kinetic of micelle formation. Fresh LDAO samples would exhibit a large majority of monomer LDAO 
(around 4 nm in size) and would shift toward a bigger micelle after a few days. Considering the different 
LDAO samples subjected to SAXS were prepared in the same conditions, it is likely the micelles could 
stabilize and grow bigger in size after a few more days of incubation. Thus, the odd shapes observed 
here are likely the result of the slow kinetic of micelle in the process of stabilization. An interesting 
experiment could be designed to further characterize the kinetic of micelle formation using SAXS and 
samples mixed and incubated at various time-points.  
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6. Chapter 6: The Kinesin-like mKlp2C-Ter 
In parallel to the structural and functional characterization of AtVDAC1 and its mutant D177N, D258N 
and T156C, several potential AtVDAC partner proteins such as A.thaliana Hexokinase 1, Bcl-Xs and 
mKlp2 were investigated for their ability to bind AtVDACs (see section 1.10.1). Only one protein was 
brought to the purification stage, namely mKlp2C-Ter, a truncated version of mKlp2 protein. 
This Kinesin-like protein, called KIN-7D, MKRP2 or mKlp2 (accession number; Q8W5R5), contains 
an extended region in its N-Terminal motor domain that has been proven to act as an MTS 
(mitochondrial targeting signal) in plants (Itoh, Fujiwara et al. 2001). Moreover, it has already been 
demonstrated to harbour a microtubule-enhanced ATPase activity, an ability to bind ATP and ADP in 
vitro, as well as retaining its total enzymatic activity even after the removal of the ADP bound in the 
active site (Kondo, Umeki et al. 2006, Umeki, Maruta et al. 2006). 
 
Figure 6.1 Identification of a zinc finger in the C-Terminal domain of mKlp2. Domain prediction was 
performed using Prosite webserver (Sigrist, de Castro et al. 2013) on the last 345 amino acids of mKlp2 (accession 
number; Q8W5R5). The typical cysteine and histidine residues forming the ring finger domain are indicated by a 
red and blue line respectively. 
 
Interestingly, its record in UniProt Database (The UniProt 2018) revealed a potential zinc finger in the 
last 40 amino acids of its C-Terminal domain (Figure 6.1). Considering ring fingers are known mediator 
of ubiquitin ligase activity (Lorick, Jensen et al. 1999, Joazeiro and Weissman 2000), its presence on 
mKlp2 protein might suggest this kinesin might play a role in the mediation of mitochondrial protein 
degradation via the ubiquitination pathway. 
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To further characterize this specific region of the mKlp2 protein, a truncated version containing only 
the last 345 amino acids of the Native protein was designed. This truncated protein contained an His-
tag on its N-Terminal domain for subsequent purification, and a thrombin cleavage site for the removal 
of the tag (post-purification). Tagged and untagged truncated mKlp2C-Ter would then be assessed by 
Iso-thermal calorimetry (ITC, section 6.7) for their ability to bind zinc ions via the ring finger domain. 






Expression plasmid pET-20b(+) constructs harbouring the mKlp2C-Ter were constructed by Muktar 
Farah (MSc thesis 2014) under the supervision of Dr Georgios Psakis at the University of Huddersfield. 
Plasmid stocks were replenished by frequent mini-preps of transformed with the desired plasmid DH5α 
to ensure constant supply of fresh DNA (section 2.3.3). 
 
BL21 DE3 cells (Table 2.4) were first chemically transformed with the plasmid harbouring the mKlp2C-
Ter gene (Kin-7D, locus At4g39050) and grown on selective medium. Typical expression conditions 
were screened (concentration of IPTG and time of incubation) and the optimal set of conditions was 
chosen (results not shown). This screen was conducted by Muktar Farah (MSc thesis 2014; results not 
shown) and would prove to work consistently. As a result, MKLP2 gene expression in BL21D(DE3) 
cells was induced with 1 mM IPTG at 37 °C for 4h (see section 2.3.4.1). 
 
Following overexpression, IPTG-induced cells were harvested and resuspended in lysis buffer (see 
Table 2.1). Cells were then sonicated (Figure 6.2A lane 2) and harvested again, and the supernatant 
(Figure 6.2A lane 3) was applied onto a Protino 5 mL HisTrap Ni-NTA column from Merck Millipore® 
(see 2.5.4.2) and eluted using a high concentration of imidazole (see Table 2.1) using an Akta Start ®. 
Most of the protein bound to the matrix, as evidenced by the SDS-PAGE purification profile of the 
protein (Figure 6.2A; lane 4). To further investigate the ideal concentration of imidazole to use for the 
elution step, a gradient (up to 500 mM imidazole) was used (Figure 6.2B). Protein kept eluting during 
the experiment, to finally peak once 500 mM imidazole concentration was reached. Overall, all samples 
exhibited a high purity (above 90 %), with minor amounts of contaminants. As a result, a step gradient 








Figure 6.2 Ni-NTA affinity chromatography for mKlp2-Cter with an increasing gradient of [Imidazole] 
using a Protino 5 mL HisTrap. (A) Different samples taken during mKlp2C-Ter purification were analysed on 
10 % (v/v) SDS-PAGE in 1x Laemmli buffer. First lane; ladder from Novex®. Lane 2; sonicated cell extract of 
BL21 DE3 cells expressing mKlp2; Lane 3; supernatant after sonication; Lane 4; flow-through after binding to the 
Ni-NTA column; Lanes 5 to 10; after 15, 16, 17, 18, 20 and 22 mL respectively. Lanes 11 and 12; samples collected 
after reaching the maximum concentration of imidazole (500 mM), at 24 and 26 mL, respectively. Position of 
mKlp2C-Ter on the gel is indicated (green arrow). (B) Elution profile (UV absorbance in blue) of the Ni-NTA 











































Protein eluted as a relatively broad single peak (see Figure 6.3B) of around 4 column volumes (CV) and 
tailing at the end. No further improvement on the maximum collection volume was made by using higher 
concentrations of imidazole (results not shown). No clear difference could be observed in terms of 
impurity on the main peak (Figure 6.3A, lane 4 to 8), thus final collection criteria were chosen (around 
2 CV, Figure 6.3B green line) for subsequent purifications. Routinely, mKlp2C-Ter was purified to a 
volume of around 10 mL, with a concentration ranging from 6 to 8 mg/mL, from a 100 mg cell lysate.  
Collected fractions were concentrated using a 30K cut-off AMICON Ultra-15 Centrifugal Filter Units® 
according to section 2.5.5. When attempting to concentrate the protein to higher than 10 mg/mL, the 
protein started exhibiting mild to severe aggregation. The presence of glycerol in the buffer did not 






Figure 6.3 Ni-NTA affinity chromatography of mKlp2-Cter with a step-gradient of [Imidazole] using a 
Protino 5 mL HisTrap. (A) Different samples taken during mKlp2C-Ter purification were analysed on 10 % 
(v/v) SDS-PAGE in 1x Laemmli buffer. First lane; ladder from Novex®. Lane 2; samples from the flow-through 
after binding to the Ni-Nta column. Lanes 4 to 9; samples collected after 5, 7.5, 10, 12.5, 15 and 17.5 mL 
respectively. Lane 10; sample collected from the tail, around 24 mL. Position of mKlp2C-Ter on the gel is indicated 
(green arrow). (B). Elution profile (UV absorbance in blue) of the affinity chromatography performed on mKlp2-
Cter using a single-step gradient of 500 mM imidazole. Pooling criteria is shown in yellow.  
  
  








































Resin re-use was monitored throughout the PhD, and profiles were examined for reproducibility. After 
three years and above fifty purification runs, the binding capacity decreased over time. As a result, last 
runs yielded much lower amount of protein per cycle, which was confirmed by a lower maximum 
absorbance (170 mAU against 500 mAU previously) on the elution profile (Figure 6.4). Although 
sharper than previous experiments, the purity/impurity ratio was left unaffected. If needed, the 
supernatant would be reapplied to the matrix after a first run of affinity chromatography, and re-eluted 
using the same criteria. 
 
Figure 6.4 Ni-NTA affinity chromatography of mKlp2-Cter with a step-gradient of [Imidazole] using a 
Protino 5 mL HisTrap after 20 cycles. Elution profile (Absorbance in blue) of the affinity chromatography 
























Size exclusion chromatography (SEC) was first performed using a Superdex 75 10/300 GL (Life 
Sciences®) column. Unfortunately, due to its aggregation-prone behaviour (section 6.3), the sample was 
not resolved on the column. In consequence, SEC was attempted using a Superose6 10/300 GL (Life 
Sciences®) column. A sample (500 µL of a 10 mg/mL eluate from affinity chromatography) was 
injected onto the column in SEC buffer (25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) Glycerol) 
using an Akta Prime ® and the elution profile was recorded (Figure 6.5B). Collected fractions were 
analysed by 10 % (v/v) SDS PAGE in 1x Laemmli buffer (Figure 6.5A). mKlp2C-Ter eluted as a single 
peak, and the chromatography overall offered some impurity clearance. Indeed, two small peaks eluted 
at the end of the purification (Figure 6.5B, after 20 mL), and contained mostly lower molecular weight 
contaminants (Figure 6.5A lane 10).  
However, this single peak maximum was observed around 15 mL after injection of the protein in the 
column, corresponding to an approximate size of 120 kDa, contrary to the expected 40 to 42 kDa size 
observed on SDS PAGE gels. To further understand whether the aforementioned SEC behaviour 
stemmed from protein aggregation resulting from sample over-concentrating, a second mKlp2C-Ter 
sample was two-fold diluted prior to injection onto the column. The two-fold diluted protein exhibited 
a complex profile (Figure 6.6A); most of the protein eluted with early peak maxima at 17.1 mL, 
corresponding to an approximate size of 45kDa. The maxima of later peaks correlated with the elution 














Figure 6.5 Size exclusion chromatography of 8 mg/mL (undiluted) mKlp2-Cter using a Superose6 
Increase®. SEC was carried out in an Akta Prime ® device in SEC buffer (25 mM Tris-HCl (pH 7.0), 100 mM 
NaCl, 3 % (w/v) Glycerol). (A) 10 µL of each purified sample taken during mKlp2C-Ter SEC were analysed on 
10 % (v/v) SDS-PAGE in 1x Laemmli buffer. First lane; ladder from Novex®. Lane 2 to 10; samples collected at 
14, 15, 16, 17, 18 19, 20, 21 and 22 mL from 8 mg/mL mKlp2C-Ter loaded onto Superose6. Position of mKlp2C-
Ter on the gel is indicated (green arrow). (B) Elution profile (UV absorbance in blue) of the size exclusion 
chromatography performed on mKlp2-Cter after injection of a purified sample (500 µL of an 8 mg/mL solution). 







































































Figure 6.6 Size exclusion chromatography of 4 mg/mL (diluted) mKlp2-Cter using a Superose6 Increase®. 
SEC was carried out in an Akta Prime ® device in SEC buffer (25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % 
(w/v) Glycerol). (A) 10 µL of each purified sample taken during mKlp2C-Ter SEC were analysed on 10 % (v/v) 
SDS-PAGE in 1x Laemmli buffer. First lane; ladder from Novex®. Lane 2 to 8; samples collected 15, 16, 17, 18 
19, 20, and 21 mL from 4 mg/mL mKlp2C-Ter loaded onto Superose6. Position of mKlp2C-Ter on the gel is 
indicated (green arrow). (B) Elution profile (UV absorbance in blue and orange) of the size exclusion 
chromatography performed on mKlp2-Cter after injection of a diluted sample (4 mg/mL, orange line) and 




























































The main two techniques used for the study of mKlp2C-Ter were SAXS (Small Angle X-Ray Scattering, 
see 2.6.1) and ITC (iso-thermal calorimetry, see 2.3.3), aimed at characterizing its structure in solution 
and testing its ability to bind zinc ions via its ring finger domain, respectively. Hence, dialysis had to be 
performed prior to SAXS studies and samples had to be titrated with Zinc, for ITC studies. The stability 
of mKlp2C-Ter was then assessed to define the experimental limitations of the different assays 
mentioned above.   
 
A sample of mKlp2C-Ter (500 µL of a 10mg/mL solution, Figure 6.7 lane 2) was dialyzed for up to 
four days in SEC buffer (25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) Glycerol), and samples 
were collected on each day, centrifugated and loaded (10 µL per lane) onto 10 % (v/v) SDS-PAGE in 
1x Laemmli buffer (Figure 6.7, lane 3 to 5).  
A significant loss of protein was observed after only few hours (Figure 6.7, lane 3), and most of the 
protein would aggregate after two days, leading to a near complete loss of the signal intensity (Figure 
6.7, lane 4 and 5). Similar analysis was performed on mKlp2C-Ter samples pro- and post SAXS (X-ray 
exposure of around 10 hours) treatments (Figure 6.7, lane 6). Noticeably, the sample survived the 
exposure to X-Rays, as the band intensity observed post X-ray treatment (Figure 6.7 lane 6) remained 
similar to that of the pre-SAXS studied sample, and no apparent degradation was observed.  
To further investigate the effect of imidazole, from the affinity chromatography elution step (using 25 
mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) Glycerol, 500 mM Imidazole), on the stability of 
mKlp2C-Ter during dialysis and X-Ray exposure, affinity chromatography eluted protein samples were 
buffer exchanged in SEC buffer and further dialyzed extensively in SEC buffer, before analysis of 
samples by SDS-PAGE (Figure 6.7, lane 7 to 10) . This time, the loss of protein was even faster, leading 
to a barely detectable signal of the mKlp2C-Ter monomer on 10 % (v/v) SDS-PAGE, even after one 
day (Figure 6.7 lane 8). Sample dialyzed for one day was subjected to SAXS, and subsequently loaded 
post SAXS exposure on a 10 % (v/v) SDS-PAGE in 1x Laemmli buffer (20 µL, Figure 6.7 lane 10). In 
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the latter case, sample volume had to be doubled (20 µL instead of 10 µL), to allow detection on 
Coomassie Blue stained SDS PAGE.  
Decision was made to buffer exchange samples (in SEC buffer) for future SAXS studies, rather than 





Figure 6.7 Stability study of dialyzed mKlp2C-Ter. Concentrated, and dialyzed samples of purified mKlp2C-
Ter protein were analysed on 10 % (v/v) SDS-PAGE in 1x Laemmli buffer. First lane; ladder from Novex®. lane 
2; concentrated mKlp2C-Ter protein (8 mg/mL); Lane 3 to 5; mKlp2C-Ter, dialyzed after 1, 3 or 4 days, 
respectively; lane 6; mKlp2C-Ter (after a 4-day dialysis), post SAXS exposure. Lane 7; buffer exchanged (in SEC 
buffer (25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) Glycerol) and concentrated mKlp2C-Ter (8 mg/mL). 
Lane 8 to 9; mKlp2C-Ter dialyzed in SEC buffer after 1 or 4 days, respectively; lane 10 mKlp2C-Ter (after a 1day 
dialysis) post SAXS exposure. 
  
 
The second stability assay probed the utilization of zinc as a potential co-factor via ITC experiments. 
As a result, it was necessary to understand the effect of zinc on mKlp2C-Ter over time. A freshly purified 
and buffer exchanged 8 mg/mL mKlp2C-Ter sample (in 50 mM Tris-HCl (pH 7.5), 0.1 mM TCEP, 100 
mM NaCl, 3 % (v/v) glycerol, Figure 6.8, lane 2), was mixed with zinc chloride to a final concentration 
of 10 mM (same as titrant solution in ITC assays) and left mixing for up to a week. Samples and controls 
(left mixing in absence of zinc) were collected daily and loaded onto 10 % (v/v) SDS-PAGE in 1x 














Laemmli buffer (Figure 6.8A). Protein concentrations were determined daily by the BCA assay and 
reported for both the control and zinc-mixed samples (Figure 6.8B, blue and orange lines respectively).  
Over the first 24 to 30 hours, both control and sample would remain relatively stable (Figure 6.8A, lane 
2 and 3). However, both SDS-PAGE analysis and concentration determinations confirmed a negative 
effect of the zinc on the stability of the protein after more than 30 hours exposure (Figure 6.8A, lane 4 
and 5). A 1.3-fold difference could be observed after only two days (1.5 versus 2 mg/mL for the control, 
Figure 6.8B). Following that time period, the protein reached a lower threshold (4 days) at which it 
remained stable over the next 3 days. However, the control sample exhibited a more linear precipitation 
pattern, with a similar reduction in gel staining intensity and concentration values (Figure 6.8B, after 5 
days). 
Altogether, these results highlighted a negative effect of zinc on the stability of mKlp2C-Ter over 
extended periods of time. Consequently, samples of mKlp2C-Ter would have to be exposed to zinc for 









Figure 6.8 Stability study on mKlp2C-Ter in the presence of 10 mM zinc. (A) mKlp2C-Ter samples (8 mg/mL) 
mixed with Zinc Chloride at a final concentration of 10 mM were analysed on 10 % (v/v) SDS-PAGE in 1x 
Laemmli buffer. First lane; ladder from Novex®. Lanes 2, 4 and 6; control mKlp2C-Ter sample (10 µL of a 
10mg/mL solution) left mixing at room temperature for 1, 2 and 3 days, respectively, in the absence of zinc. Lanes 
3, 5 and 7; mKlp2C-Ter mixed with zinc chloride (final concentration of 10 mM) and left mixing at room 
temperature for 1, 2 and 3 days, respectively. (B) Investigation of sample stability, as a function of protein 


























1 2 3 4 5 6 7 
















Although the use of a tag can greatly help in rapidly purifying great amounts of recombinant protein, its 
potential interference in various assays such as ITC or SAXS needs to be assessed. In the case of 
mKlp2C-Ter, a 6xHis-Tag was used to purify the protein using a Ni-Nta solid support for affinity 
chromatography (Figure 6.9, grey rectangle). Following its purification, the removal of the histidine tag 
could be achieved using a thrombin cleavage site introduced near the tag, downstream its location 
(Figure 6.9, blue rectangle). 
 
MGSSHHHHHHSSGLVPRGSHAVSGEYADELKKKIQ--- 
Figure 6.9 N-Terminal domain of mKlp2C-Ter. First 35 amino acids of the N-terminal domain of mKlp2C-Ter. 
The 6xHis-Tag introduced for its purification by Ni-Nta affinity chromatography is highlighted in red, whereas 
the thrombin cleavage site used for the removal of the tag is highlighted in yellow. 
 
 
A first screen of the optimal conditions for the digestion of the Histidine-tag from mKlp2C-Ter was 
carried out using two parameters, a) time of incubation and b) thrombin concentration. amounts of 
thrombin used were decided according to the supplier’s recommendations (1U thrombin/4mg of protein, 
according to Sigma-Aldrich®). 20 µg of freshly Ni-NTA-affinity purified mKlp2C-Ter were incubated 
with different thrombin dilutions for either 1, 2, 4, 6 or 18 hours. Reactions were stopped by the addition 
of 10 mM PMSF (phenylmethylsulfonyl fluoride), an inhibiter of serine (and cysteine) proteases. 
Samples were loaded on an 10% (v/v) SDS PAGE in 1x Laemmli buffer (Figure 6.10, panel A and B, 
“+” imidazole). In parallel, 20 µg of freshly Ni-NTA-affinity purified and without imidazole (removed 
by buffer exchange in SEC buffer through a PD-10 desalting column from GE Healthcare Life 
Sciences®) were treated and analysed in the same manner (Figure 6.10, panel A and B, “-” imidazole). 
Following a one- or two-hour digestion, most of mKlp2C-Ter-His6 was digested by thrombin in the 




approximately 39 kDa (black arrow), resulting from the shift due to the His-Tag (1.6 kDa) removal, is 
clearly produced and none of the original 41 kDa protein (green arrow) is present anymore. However, 
an additional fragment (black arrow) is produced when samples were subjected to thrombin digest longer 
than two hours, suggesting an over-digestion of mKlp2C-Ter by the protease. This is evident by the 
increasing band intensity (just below 30 kDa) with incubation time (Figure 6.10, all samples after 18 
hours, lane 8 of each gel). 
In the presence of imidazole (Figure 6.10, A and B, “+” imidazole), the full digestion of His-tagged 
mKlp2C-Ter required 4 to 6 hours depending on the dilution factor (1/50 and 1/100 respectively). Again, 
over time additional protein fragmentation occurred (Figure 6.10, black arrow).  
In conclusion, a clear difference can be observed in the digestion patterns of the samples when imidazole 
was present. Although the complete removal of the tag was achieved faster without imidazole, the 
presence of imidazole allowed more control on the over-digestion of mKlp2C-Ter at lab-scale. The 1/50 
dilution in the presence of imidazole was chosen for the large-scale digest of His-tagged mKlp2C-Ter. 










Figure 6.10 Optimisation of His-tag digestion from mKlp2C-Ter with thrombin cleavage. (A) 20 µg of freshly 
purified mKlp2C-Ter were incubated with a 1/50 (panel A) or 1/100 (panel B) dilution of the thrombin (0.0002 or 
0.0001 UE per sample) and incubated for either 1, 2, 4, 6 or 18 hours at room temperature. PMSF was added as an 
inhibitor (to stop the thrombin cleavage) and samples were loaded on an 10% (v/v) SDS PAGE in 1x Laemmli 
buffer. (B) 20 µg of freshly purified and buffer exchanged mKlp2C-Ter (in 25 mM Tris-HCl (pH 7.0), 100 mM 
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Having identified the best conditions for the cleavage of the purification tag from mKlp2C-Ter (section 
6.6.1), a large-scale His-Tag removal experiment was performed on freshly purified mKlp2C-Ter (see 
section 6.3). A volume (8 mL) of a solution containing Ni-Nta purified mKlp2C-Ter-His6 (4 mg/mL, 
Figure 6.11 lane 2) was digested with 0.16 UE of thrombin (1/50 dilution of 8 Units). The mixture was 
incubated for 2 hours at room temperature and the correct removal of the tag was assessed via SDS 
PAGE (Figure 6.11). Samples were taken every fifteen minutes and loaded on 10 % (v/v) SDS PAGE 
in 1x Laemmli buffer for control.  
After a 2 hour-incubation of mKlp2C-Ter with the thrombin, a complete digest of the His-tagged 
mKlp2C-Ter was achieved (Figure 6.11, lane 8). Only traces of undigested His-tagged mKlp2C-Ter-
His6 can be found in the samples. After applying the solution through a Ni-NTA affinity column, the 
flow-through (Figure 6.11, lane 9) is completely free of undigested His-Tagged mKlp2C-Ter. The 









Figure 6.11 Large scale digestion of mKlp2C-Ter-His6 with thrombin. 8 mL of a solution containing purified 
mKlp2C-Ter-His6 (4 mg/mL, lane 2) was digested with 0.16 UE of thrombin (1/50 dilution of 8 Units), following 
the results obtained from the small-scale screen digest (section 6.6.1). The mixture was incubated for 2 hours at 
room temperature, and samples were taken every 15 minutes (lane 3 to 8) and analysed on 10% (v/v) SDS PAGE 
in 1x Laemmli buffer. After incubation and addition of PMSF to stop the reaction, the mixture was re-applied on 
a Ni-NTA matrix. A sample from the flow-through (lane 9) was taken and loaded on 10% (v/v) SDS PAGE to 
assess completeness in the removal of undigested His-tagged mKlp2C-Ter (green arrow). Digested mKlp2C-Ter 


















Isothermal Titration Calorimetry (ITC) is a powerful technique for the study of molecular interactions. 
ITC instrument such as the Malvern MicroCal VP-ITC® can perform quantitative measurements of the 
molecular interaction between a ligand and its receptor. One of the most important features of this 
methodology is the ability to determine every binding parameter (stoichiometry of the interaction (n), 
the association constant (K(a)), the free energy (∆G), enthalpy (∆H), entropy (∆S) associated with the 
binding event(Pierce, Raman et al. 1999). Additionally, the experiments are normally conducted at room 
temperature in a closed chamber with the molecule being in solution, providing a more accurate probing 
of potential interactions in their native state.  
Typically, sample (receptor) is titrated by a solution of ligand at specific concentrations. Multiple 
injections of a pre-defined volume of ligand into the solution will lead to a variation in the overall 
enthalpy of the chamber (Pierce, Raman et al. 1999). In fact, the binding event will lead to an absorption 
(endothermic reaction) or release of heat. As the chamber is set to a constant temperature (25 degrees 
Celcius conventionally, although it is possible to perform experiments under different conditions), any 
variation of heat will be compensated by the calorimeter (Pierce, Raman et al. 1999). As a result, the 
energy needed to keep the chamber at a set temperature can be quantified (in µCal/s) and an overall 
titration profile can be generated over time. 
According to the second and third laws of thermodynamics, calculation of the Gibbs free energy of the 
system can be obtained from the equation 6.1, where T is the temperature, ∆G is the variation of free 
energy, ∆H is the variation of enthalpy and ∆S is the variation of entropy within the system.  
 
∆G° =  ∆H° − T∆S° 
Equation 6.1 Gibbs free energy main formula. T is the temperature, ∆G is the variation of free energy, ∆H is 




In parallel, the binding constant of a ligand to its binding site can be defined as in equation 6.2, where ∂ 




) × [𝐿] 
Equation 6.2 Definition of the binding affinity constant K for a single independent site. ∂ is the number of 
sites occupied by the ligand and [L] is the concentration of free ligand. 
 
Using mass conservation and chemical equilibrium equations it is possible to express the heat recorded 
as a function of the concentration of reactants, the association constant a ligand to its binding site and 
the enthalpy of binding (see equation 2.2). The affinity, enthalpy and stoichiometry for the binding 
reaction can be derived mathematically using software such as the OriginLab® or AFFINImeter®. A 
description of the analysis process is provided below.   
 
 
Original in silico analysis of mKlp2C-Ter protein secondary structure revealed a potential zinc finger 
motif, likely capable of mediating the binding of divalent cations to the kinesin (REF). Hence, the 
potential binding of zinc ions to the protein was probed by ITC using a Malvern MicroCal VP-ITC at 
the University of Huddersfield. 
ITC experiment was performed on freshly purified mKlp2C-Ter protein at a concentration of 1.2 mg/mL 
or 31 µM. The protein was buffer exchanged prior to the experiment in ITC buffer (50 mM Tris-HCl 
(pH 7.5), 0.1 mM TCEP, 100 mM NaCl, 3 % (v/v) glycerol). Protein sample was left mixing in the main 
chamber at a constant temperature of 25 degrees Celsius. Titration of mKlp2C-Ter was achieved via 
series of 5 microliters injections using a solution of ZnCl2at 40 mM in ITC buffer.  
Additional control experiments such as the titration of the buffer with buffer, the titration of the buffer 
with ZnCl2 and the titration of mKlp2C-Ter with the buffer alone were also conducted. Curve isotherms 




Figure 6.12 Single titration of 31 µM mKlp2C-Ter with 40 mM ZnCl2. (Top) Thermogram of ITC 
measurements. (Bottom) Peak-by peak integrated thermogram (with their error bars) with its mathematical fit, in 
red.One round of 50 injections (5 µL each) of 40 mM ZnCl2 in 50 mM Tris-HCl (pH 7.5), 0.1 mM TCEP, 100 
mM NaCl, 3 % (v/v) glycerol, was performed and analysed using AFFINImeter®.  
 
Analysis of the data was performed with AFFINImeter® as well as OriginLab®. Unfortunately, no 
conventional models could fit the recorded data and provide binding parameters. Usually, one or two 
binding sites titration functions are used to analyse the data. This scenario involves independent binding 
sites, where the binding of the ligand on one site is independent from the second, although competition 
and inhibition can be involved (Pierce, Raman et al. 1999). In this instance, a combined approach had 
to be used, with a conventional binding analysis for the first event and an alternative but more permissive 
function called sequential binding (with n binding sites) for the second event (Duff, Grubbs et al. 2011). 
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This function relates to more than two ligand binding sites that might be identical or non-identical, 
regardless of cooperativity. The affinity constant is then defined as in equation 6.3. 
𝐾𝑖 =




Equation 6.3 Definition of the binding affinity constant Ki in sequential binding. More than two ligand binding 
sites (i) might be identical or non-identical regardless of cooperativity. 
 
In essence, all possible states co-exist in equilibrium, but there is no specific order in which the binding 
sites are saturated (Duff, Grubbs et al. 2011). The data were analysed using this combined binding model 
in AFFINImeter® sofware, a user-friendly ITC analysis package for studying a particular binding 
hypothesis(Piñeiro, Muñoz et al. 2019). The binding parameters for the titration of mKlp2C-Ter with 
ZnCl2 are presented in Table 6.1   
Table 6.1 Binding parameters of zinc (40 mM) to mKlp2C-Ter (31 µM).  
 First binding event Second binding event 
Parameter Value Error Value Error 
ΔH (cal/mol) -22.36 1.761 -1460 7.836 
KA (mM-1) 0.437 1.640 1.378x106  0.017 
KD (nM) 2.286 0.86 725 9.25 
Values were calculated by AFFINIMETER® using a combined model of unique and sequential binding event. 
Errors are given and can be used to assess the statistical relevance of the data. An order of magnitude above 2 is 
preferable. 
 
Unfortunately, the error in the calculation of the first binding site parameters was significant. It is 
recommended to have at least 2 orders of magnitude difference between the actual values of the binding 
parameters and their errors (Muñoz and Sabín 2019, Piñeiro, Muñoz et al. 2019). The lack of statistical 
relevance was attributed to the low number of points recorded during the first binding event, as only 8 
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injections covered the area of binding. A minimum of 10 to 15 was recommended by Malvern® and 
AFFINImeter® to produce statistically strong data.  
The second binding event exhibited a sequential binding type of site (as mentioned above), thus any 
constants or parameter is to be taken with caution, as they represent not one binding site but a multitude 
of them (equation 6.3) (Duff, Grubbs et al. 2011). However, the absence of saturation at the end of the 
titration profile suggested some additional binding was possible, affecting the stoichiometry 
measurements (Pierce, Raman et al. 1999).  
Reaching the saturation point is paramount in getting accurate and representative data for the different 
binding parameters. Additional injections were performed on the same sample, by simply refilling the 
syringe and restarting the titration. As usual, controls had to be performed again in parallel, mimicking 
the parameters used for the main experiment (injection volume, number of injections etc). They were 
subtracted from the main signal, and both runs were compiled in EXCEL®. The resulting curve is 
presented in Figure 6.13. 
 
Figure 6.13 Prolonged titration of 31 µM mKlp2C-Ter with 40 mM ZnCl2. Raw thermogram of ITC 
measurements. Two rounds of 50 injections (5 µL each) of 40 mM ZnCl2 in 50 mM Tris-HCl (pH 7.5), 0.1 mM 
























Noticeably, the titration procedure led to a discrepancy between the first injection profile and the 
additional injections. One of the main issues encountered was the recalibration of the instrument, which 
had to be overcome by exporting the data to EXCEL®, removing the first injection of the second round 
and adjust the signal to the last point of the first round. Nevertheless, the corrected profile lacked 
smoothness and another hypothesis had to be formulated.  
Looking at the original signal (Figure 6.13), the variation observed between first and second round of 
injection could stem from a readjustment of the baseline during the beginning of the second round 
(hypothesis explored so far). However, this variation could also be accounted by dissociation events 
happening between the end of the last injection of the first round and the beginning of the first injection 
of the second round. In this scenario, the data could be adjusted following the hypothesis that the second 
point (second injection since the first one is always considered an outlier) of the second round should 
coincide with one of the previous points in the first round. Once the correct point is identified, data are 






Figure 6.14 Corrected prolonged titration of 31 µM mKlp2C-Ter with 40 mM ZnCl2. Raw thermogram of 
ITC measurements. Two rounds of 50 injections (5 µL each) of 40 mM ZnCl2 in 50 mM Tris-HCl (pH 7.5), 0.1 
mM TCEP, 100 mM NaCl, 3 % (v/v) glycerol,) were performed merged and re-adjusted using EXCEL® depending 
on a dissociation hypothesis. 
 
A greater smoothness of the data was obtained using the newest methodology. This indicates the 
dissociation of zinc ions from mKlp2C-Ter is likely to be the cause of the variation between first and 
second rounds of injection. Although this new graph is probably more representative of the actual 
binding events occurring between mKlp2C-Ter and zinc ions, the data cannot be used. Indeed, since 
data are adjusted to a previous point from the first round of injection, a decent number of injections from 
the second round (first 5 to 8) were discarded. Hence, the final molar ratio was affected and was not 



























Different conditions had to be screened to further optimize the experiment. Therefore, various 
concentrations of ZnCl2 and mKlp2C-Ter protein were tested in subsequent experiments. Surprisingly, 
the dilution of the protein by a factor of 5 in ITC buffer improved greatly the quality of the data compared 
to the concentration of zinc. Conversely, the concentration of titrant (zinc ions) was slightly increased 
to 50 mM. Results of the titration are compiled in Figure 6.15.  
 
Figure 6.15 Single titration of 6 µM mKlp2C-Ter with 50 mM ZnCl2. (Top) Thermogram of ITC 
measurements. (Bottom) Peak-by peak integrated thermogram (with their error bars) with its mathematical fit, in 
red. One round of 50 injections (5 µL each) of 50 mM ZnCl2 in 50 mM Tris-HCl (pH 7.5), 0.1 mM TCEP, 100 





The dilution of the protein offered more binding opportunities for the zinc onto mKlp2C-Ter, as the total 
number of injections covering the first binding event increased above 15. This was reflected in the 
accuracy of the parameters as the errors decreased significantly for all of them (Table 6.2). Both 
reactions were exothermic with variations of enthalpy (ΔH) of -1.913 and -2.899). Noticeably, the first 
binding event affinity is twice higher for zinc ions compared to the second, confirming the observations 
made on the raw data. Nevertheless, despite relatively good accuracy in most of the constants, the profile 
was still limiting for a precise calculation of the stoichiometry parameter. The lack of smoothness and 
high upturn at the start of the titration could be greatly improved to include the first inflexion point of 
the titration curve and further characterize this binding site.     
Table 6.2 Binding parameters of zinc (40 mM) to mKlp2C-Ter (6 µM).  
 First binding event Second binding event 
Parameter Value Error Value Error 
ΔH (kcal/mol) -1.913 0.0356 -2.899 0.0054 
KA (mM-1) 3.482 0.0098 1.540  0.0056 
KD (mM) 0.2872 0.0081 0.649 0.0023 
Values were calculated by AFFINIMETER® using a combined model of unique and sequential binding event. 
Errors are given and can be used to assess the statistical relevance of the data. An order of magnitude above 2 is 
preferable. 
 
Finally, despite dilution of the protein and the increase in concentration of its ligand, the saturation point 
was still not reached, thus the stoichiometry for the second set of sites was still inaccurate. A second 
round of injection was attempted, but the protein started aggregating dramatically. This was likely due 
to its lack of stability in the presence of zinc, highlighted during the stability study of mKlp2C-Ter after 
two days in 10 mM zinc (see section 6.5.2). Higher concentration of zinc was explored but did not fit 
within the instrument measurement capabilities.  
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Additional series of experiments were performed to reach the saturation point earlier. This was limited 
by the minimum and maximum signal the instrument can measure. Indeed, the signal recorded needs to 
be high enough to be distinguished from the noise, and low enough to be recorded. For the latter, the 
Malvern MicroCal VP-ITC has total coverage of 40 µCal/s, which can be used to its fullest by adjusting 
the reference baseline. Besides, a limitation in the injection volume (no more than 5 microliters) is 
another parameter that must be taken into consideration. In the end, the experiment was stopped until 






SAXS data were collected for mKlp2C-Ter at the Beamline B21 at three different concentrations. 
Sample (4 mg/mL) was diluted in a 96-well plate three times, each time by a factor of 2. The resulting 
samples (4, 2 and 1 mg/mL) were all subjected to SAXS for 2 seconds, and triplicated. Series of 
triplicates were then averaged to produce a final scattering profile for each of the different concentrations 
(Figure 6.16A). The buffer blank (25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) Glycerol) was 
subjected to SAXS and its scattering profile (Figure 6.16A blue line) was removed from the samples 
data sets (Figure 6.16B). As for most previous proteins (section 5.5, 5.6 and 5.7), a high upturn of the 
scattering intensity at low q values could be observed for each mKlp2C-Ter sample. Consequently, 
sample dilution did not reduce this effect. This indicates a degree of polydispersity in the samples, 





Figure 6.16 Raw Scattering Intensity plots of mKlp2C-Ter at 4, 2 and 1 mg/mL. Scattering data recorded at 
the Beamline B21 and displayed as log of intensity over the scattering vector q (Ǻ) and created using ScAtter 
Software® (Förster, Apostol et al. 2010). Samples were dialyzed for 1 hour in 25 mM Tris-HCl (pH 7.0), 100 mM 
NaCl, 3 % (w/v) Glycerol. (A) Raw Scattering data of mKlp2C-Ter. The buffer blank (as above) is represented by 
blue line. The scattering intensity curves for the mKlp2C-Ter sample at 4, 2 and 1 mg/mL mg/mL are represented 








Data analysis for mKlp2C-Ter at 2, 1, 0.5 and 0.25 mg/mL was carried out as previously described 
(sections 5.4 to 5.7). The Rg was calculated using the Guinier approximation (Figure 6.17) and 





Figure 6.17 Guinier analysis of mKlp2C-Ter at at 4, 2 and 1 mg/mL. First data points of the recorded scattering data displayed as log of intensity over the scattering vector 
q (Ǻ) and created using ScAtter Software® (Förster, Apostol et al. 2010). The first 200 points were used to fit a linear curve (red) that would be used to calculate the hypothetical 
Rg. Guinier plots of mKlp2C-Ter at 4 mg/mL (A), 2 mg/mL (B) and 1 mg/mL (C) are represented by red, grey and yellow dots respectively. Residual analysis of the scattering 






Table 6.3 Summary Table of Rg values for mKlp2C-Ter. 
Sample Rg (Reciprocal Space) Rg (Real space) 
mKlp2C-Ter at 4 mg/mL 53.94 53.18 
mKlp2C-Ter at 2 mg/mL 53.68 53.55 
mKlp2C-Ter at 1 mg/mL 53.89 53.22 
Parameters Rg calculated by Scatter Software ® using approximation (reciprocal space) and GNOM (Real Space). 
 
Reciprocal Space and real Rg values were relatively constant across the different samples. Moreover, 
reciprocal space Rg values were highly similar to their real (actual) value calculated by GNOM using 
Scatter® software (overall less than 0.5 units difference).  
 
Initial assessment of the data quality was performed on mKlp2C-Ter at at 4, 2 and 1 mg/mL (Figure 
6.18). Kratky plots for mKlp2C-Ter showed a low degree of folding, particularly for the two dilutions 
(2 and 1 mg/mL, Figure 6.18 A, grey and yellow lines). In addition, Porod plots suggested a high degree 
of flexibility for all mKlp2C-Ter samples. As a result, only the first concentration of mKlp2C-Ter (4 
mg/mL) was used for further ab initio modelling. The other two dilutions (0.5 and 0.25 mg/mL) did not 
produce final models of good quality to guarantee statistically relevant molecular envelopes, as their 
concentrations were too low, and their quality analysis suggested a dramatic loss in compaction upon 




Figure 6.18 Quality assessment of mKlp2C-Ter. (A) Kratky plot of mKlp2C-Ter at at 4, 2 and 1 mg/mL are 
represented by a red, grey and yellow line respectively. (B) Corresponding Porod plots for mKlp2C-Ter samples. 
Colours are as above. 
   
 
Following the initial analysis of the scattering data from mKlp2C-Ter at various concentrations 
(section 6.8.2 and 6.8.3), GNOM was used as an indirect transform program for the establishment 
of the P(r) function for further ab initio modelling (Figure 6.19) and only the sample of highest 
concentration (4 mg/mL) was processed. The P(r) distribution function for this sample revealed a 







Figure 6. 19 P(r) distribution plot of mKlp2C-Ter scattering data at 4 mg/mL. (A) P(r) distribution function 
of the mKlp2C-Ter at at 4 mg/mL (red) in 25 mM Tris-HCl (pH 7.0), 100 mM NaCl, 3 % (w/v) Glycerol. (B) 
Scattering intensity of mKlp2C-Ter with the tendency curve representing the P(r) distribution indicated in red. 
 
 
Assessment of the generated envelopes (Table 6.4) for mKlp2C-Ter was carried out by DAMSEL and 
DAMSUP as previously described for the previous proteins (sections 5.4.5, 5.5.5, 5.6.5 and 5.7.5). On 
one hand, envelope 1 was identified as having the best NSD value (0.634) and was used as a reference 
for DAMSUP superposition. On the other hand, no model was considered an outlier and discarded since 
their associated NSD values were all within two standard deviation units (one standard deviation = 





Table 6.4 Summary of DAMSEL and DAMSUP results for mKlp2C-Ter at 4 mg/mL.  
Model DAMSEL NSD FATE DAMSUP NSD 
mKlp2C-Ter at 4 mg/mL 
7 0.634 Reference 0.000 
9 0.635 Include 0.554 
17 0.636 Include 0.603 
13 0.640 Include 0.550 
21 0.642 Include 0.531 
12 0. 650 Include 0.596 
16 0. 656 Include 0.624 
3 0.665 Include 0.622 
18 0.668 Include 0.567 
14 0.669 Include 0.622 
5 0.677 Include 0.576 
2 0.680 Include 0.601 
1 0.684 Include 0.658 
4 0.690 Include 0.606 
23 0.695 Include 0.721 
11 0.699 Include 0.592 
22 0.701 Include 0.615 
15 0.702 Include 0.679 
19 0.717 Include 0.703 
20 0.723 Include 0.735 
8 0.726 Include 0.722 
10 0.735 Include 0.734 
6 0.740 Include 0.532 
The mean NSD value was calculated to be 0.681 with a standard deviation of 0.033. Models are sorted from the 
lowest to the highest NSD value, and all are within two standard deviations from the mean NSD. As a consequence, 
no outlier was identified using this criterion. Model 1 showed the best NSD at 0.634 and was taken as the reference 
for the superposition with DAMSUP. DAMSUP superposed the models and calculated a deviation from the 
reference NSD. 
Following all twenty-three models’ refinement by DAMAVER, the averaged probability map was 
created, then filtered by DAMFILT removing regions of low occupancy, leading to the generation 






Figure 6.20 Final molecular envelopes for mKlp2C-Ter at 4 mg/mL. (A) Probability map (grey) and filtered 
(blue) molecular envelope generated by DAMAVER on mKlp2C-Ter at at 4 mg/mL in 25 mM Tris-HCl (pH 7.0), 
100 mM NaCl, 3 % (w/v) Glycerol. (B) Superposition of the crystal structure of Kinesin-1 heavy chain from human 











The successful cloning of mKlp2 gene into the pET-20b(+) was performed by Muktar Farah at the 
University of Huddersfield under the supervision of Dr Georgios Psakis. The expression of mKlp2C-
Ter protein in BL21(DE3) E. coli cells using 1 mM IPTG proved very successful in yielding great 
amount of protein (up to 80 mg per 100 mg of cell lysate) that would be subsequently purified using a 
Protino HisTrap NiNta solid support from Merck®.   
The protein eluted as a single peak using a single step gradient of 500 mM imidazole (25 mM Tris-HCl 
(pH 7.0), 100 mM NaCl, 3 % (w/v) Glycerol, 500 mM Imidazole), and its purity was estimated to be 
above 99 % on denaturing 10 % (v/v) SDS PAGE in 1x Laemmli buffer (section 6.3, Figure 6.3). This 
is mainly due to the presence of the 6xHis-Tag on the N-terminal extension of the mKlp2C-Ter protein.  
The assessment of the monodispersity by Size exclusion chromatography using the Superose6 Increase® 
revealed a single peak with a maximal absorbance recorded at 15 mL (section 6.4, Figure 6.5), 
corresponding to an approximate size of 120 kDa, which was around 3 times the expected calculated 
size of mKlp2C-Ter (42 kDa from Expasy webserver (Artimo, Jonnalagedda et al. 2012)). This 
suggested the protein could form aggregates or oligomers and would rarely exist as a monomer. 
Interestingly, the dilution of the protein sample by a factor of 2 in SEC buffer 25 mM Tris-HCl (pH 7.0), 
100 mM NaCl, 3 % (w/v) Glycerol) resulted in a shift of the profile, with a new maximum for the first 
peak culminating at 17 mL after injection (section 6.4, Figure 6.6). This elution volume corresponded 
to an approximate size of 40-45 kDa, in agreement with the expected size of the mKlp2C-Ter protein. 
This result highlighted a possible concentration dependence of the aggregate/oligomer formation. This 
hypothesis was reinforced by the high aggregation patterns exhibited when concentrating the protein 
above 10 mg/mL. The presence of glycerol in the buffer (10 % v/v) did not minimize the aggregation 
propensity of the molecule, thus further stabilizing agents must be screened to control the aggregation 
propensity of mKlp2C-Ter more effectively. 
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The relative dynamicity of the molecule and its response to the dilution likely arises from its native 
structure. Indeed, kinesins are usually composed of random coils and alpha helix (see chapter 1). In the 
case of mKlp2C-Ter, the truncated protein lacks most of the N-terminal sequence and only contains the 
last 345 amino acids of the native protein. Although the remaining domain is supposed to include a 
potential zinc finger motif, the rest of the protein is largely composed of helix, according to Jpred 
(Drozdetskiy, Cole et al. 2015) secondary structure predictions (see Appendix 9.6 for the simplified 
model). For this reason, homology modelling on mKlp2C-Ter was very difficult and often resulted in 
significant portion of sequence missing.  
Finally, the concentrations, amounts and purity of the protein after its purification by affinity 
chromatography were all deemed suitable for downstream applications such as SAXS or Isothermal 
Titration Calorimetry. 
 
The removal of the 6xHis-Tag From mKlp2C-Ter was needed to assess the effect of the tag on the 
structure and function of the truncated protein. For example, early ITC data (Section 6.7.2) suggested 
the presence of at least two binding sites for zinc ions on mKlp2C-Ter. The removal of the tag would 
then allow distinguish if one of the binding event is due to the interaction between zinc ions and 
histidines (Kluska, Adamczyk et al. 2018). 
The screen for the identification of the best thrombin digestion conditions helped greatly in identifying 
optimal parameters for the complete removal of the purification tag (containing the 6xHis-Tag see figure 
6.1). Optimal conditions were chosen based on the ability to control the over digestion of mKlp2C-Ter. 
Hence, a 2-hour incubation with 0.005 units/mg of protein were used for large scale experiments. 
Large scale experiments proved highly successful in removing the tag as almost no undigested mKlp2C-
Ter could be identified on 10 % (v/v) SDS PAGE. The mixture was then applied to the NiNta solid 
support to ensure the removal of the free 6xHis-Tag as well as the traces of undigested mKlp2C-Ter.  
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Finally, the removal of the thrombin from the protein mixture is the last stage in producing His-Tag-less 
mKlp2C-Ter. The use of a specific IEX solid support, HiTrap Benzamidine FF (Sepharose High Sub) 
was recommended, as Sepharose resin can efficiently remove proteases from a protein preparation 
(Rajalingam, Kathir et al. 2008). Unfortunately, both mKlp2C-Ter and the thrombin would bind the 
resin and could not be separated using a salt gradient (results not shown). Further improvements are 
required to optimize the removal of the thrombin from the digested mixture. 
Noticeably, on occasion the addition of thrombin to the mixture often reduced the opaqueness of 
concentrated mKlp2C-Ter solutions, strongly suggesting the Tag might enhance the aggregation 
propensity of mKlp2C-Ter. The removal of the Tag along with stabilizing agents could greatly help in 






The protein mKlp2C-Ter proved very difficult to handle and showed high levels of aggregation in all of 
the profiles obtained from SAXS experiments. The presence of glycerol in the buffer did not seem to 
help stabilizing the protein to a great extent and only the highest concentration yielded decent scattering 
data that could be processed. The high flexibility and lack of completely folded structure lead to an 
elongated envelope with multiple domains (section 6.8.5, Figure 6.20). These four domains had an 
apparent shape of a chain, with repetitive motifs. Kinesins have the ability to form oligomers (Lawrence, 
Dawe et al. 2004, Li, Xu et al. 2012, Gigant, Wang et al. 2013) and the apparent aggregation observed 
at low q values might be the probable cause for this atypical shape (Petoukhov and Svergun 2013, 
Kikhney and Svergun 2015). Further experiments were undertaken at the Beamline with the buffer used 
for the elution of mKlp2-Cter protein but did not improve the scattering profile. The apparent instability 
of this protein has to be overcome before robust data can be collected in future SAXS studies.      
As mentioned in 7.6.1 and 7.6.2, the aggregation prone-behaviour of the protein and its profile on SEC 
suggested the protein would mostly be oligomerized (or soluble aggregates) in solution. Although 
dilution was shown to modulate the equilibrium between oligomer and monomer, the diluted samples 
neither produce statistically relevant molecular envelopes nor displayed compaction.  
In fact, mKlp2C-Ter is mainly composed of alpha helix and extended regions (see appendix 9.6), as well 
as zinc finger motif, containing 9 cysteine residues (Figure 6.1). The aggregation propensity of mKlp2C-
Ter might be explained by a combination of these two factors. Indeed, Alpha helix are known to be able 
to promote aggregation (Ding, LaRocque et al. 2005, Kunjithapatham, Oliva et al. 2005, Ghosh, Singh 
et al. 2015) and cysteines can form disulphide bonds between each other. The addition of a reducing 
agent in the SEC buffer might help in enhancing the release of monomer from the oligomeric form. 
The apparent dynamicity of kinesins is due to their role as cargo transporter in the cell and is the main 
cause for the lack of full crystal structures. For instance, the motor domain of kinesins has been mostly 
probed using crystallography experiments (Wang, Cao et al. 2015). In the case of the mKlp2C-Ter, the 
native mKlp2 protein was largely truncated, thus no motor domain is present in the protein. Therefore, 
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the design of hypothetical three-dimensional structure proved very difficult, often leading to largely 
truncated models. In an effort to illustrate the secondary structure predictions, hypothetical structures 
from segments of mKlp2C-Ter were created by homology modelling using SWISS MODELLER 
(Waterhouse, Rempfer et al. 2018) and reunited manually in Pymol (L DeLano 2002) (Figure 7.4).   
 
   
Figure 6.21 Hypothetical structure of mKlp2C-Ter by segmented homology modelling. A hypothetical 
structure of mKlp2C-Ter was created by homology modelling using SWISS MODELLER (Waterhouse, Rempfer 
et al. 2018),  C-Terminal domain is thought to form a long alpha helix (in green), with a relatively well-defined 
tail domain (in blue), which include the hypothetical zinc finger motif. 
 
As expected from the secondary structure predictions on mKlp2C-Ter, the reunited segments formed a 
long alpha helical segment (Figure 7.4, blue) with tail domain (containing the ring finger) composed of 
β-sheets, alpha helix and extended segments.  
Even though this approach cannot generate a “valid” homology model, it offers an illustration of the 
three-dimensional structure of mKlp2C-Ter. In future studies, the use of RosettaCM (Song, DiMaio et 






In summary, the mKlp2C-Ter protein displayed two separate binding events when titrated with zinc ions 
(section 6.7.2, Figure 6.15). Both reactions were exothermic (ΔH < 0) at room temperature in 50 mM 
Tris-HCl (pH 7.5), 0.1 mM TCEP, 100 mM NaCl, 3 % (v/v) glycerol.  
The first binding event (Figure 6.15) can be defined as a unique site displaying an affinity constant KA 
for zinc ions of 3.482 mM-1, relatively lower (one order of magnitude at best) than other proteins reported 
in previous publications, it is far weaker than some study reported (3 orders of magnitude) on zinc 
binding to zinc finger motifs (Lorick, Jensen et al. 1999, Kluska, Adamczyk et al. 2018).   
The second binding event (with an affinity constant KA equal to 1.540 mM-1) is defined as sequential, 
implying more than one site involved. Although similar sequential binding mechanism has been 
identified for the binding of zinc by metalloregulator BsZur (Ma, Gabriel et al. 2011), the affinity 
parameters such as the KA are still far from previous findings (3 orders of magnitude on average).  
Since the binding of zinc to Histidine is possible (Kluska, Adamczyk et al. 2018), it is likely that the 
His-Tag used for the purification might interfere in the assay. The multitude of Histidine (6 repeats, see 
chapter 6 for the deduced amino acid sequence of mKlp2C-Ter N-Terminal tail) amino acids might as 
well explain the sequential type of scenario. As there is likely no preference for the binding of zinc to 
each histidine in the tag, the resulting binding kinetic should reflect this scenario. In conclusion, the 
removal of the 6xHis-tag would greatly help in confirming the identity of each binding site by potentially 
suppressing one of the two binding events.  
Even though this experiment could not yet fully unveil the mechanism of zinc binding to mKlp2C-Ter, 
their interaction has been confirmed with this assay. The presence of at least two clear binding events 
indicate the zinc finger is likely capable of binding zinc ions. Considering other kinesins have 
demonstrated an ability to recruit ubiquitin ligase (Sako-Kubota, Tanaka et al. 2014), whereas zinc 
finger are known interactor of ubiquitin ligase, it is possible these feature was conserved in mKlp2. In 
parallel, the ability of mKlp2 to bind the mitochondria (Itoh, Fujiwara et al. 2001) might confer the 
kinesin a regulatory role in the degradation of the organelle. Finally, the established interaction between 
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VDAC3 and mKlp1 (Itoh, Fujiwara et al. 2001), the second kinesin-like isoform from A.thaliana, 
indicate the kinesin regulation of mitochondrial fate could be achieved through its interaction with the 
VDAC channel in plant.     
Primarily, further optimization is needed to fully characterize the binding of zinc ions to mKlp2C-Ter. 
Different concentrations of protein in combination with various concentrations of zinc must be screened 
to determine the best parameters and clearly define the binding at low Zn2+ concentrations. Indeed, the 
lack of a clear sigmoidal curve suggests that the early binding of low Zn2+ ions to the protein, is perhaps 
masked by the presence of low traces of divalent ions in solution, leading to a rapid saturation of the 
first mKlp2C-Ter binding site. Although lower concentrations of zinc were tested (from 5 to 50 mM) 
they did not improve the quality of the generated titration curve. Instead, the dilution of the protein by 
a factor of five proved to be the main factor in generating a reasonable amount of data for the first 
binding site. Therefore, a two-dimensional screen must be performed, using different zinc concentration 
and various protein dilutions before attempting further ITC experiments. Finally, the beginning of the 
linear slope of the first binding event was very close to 0, indicating a possible low molar ratio. 
Considering, ring finger domains have the ability to bind one or two zinc ions (Kluska, Adamczyk et al. 
2018), the expected molar ratio would likely be 1:1 or 2:1.   
Another parameter that was not properly assessed in the ITC work, was the saturation point. Incidentally, 
the apparent dissociation of the protein from the zinc ions at the end of the run seems to prevent further 
rounds of injection to be performed. Although dissociation events can be mitigated by restarting the 
titration straight after the end of the first round, results still were affected and not representative of the 
actual stoichiometry. In the end, the ideal scenario would include reaching the saturation point during 
the first round of injection.  
The second issue highlighted here is the propensity of the protein to aggregate, preventing additional 
rounds of injections. Further development is essential to find potential stabilizing agents for mKlp2C-
Ter. Interestingly, the dilution of the protein seemed to greatly help in capturing good data for the first 
binding event. Observations during its production and purification led to the conclusion that high 
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concentrations (above 8 mg/mL) induced significant aggregation of the kinesin-like protein. 
Consequently, a small percentage of aggregates must coexist in equilibrium with the soluble protein, 
even at lower concentration. The great number of cysteines that can be found typically in a zinc finger 
motif could explain this propensity (Lorick, Jensen et al. 1999, Kluska, Adamczyk et al. 2018), since 
the reducing agent TCEP (tris(2-carboxyethylphosphine) is present in the ITC buffer. As the 
concentration of protein decreases during its dilution with the buffer, the ratio between TCEP and 
mKlp2C-Ter increases, thus enabling more cysteines to be reduced and exposed for the zinc ions to 
interact with.  
The removal of the 6xHis-tag might contribute to enhance the overall stability of the protein. 
Experiments conducted during its purification revealed a clarification of the protein solution upon 
digestion of the tag by Thrombin (section 6.6), indicating an aggregation-prone effect of the 6xHis-tag 




7. Conclusion and Future directions 
The main aim of this research was to primarily characterize the Voltage-dependent Anion channel 
AtVDAC1 from Arabidopsis thaliana. Being the most abundant protein in the mitochondrial outer 
membrane as well as playing a key role in the regulation and transport of metabolites and ions across 
the mitochondrial membrane (see Chapter 1), it was important to further understand the basic properties 
of such an indispensable protein. Its direct or indirect involvement in numerous cell processes such as 
the regulation of mitochondrial osmosis or the Krebs cycle, as well as its impact on plant resistance 
(Greenberg 1996), reinforced this need. Furthermore, this work helped to initiate the groundwork for 
future binding studies focusing on AtVDAC1 interaction with cytosolic partners. 
First and foremost, a reproducible and consistent purification pipeline was successfully designed and 
tested on the native AtVDAC1 channel, generating suitable amount of pure protein for downstream 
applications such as SAXS, CD, and BLM. 
The AtVDAC1 channel secondary structure content was then examined using CD and confirmed the 
successful refolding of the Native channel in 0.1 % (v/v) LDAO. The AtVDAC1 channel was mainly 
composed of beta sheet with a small helicity, in accordance with its secondary structure predictions, 
previously published VDAC crystal structures and CD studies on VDAC in detergent. 
Furthermore, AtVDAC1 function as an ion channel was tested in BLM assays. The channel exhibited 
activity in 10 mM Tris-HCl (pH 7.4), 150 mM KCl, 50 mM CaCl2, displaying an open state (S0) 
conductance of 0.54 nS and at least two closed states, named S1 and S2, with respective conductance of 
0.43 nS and 0.31 nS. These conductance values were in accordance with other VDACs at similar salt 
concentration. 
Altogether, these data confirmed the successful purification and primary characterization of in vitro 
refolded AtVDAC1. The close proximity of the structural content and the conductance values to other 
VDACs confirmed the potential of AtVDACs as models for the study of VDAC properties in vitro. 
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Besides, the number of isoforms (4) and their apparent functional differences could broaden our 
understanding of the channel using the aforementioned assays on these isoforms. 
In addition, a fast and relatively efficient mutagenesis method was successfully applied and allowed the 
generation of single point mutant of AtVDAC1. Three mutants, namely D177N, D258N and T156C 
were all purified using the approved methodology tested on the Native AtVDAC1, confirming the 
efficiency of the mutagenesis using the PCR-site directed mutagenesis and of the purification pipeline 
using the HiTrap SP XL ® and the Superose6 Increase®. This methodology will be re-used for the 
generation of additional AtVDAC mutants. 
Following their purification, the Native and mutant AtVDAC1 proteins were all subjected to SAXS, 
revealing a compact and micelle-embedded structure for all proteins. Thus, this experiment successfully 
provided primary three-dimensional structural data on AtVDAC proteins in detergent solutions. 
In parallel, a truncated version of the kinesin-like protein mKlp2, a potential AtVDAC partner, was also 
successfully purified, this time using an 6xHisTag and Ni-Nta affinity chromatography. 
This protein, named mKlp2C-Ter, displayed an ability to bind zinc ions in ITC experiments, and a 
remarkable flexibility in SAXS. The SEC, ITC, and SAXS experiments all suggested this protein is in 
constant equilibrium between its monomeric and oligomeric form. The effect of dilution was also 
monitored, improving greatly the solubilization of the mKlp2C-Ter monomer. 
These data indicate a potential function of mKlp2C-Ter in the ubiquitination pathway through its ring 
finger domain. Considering the restriction of the Native mKlp2 protein to the mitochondria, a 
hypothetical role as mitochondrial (or VDAC) regulator could be unveiled. 
In conclusion, the objectives of this research were mostly achieved, and helped building knowledge and 
a consistent model for future studies on AtVDAC proteins and their interactions with multiple partners. 
Further work has already been undertaken, such as the cloning of the other AtVDAC isoform 2 and 4 
(in progress) as well as additional cytosolic partners such as the N. benthamiana Hexokinase 1. Finally, 
various binding assays such as Far Western Blotting and Dot blotting are already in development and 
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9. Chapter 8 Appendixes 
 
Table 9.1 Sanger sequencing of AtVDAC proteins. DNA sequences (in FASTA format) obtained by Sanger 
sequencing using the T7 forward and reverse primers (see Figure 2.1). Primers used for the mutagenesis of 






























































































































































































600 uL of DMPC (50 mg/mL or 73 mM in 0.1% (v/v) LDAO and 0.1% w/v Octyl glucoside) 
=43.8 umoles 
To mix with 1/2000*43.8=21.9 nmole of AtVDAC1 
[SECAtVDAC1Hitrap5mL oligo] =2.35 mg/mL= 7.885 10-5 M 
So VAtVDAC1 = 21.9 10-9 / 7.885 10-5 = 2.77*10-4 L = 277 µL 
STEP B: 
-1 mL of washed biobeads=75 mg 
-DMPC (50 mg/mL or 73 mM in 0.1 % (v/v) LDAO and 0.1% w/v OG) 
So 100 µL corresponds to 1 mg/mL*100 µL= 100 µg of OG and 100 µL*0.996 µg/L = 99.6 µg 
So Total amount of detergent= 200 µg 
So wbeads/wdetergent= 75/0.2= 375 (>100) 
End: 877 µL of DMPC+protein+detergent 
WOG = 600 µL*1 mg/mL= 600 µg of OG 
WLDAO = 600 µL*1 mg/mL (lipids) + 200 µL*1.15 mg/mL (protein in SEC buffer) 
WLDAO = 600 + 230 = 830 µg 
WDetergent = 830 + 600 = 1.43 mg 
STEP C: Mix 877 µL lipids+refolded protein solution with 20 mL of lipid-presaturated biobeads: 
-20 mL of lipid-presaturated biobeads = 150 mg 
324 
 
- WDetergent = 1.43 mg (lipids+protein solution) + 200 µg*2 (biobeads) = 1.83 mg of detergent 
So wbeads/wdetergent= 150/1.83 = 82 
Or wbeads/wdetergent protein+lipid only = 150/1.43 
 
 
Isoform AtVDAC1 AtVDAC2 AtVDAC4 
Docking model 1 2 1 2 3 4 1 2 
Amino acids 
involved  
50D 48K 48K 48K 48K 24Q 48K 16K 
74D 50D 50G 50G 254E 27Q 49D 48K 
76T 74D 208E 74D 256E 47N 50D 49D 
97K 97K 254E 97K 258D 48K 72D 50D 
100D 99P 256E 99P 259A 154N 76S 180E 
101Q 100D 258D 101H 260I 156K 102K 203R 
103S 101Q 261D 156K 261D 177D 105K 205S 
105K 103S 262K 254E 262K 180E 124N 206N 
124T 105K 263S 256E 263S 181K 156T 207Y 
156T 124T 265K 258D 265K 205T 177D 208N 
177D 125Q  265K  208E 180E 228R 
180D 149D    228R 203R 230S 
205K 205K    254E 206N 231N 
210D 207S    256E 208N 232S 
230R 210D    258D 234K 256E 
232N 233S    261D 265K 258D 
256E 234A    262K  265K 
258D 256E    263S   
267K 258D    265K   
 259T       







AtVDAC1               
-------------------------MVKGPGLYTEIGKKARDLLYKDHNSDQ-KFSITTF 
hVDAC3a              
--------------------------MCNTPTYCDLGKAAKDVFNKGYGFGMVKIDLKTK 
hVDAC3b              
--------------------------MCNTPTYCDLGKAAKDVFNKGYGFGMVKIDLKTK 
mVDAC1               
--------------------------MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTK 
XmVDAC1              
--------------MRGSHHHHHHGSMAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTK 
hVDAC1               
--------------------------MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTK 
hVDAC1micelles       
--------------------------MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTK 
zfVDAC2              
--------------------------MAVPPAYADLGKSAKDIFNKGYGFGMVKLDVKTK 
MmVDAC2              
MAECC--------------VPVCPRPMCIPPPYADLGKAARDIFNKGFGFGLVKLDVKTK 
hVDAC2a             
MSWCNELRLPALKQHSIGRGLESHITMCIPPSYADLGKAARDIFNKGFGFGLVKLDVKTK 
hVDAC2b              
---------------MATHGQTCARPMCIPPSYADLGKAARDIFNKGFGFGLVKLDVKTK 
hVDAC2c              
------------------------------------------------------MLVIPA 
AtVDAC4              
-------------------------MGSSPAPFADIGKKAKDLLNKDYIFDH-KFTLTML 
AtVDAC2              
-------------------------MSKGPGLFTDIGKKAKDLLTRDYNSDQ-KFSISTY 
                                    : :    
AtVDAC1               
SPAGV-AITSTGTKKGD--LLLGDVAFQSRRKN--ITTDLKVCTDSTFLITATVDEAA-P 
hVDAC3a              
SCSGV-EFSTSGHAYTDTGKASGNLETKYKVCNYGLTFTQKWNTDNTLGTEISWENKLAE 
hVDAC3b             
SCSGVMEFSTSGHAYTDTGKASGNLETKYKVCNYGLTFTQKWNTDNTLGTEISWENKLAE 
mVDAC1               
SENGL-EFTSSGSANTETTKVNGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLAR 
XmVDAC1              
SENGL-EFTSSGSANTETTKVNGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLAR 
hVDAC1               
SENGL-EFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLAR 
hVDAC1micelles       
SENGL-EFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLAR 
zfVDAC2              
SASGV-EFKTSGSSNTDTSKVVGSLETKYKRSEYGLTFTEKWNTDNTLGTEINIEDQIAK 
MmVDAC2              
SCSGV-EFSTSGSSNTDTGKVSGTLETKYKWCEYGLTFTEKWNTDNTLGTEIAIEDQICQ 
hVDAC2a              
SCSGV-EFSTSGSSNTDTGKVTGTLETKYKWCEYGLTFTEKWNTDNTLGTEIAIEDQICQ 
hVDAC2b              
SCSGV-EFSTSGSSNTDTGKVTGTLETKYKWCEYGLTFTEKWNTDNTLGTEIAIEDQICQ 
hVDAC2c              
TQEAE-EFSTSGSSNTDTGKVTGTLETKYKWCEYGLTFTEKWNTDNTLGTEIAIEDQICQ 
AtVDAC4              
SATGT-EFVATGLKKDD--FFFGDISTLYKGQN--TIVDLKIDSHSSVSTKVTLKNLL-P 






    :  .   : ::.          . :    :  :       *  :..:.       :     
AtVDAC1               
GLRSIFSF---KVPDQNSGKVELQYLHEYAGISTSMGLT-QNPTVNFSGVIGSNVLAVGT 
hVDAC3a             
GLKLTLDTIFVPNTGKKSGKLKASYKRDCFSVGSNVDIDFSGPTIYGWAVLAFEGWLAGY 
hVDAC3b             
GLKLTLDTIFVPNTGKKSGKLKASYKRDCFSVGSNVDIDFSGPTIYGWAVLAFEGWLAGY 
mVDAC1              
GLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDVDFDIAGPSIRGALVLGYEGWLAGY 
XmVDAC1             
GLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDVDFDIAGPSIRGALVLGYEGWLAGY 
hVDAC1              
GLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGY 
hVDAC1micelles      
GLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGY 
zfVDAC2             
GLKLTFDTTFSPNTGKKSGKVKTAYKREFVNLGCDVDFDFAGPTIHGAAVVGYEGWLAGY 
MmVDAC2             
GLKLTFDTTFSPNTGKKSGKIKSAYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGY 
hVDAC2a             
GLKLTFDTTFSPNTGKKSGKIKSSYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGY 
hVDAC2b             
GLKLTFDTTFSPNTGKKSGKIKSSYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGY 
hVDAC2c             
GLKLTFDTTFSPNTGKKSGKIKSSYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGY 
AtVDAC4              
SAKAVISF---KIPDHKSGKLDVQYVHPHATLNSSIGLN-PTPLLDLSATIGSQNVCLGG 
AtVDAC2              
STKAIASF---KVPDYNSAKLEVQYFHDHATVTAAAALK-QNPLIDITATLGSPVISFGA 
 . :   .         :..*:.  * :    :     :    * :    ...      *  
AtVDAC1              
DVSFDTKSGNFTKINAGLSFTKEDLIASLTVNDKGDLLNASYYHIVNPLFNTAVGAEVSH 
hVDAC3a              
QMSFDTAKSKLSQNNFALGYKAADFQLHTHVNDGTE-FGGSIYQKVNEKIETSIN--LAW 
hVDAC3b              
QMSFDTAKSKLSQNNFALGYKAADFQLHTHVNDGTE-FGGSIYQKVNEKIETSIN--LAW 
mVDAC1               
QMNFETSKSRVTQSNFAVGYKTDEFQLHTNVNDGTE-FGGSIYQKVNKKLETAVN--LAW 
XmVDAC1              
QMNFETSKSRVTQSNFAVGYKTDEFQLHTNVNDGTE-FGGSIYQKVNKKLETAVN--LAW 
hVDAC1               
QMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTE-FGGSIYQKVNKKLETAVN--LAW 
hVDAC1micelles       
QMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTE-FGGSIYQKVNKKLETAVN--LAW 
zfVDAC2              
QMSFDTAKSKMTQNNFAVGYKTGDFQLHTNVNDGSE-FGGSIYQKVSDKLETAVN--LAW 
MmVDAC2              
QMTFDSAKSKLTRSNFAVGYRTGDFQLHTNVNNGTE-FGGSIYQKVCEDFDTSVN--LAW 
hVDAC2a              
QMTFDSAKSKLTRNNFAVGYRTGDFQLHTNVNDGTE-FGGSIYQKVCEDLDTSVN--LAW 
hVDAC2b              
QMTFDSAKSKLTRNNFAVGYRTGDFQLHTNVNDGTE-FGGSIYQKVCEDLDTSVN--LAW 
hVDAC2c              
QMTFDSAKSKLTRNNFAVGYRTGDFQLHTNVNDGTE-FGGSIYQKVCEDLDTSVN--LAW 
AtVDAC4              
EVSFDTASSSLTKYNAGIGFNNQGVSAALILEDKGESLRATYVHTVNPT--TSFGAELIR 
AtVDAC2             
EAGYDTTSKTFTKYNAGISVTKPDACLSIILGDKGDSLKASYLHHFDEFKRTAAVGEVYR 







AtVDAC1              
KLSSKDSTITVGTQHSLDPLTSVKARVNSAGIASALIQHEWKPKSFFTISGEVDTKSIDK 
hVDAC3a             
TAGSNNTRFGIAAKYMLDCRTSLSAKVNNASLIGLGYTQTLRPGVKLTLSALIDGKNFSA 
hVDAC3b             
TAGSNNTRFGIAAKYMLDCRTSLSAKVNNASLIGLGYTQTLRPGVKLTLSALIDGKNFSA 
mVDAC1              
TAGNSNTRFGIAAKYQVDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNA 
XmVDAC1             
TAGNSNTRFGIAAKYQVDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNA 
hVDAC1              
TAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNA 
hVDAC1micelles      
TAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNA 
zfVDAC2             
TAGSNSTRFGIAAKYQLDKDASISAKVNNTSLVGVGYTQSLRPGIKLTLSALVDGKSINS 
MmVDAC2             
TSGTNCTRFGIAAKYQLDPTASISAKVNNSSLIGVGYTQTLRPGVKLTLSALVDGKSFNA 
hVDAC2a             
TSGTNCTRFGIAAKYQLDPTASISAKVNNSSLIGVGYTQTLRPGVKLTLSALVDGKSINA 
hVDAC2b             
TSGTNCTRFGIAAKYQLDPTASISAKVNNSSLIGVGYTQTLRPGVKLTLSALVDGKSINA 
hVDAC2c             
TSGTNCTRFGIAAKYQLDPTASISAKVNNSSLIGVGYTQTLRPGVKLTLSALVDGKSINA 
AtVDAC4             
RFSNYNNSFTVGSSHSVDQFTVVKTRFSNSGKAGMVVQREWRPKSHITFSAEYDSKAVTS 
AtVDAC2             
KFSTNENTITVGGLYAIDHSTAVKAKLNNHGTLGALLQHEVLPRSLVTVSSEIDTKALEK 
  ..  . : :.  : :*  : ..::... .  .    :   *   .*.*.  * * .   
AtVDAC1             -SAKVGLALALKP-------- 
hVDAC3a             GGHKVGLGFELEA-------- 
hVDAC3b             GGHKVGLGFELEA-------- 
mVDAC1              GGHKLGLGLEFQA-------- 
XmVDAC1             GGHKLGLGLEFQA-------- 
hVDAC1              GGHKLGLGLEFQA-------- 
hVDAC1micelles      GGHKLGLGLEFQALEHHHHHH 
zfVDAC2             GGHKLGLGLELEAHHHHHH-- 
MmVDAC2             GGHKLGLALELEA-------- 
hVDAC2a             GGHKVGLALELEA-------- 
hVDAC2b             GGHKVGLALELEA-------- 
hVDAC2c             GGHKVGLALELEA-------- 
AtVDAC4             -SPKLGLALALKP-------- 
AtVDAC2             -HPRFGLSLALKP-------- 
                       :.**.: ::       
Figure 9.1 Multiple sequence alignment os VDAC orthologues. Sequence alignment of VDAC ORFs (open 
reading frames) from human (hVDAC1, 2 and 3), mouse (mVDAC1, MmVDAC2 and its crystallized form 
XmVDAC1) and zebrafish (zfVDAC2).  Amino acids used for mutagenesis are indicated in bold colours: T156C 
in light blue, D177N in orange and D258N in red. The position of amino acids in AtVDAC1 protein is taken as a 











Figure 9.2 Thin layer Chromatography (TLC) experiments on AtVDAC1 samples. 1 to 5 µL of purified 
AtVDAC1 oligomer fractions (AtVDAC1 oligomer, 1 to 5) or monomer fractions (AtVDAC1 monomer), 1 to 5 
were loaded and analysed by TLC using a TLC solvent (63: 35: 5, v/v/v chloroform: methanol: ammonium 


















Figure 9.3 Secondary structure prediction of mKlp2C-Ter. Simplified secondary structure prediction of the 
His-Tag-less mKlp2C-Ter using Jpred webserver [57]. The amino acids involved in the formation of a hypothetical 
alpha helix are highlighted by red “H”. Extended regions are highlighted by a yellow “E”.  
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Figure 9.4 HT Voltage of AtVDAC1 oligomer and monomer fraction at various temperature. HT (High 
tension) Voltage curves of AtVDAC1 monomer (A) and oligomer (B) fractions during CD experiments. 





𝑐 × 𝑙 × 32980
 
Equation 9.1 Relationship between Theta (θ) et delta epsilon (Δε). MRW is the mean residual weight of the 
protein (molecular weight divided by the total number of amino acids), c is the concentration of the sample (in 















































θobs × 100 × MW
𝑐 × 𝑙 × 𝑛
 
Equation 9.2 Relationship between Theta (θ) et delta epsilon (Δε). Θobs is the observed ellipticity in degrees, 
MW is the molecular weight of the protein, c is the concentration of the sample (in mg/mL), l is the path length 
(in cm) and n is the number of amino acids. 
 
 
Table 9.2 Dichroweb CD analysis. Raw data obtained during the analysis of different samples using Dichroweb 
webserver, using either CONTINLL and CDSSTR algorithms and SMP180 database (optimized for 190 nm to 
240 nm). The analysis was not successful for mVDAC1 3EMN using CDSSTR and any database. The analysis 
was performed with the most recent version of the database (2019), thus can differ slightly from the original data 
for this study (performed in 2015).   
Sample Algorithm Helix Strand Turns Unordered Total 
AtVDAC1 oligo 
CONTINLL 0.061 0.352 0.188 0.399 1 
CDSSTR 0.41 0.14 0.13 0.30 0.98 
AtVDAC1 mono 
CONTINLL 0.107 0.281 0.156 0.456 1 
CDSSTR 0.34 0.13 0.16 0.36 0.99 
mVDAC1 3EMN 
CONTINLL 0.048 0.441 0.110 0.400 0.999 
CDSSTR      
AtVDACs (predicted) 
CONTINLL 0.048 0.441 0.111 0.400 1 
CDSSTR 0.01 0.45 0.07 0.46 0.99 
 
